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Cplx TKO neurons expressing EGFP, Cplx3-WT, Cplx3-K79A/Y80A and 
Cplx3-C155S proteins 
Figure 30 (A.) Evoked EPSC amplitudes in autaptic hippocampal Cplx TKO neurons 
expressing EGFP, Cplx4-WT, Cplx4-K80A/Y81A and Cplx4-C157S proteins 
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Figure 30 (B.) Synchronous release in autaptic hippocampal Cplx TKO neurons 
expressing EGFP, Cplx4-WT, Cplx4-K80A/Y81A and Cplx4-C157S proteins 
Figure 30 (C. and D.) RRP size and vesicular release probability in Cplx TKO neurons 
expressing EGFP, EGFP, Cplx4-WT, Cplx4-K80A/Y81A and Cplx4-C157S 
proteins 
Figure 30 (E. and F.) Short-term plasticity in autaptic hippocampal Cplx TKO neurons 
expressing EGFP, Cplx4-WT, Cplx4-K80A/Y81A and Cplx4-C157S proteins 
Figure 30 (G. and H.) Spontaneous neurotransmitter release (mEPSC) in autaptic hippocampal 
Cplx TKO neurons expressing EGFP, Cplx4-WT, Cplx4-K80A/Y81A and 
Cplx4-C157S 
Figure 31 (A. B. C.) Recombinant His6-tagged Cplx proteins 
Figure 32 (A. and B.) Quantification of endogenous and lentiviral Cplx1 protein expression 
Figure 33 (A. and B.) Quantification of endogenous and lentiviral Cplx2 protein expression 
Figure 34 (A.) Estimation of endogenous Cplx3 protein expression 
Figure 34 (B. and C.) Quantification of lentiviral Cplx3-WT protein expression 
Figure 35 (A. and B.) Quantification of lentiviral Cplx4 protein expression 
































Neurotransmitter release is a synergistic multistep process occurring at synapses in the brain. 
Synaptic vesicles containing neurotransmitters tether to the presynaptic active zones, upon 
which, they are docked and primed to fusion competence by a number of proteins. When an 
action potential arrives at the terminal, a concomitant rise in the intracellular Ca2+ concentration 
causes the vesicles to fuse to the presynaptic membrane and release their contents into the 
synaptic cleft. This process of neuronal excitation-secretion is tightly coupled and mediated by 
cascades of protein-protein interactions. The native SNAREs Syntaxin-1, SNAP-25 and 
Synaptobrevin-2 form a core complex that effectively facilitates the vesicle docking-priming-
fusion process. Two proteins namely Complexins and SNAP-29 that have been shown to interact 
with the native SNAREs or their paralogs are detailed in the present study.  
 
The SNAP-29 protein belongs to the SNAP-25 family and is believed to be a golgi interacting 
SNARE. It shares only 17% sequence identity with SNAP-25 due to substantial variations in its 
structure. SNAP-29 was previously shown to interact with multiple Syntaxins localized on 
various subcellular organelles and was claimed to negatively modulate synaptic transmission in 
neurons by preventing SNARE disassembly. In the present study, it is proved that conditional loss 
of SNAP-29 from the forebrain glutamatergic neurons as well as constitutive loss of SNAP-29 in 
mice did not cause any deficits in transmitter release at glutamatergic or GABAergic synapses. 
Although constitutive knockout of SNAP-29 in animals caused perinatal lethality, the normal 
functioning of glutamatergic and GABAergic synapses in the brain could not account for such a 
dramatic effect. Rather, the lethality seen in these mice was likely due to perturbations in other 
secretory pathways.  
 
The Complexin family comprises of four proteins - Cplx1, Cplx2 are expressed in the brain, while 
Cplx3 and Cplx4 are prominently expressed in the retina. Previously, it was shown that loss of 
Cplx1, 2 and 3 in hippocampal neurons (TKO) caused profound deficits in the vesicular release 
probability and synchronicity of transmitter release. In the present study, this claim was 
confirmed and also shown that the reintroduction of each of the four wild type Complexins in the 
TKO via lentiviruses could facilitate synchronous neurotransmission, to variable extents. The 
strong binding of Cplx1 and Cplx2 to the SNARE complex corroborated their higher efficacy to 
mediate synchronous transmitter release. In case of Cplx3 and Cplx4, although hardly any 
binding to the SNARE complex was detectable, they could facilitate transmitter release only if 
their SNARE binding domain was intact and when targeted to membranes due to their C-terminal 
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CAAX farnesylation. These results prove that all mammalian Complexins are indeed facilitators of 
synchronous synaptic transmission, and exert their function via SNARE complex binding and 








































1.  Introduction 
 
1.1.  Neuronal Communication  
 
The intricate architecture of the mammalian brain highlights the complexity of evolution. The 
brain is the prime functional organ of the nervous system comprising numerous neurons 
organized in composite networks across the various brain regions. Neurons are the discrete 
cellular elements of the nervous system and responsible for varied yet precise signaling. The 
morphology of a typical neuron includes a cell body or soma - for metabolic activities, axons - for 
conveying electrical impulses over long distances, and dendrites - for receiving and transmitting 
signals. Neuronal communication occurs via transmission of both chemical and electrical signals 
at specialized contact zones called synapses. Synapse formation occurs when the axonal growth 
cone of one neuron contacts a certain site on another neuron. The nascent synaptic contact so 
established between two neurons comprises an axonal presynaptic compartment that is 
separated from the postsynaptic region of the target neuron by a few nanometers of space called 
- the synaptic cleft.  
 
Intrinsically, many proteins are recruited to the presynaptic and postsynaptic sites for the 
formation, maturation and maintenance of the synapse for efficient neurotransmitter release. 
Key proteins such as Neuroligins, Neurexins, and other adhesion proteins trigger synaptic 
development (reviewed by Brose, 2009; Krueger et al., 2012; Brose 2013). Multi-domain 
scaffolding proteins aid in local trafficking of various types of receptors on the postsynaptic 
membrane (Kim and Sheng, 2004). The PDZ proteins PSD-95 and SAP-102 are essential for 
trafficking of glutamate sensing AMPA receptors and NMDA receptors at mature synapses and 
during synapse development respectively (Elias et al., 2006; Elias et al., 2008). Large clusters of 
the scaffolding protein Gephyrin anchor receptors for neurotransmitters glycine and GABAA on 
the postsynaptic membrane (Kirsch et al., 1993; Craig et al., 1996), while GluR6a mediates 
surface expression of the ionotropic kainate receptors, independent of PDZ domain interactions 
(Jaskolski et al., 2004). 
                                                          
1.2.   Physiology of synaptic neurotransmitter release 
 
1.2.1.   Action potential evoked transmitter release 
 
Synaptic networks closely resemble electrical circuits and neurons are subject to polarization 
effects due to substantial changes in transmembrane voltages. At chemical synapses, the 
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neurotransmitters are released from the synaptic vesicles at the presynaptic terminal into the 
synaptic cleft and, they bind to receptors on the postsynaptic membrane. This process is coupled 
to an action potential mediated opening or closure of ion channels and consequent flow of post-
synaptic current. An action potential (AP) is an event of short duration that occurs when the 
electrical membrane potential of a neuron rapidly changes. When the action potential arrives at a 
presynaptic site, it causes the opening of voltage gated Ca2+-channels, and Ca2+-influx, which 
triggers the fusion of transmitter filled synaptic vesicles. 
 
Electrophysiology-based studies on neurons best describe the postsynaptic currents elicited at 
excitatory and inhibitory synapses – EPSCs and IPSCs. At excitatory synapses, the 
neurotransmitter glutamate is released into the synaptic cleft, and it binds the ionotropic 
AMPA/Kainate receptors on the postsynaptic membrane allowing permeation of mainly Na+ ions 
through ligand-gated ion channels into the post-synaptic cell. This ion influx results in 
depolarization of the post-synaptic membrane, which is about -70 mV at rest. However, at 
inhibitory synapses, the binding of GABA to the GABAA receptors or glycine to glycinergic 
receptors causes receptor activation and increased permeability of Cl- ions into the cell that 
hyperpolarizes the membrane. Application of competitive receptor antagonists, such as CNQX 
and bicuculine, completely and reversibly blocks the EPSCs and IPSCs, respectively 
(Schneggenburger et al., 1992; Wilcox et al., 1994). 
 
 1.A.     1.B. 
                             EPSC                    IPSC 
                   
Figure 1 (A) Excitatory post-synaptic current (EPSC) and (B) Inhibitory post-
synaptic current (IPSC). The EPSCs decay with a lower time constant 
compared with IPSCs. The post-synaptic current is represented by the two 
distinct kinetics phases – a fast synchronous phase and a slow 
asynchronous phase of release.  
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The post-synaptic currents at central synapses are biphasic in nature, due to two kinetically 
distinct components of transmitter release - a fast synchronous component that decays rapidly 
with a time constant of 5-10 ms and a slow asynchronous component with an exponential decay 
of 100-200 ms (Goda and Stevens, 1994). The synchronous component of the postsynaptic 
response is tightly coupled to arrival of an action potential and researchers believe that a low 
affinity primary Ca2+ sensor promotes synchronous release when intraterminal Ca2+ 
concentration is enhanced within a few hundred microseconds after the stimulus. On the other 
hand, a high affinity Ca2+ sensor is believed to sustain the asynchronous phase of release that 
occurs during the clearance of residual Ca2+ from the terminal (Goda and Stevens, 1994; Sabatini 
and Regehr, 1996).  
 
1.2.2.   Spontaneous synaptic transmitter release 
 
Rate of secretion of acetylcholine in the absence of impulse propagation was first studied using 
Tetrodotoxin (TTX) that blocks electrical excitation by preventing Na+ entry through depolarized 
membrane (Katz and Miledi, 1967). Spontaneous miniature end-plate potentials of normal 
frequency and amplitude were first recorded from paralyzed Sartorius muscles of frogs by 
application of TTX (Katz and Miledi, 1967). This technique has been used to study 
neurotransmitter release at central synapses in the absence of a depolarizing stimulus. 
Spontaneous transmitter release at synapses can be measured as miniature currents that occur 
in the absence of an action potential. This form of neurotransmitter release, also known as 
quantal release, occurs at both excitatory and inhibitory synaptic terminals, due to spontaneous 
fusion of synaptic vesicles with the presynaptic plasma membrane.  
 
                                   
 
Figure 2. Spontaneous release. Spontaneously occurring miniature quantal 
release events (mEPSCs and mIPSCs) in the absence of depolarizing 
stimuli (application of 300 nM Tetrodotoxin blocks action potentials). 
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1.3.   Core molecular machinery of synaptic vesicle release 
 
Neurotransmitter release is a synergistic multistep process transpiring with high temporal and 
spatial precision at the presynaptic terminal of a neuron. The process of transmitter release is 
classified into distinctive stages: transmitter uptake by synaptic vesicles, tethering of vesicles to 
presynaptic membrane, priming vesicles to fusion competence, Ca2+ influx causing synaptic 
vesicle exocytosis, and vesicle recycling.  
 
                         
Figure 3.  Schematic representation of synaptic vesicle  
exocytosis. Synaptic vesicles take up neurotransmitters and tether to the 
active zone on the presynaptic plasma membrane, after which they are 
morphologically docked and functionally primed to fusion competence by 
a number of proteins. The vesicles fuse to the presynaptic membrane 
upon the arrival of an action potential and a concomitant rise in the 
intracellular Ca2+ concentration, and release their neurotransmitter 
content into the synaptic cleft. The fused vesicles are retrieved via 
clathrin-mediated endocytosis and are recycled for the next round of 
exocytosis. (Adapted and modified from Jahn and Fasshauer, 2012). 
 
1.3.1.  Synaptic vesicles 
 
Synaptic vesicles are spherical secretory organelles about 40 nm in diameter, found at the 
presynapse. They take up neurotransmitters with the help of vesicular transporter proteins in a 
proton-pump driven fashion. Hydrolysis of ATP in the cell causes translocation of protons onto 
the vesicular lumen, generating a potential/pH gradient that aids the transporter proteins to 
move the neurotransmitter molecules into the vesicle (reviewed by Bennett and Scheller, 1994). 
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The proteins that have been identified to aid in transport of neurotransmitters are specific to the 
type of neurotransmitter and its respective synapse. Vesicular glutamate transporters (VGLUTs) 
are required for loading synaptic vesicles with glutamate whereas the vesicular inhibitory amino 
acid transporter (VIAAT) acts as a shared vesicular carrier for the uptake and release of both 
GABA and glycine (Wojcik et al., 2004; Wojcik et al., 2006).  
 
Synaptic vesicles go through two essential steps mediated by SNAREs and SNARE regulatory 
proteins in order to release neurotransmitters - 1. Docking to the presynaptic membrane and 
priming to a release-ready state, and 2. Ca2+-mediated vesicle fusion. 
 
1.3.2.  Formation of the SNARE core complex 
 
Fusion of synaptic vesicles to the presynaptic plasma membrane requires the concerted action of 
various structurally and functionally unique presynaptic proteins at distinct steps. Three main 
proteins namely Synaptobrevin-2, Syntaxins and SNAP-25 are the core components of the 
membrane fusion apparatus at most brain synapses. They constitute the SNARE (SNAP receptor) 
complex - a receptor site for interaction of the soluble NSF attachment proteins (SNAP), and have 
a high degree of vesicle and target membrane specificity. The SNARE complex was first purified 
from a crude bovine brain detergent extract based on its ability to form the multisubunit 20S 
particle with recombinant NSF and SNAPs (Söllner et al., 1993a). Syntaxins and SNAP-25 localize 
to the plasma membrane and are termed t-SNAREs, whereas Synaptobrevin-2 (also known as 
VAMP) is partially cytoplasmic, but inserted into synaptic vesicles via its C-terminus (Söllner et 
al., 1993b). Synaptobrevin, Syntaxin and SNAP-25 form a stable ternary complex with a 1:1:1 
stoichiometry (Fasshauer et al., 1997). Such association of the SNAREs is thought to represent 
the minimal fusion machinery, and to drive the vesicle fusion reaction. Indeed, proteoliposomes 
reconstituted with the cognate SNAREs spontaneously fuse upon SNARE complex assembly 
(Weber et al., 1998). 
 
In-vivo, it is believed that the close proximity of the synaptic vesicles to the target plasma 
membrane allows the formation of a thermodynamically stable SNARE complex. Circular 
dichroism spectroscopy and crystallography have well described the structural nature of the 
SNARE complex. The α-helical content is enriched as the C-terminal H3 domain of Syntaxin-1A 
binds to the cytoplasmic domain of Synaptobrevin and the truncated N- and C-terminal 
fragments of SNAP-25B (Fasshauer et al., 1998a). The crystal structure of the SNARE complex 
resolved at 2.4 Å showed that the heterotrimeric components are arranged in a parallel 
orientation comprising of α-helical interactions between Syntaxin, Synaptobrevin and the C-
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terminal helices of SNAP-25 (Sutton et al., 1998). The ionic layer 0 at the centre of the assembled 
SNARE complex is comprised of an arginine (R) residue contributed by Synaptobrevin (R-
SNARE), and glutamine (Q) residue contributed by Syntaxin (Qa-SNARE), N-terminal SNAP-25 
(Qb-SNARE) and C-terminal SNAP-25 (Qc-SNARE) (Fasshauer et al., 1998b). Researchers believe 
that the Q-SNAREs partially assemble into a Qabc acceptor scaffold, which initiates stable SNARE 
binding and nucleates the zippering of the trans-SNARE four-helical bundle from its membrane-
distal (N-terminus) towards the membrane-proximal (C-terminus) end. This process is tightly 
coupled to vesicle fusion and the mechanical force exerted during SNARE assembly is believed to 
be sufficient to overcome the steric repulsions and energy barriers of the associating 
membranes, thus allowing them to fuse (reviewed by Jahn and Scheller, 2006).  
 
1.4.  Molecular regulators of vesicle docking, priming and fusion 
 
The process of synaptic vesicle exocytosis proceeds in distinctive steps, each mediated by 
multiple proteins.  
                                         
 
Figure 4.  Protein interactions at the active zone governing  
synaptic vesicle exocytosis. The v-SNARE Synaptobrevin-2 is anchored 
on the synaptic vesicle membrane, while the t-SNAREs Syntaxin-1 and 
SNAP-25 are anchored in the presynaptic plasma membrane. Together 
they form the four-helical bundle. Additional proteins such as Munc18, 
Munc13s and RIM contribute to vesicle docking and priming to fusion 
competence. Complexin binds to the preassembled SNARE complex at a 
late step and helps facilitate Ca2+-driven vesicle fusion. (Adapted from 





1.4.1.   Docking factors  
 
The synaptic vesicles attach at specialized areas on the presynaptic membrane - also known, as 
active zones in a process termed docking. Some SNARE and SNARE associated proteins have 
been implicated to play a significant role in docking of vesicles in neurons and neuroendocrine 
cells. Docking is observable as a morphological recruitment process of vesicles at synapses; 
hence, it has extensively been studied by analyzing the ultrastructure of presynaptic terminals in 
either chemically fixed or high-pressure frozen samples using electron tomography - the latter 
technique being preferable, as it appears to cause minimal sample perturbation and artifacts. 
Docked vesicles are measured at a distance of roughly 40 nm or closer to the presynaptic 
membrane.  
 
Munc18-1 is a member of the conserved SM family of proteins involved in membrane fusion 
reactions, from lower eukaryotes such as S. cerevisiae and C. elegans to higher mammals. 
Ultrastructure analysis by solvent fixation of adrenal glands from Munc18-1 null mutant mice 
revealed a dramatic reduction in the number of secretory large dense core vesicles attached to 
the plasma membrane of chromaffin cells, implying a deficit in vesicle docking that was rescued 
by over-expression of Munc18-1 (Voets et al., 2001). Another striking difference observed in the 
Munc18-1 null mutants compared to control animals was a ~2 fold reduction in the cellular 
expression levels of the Syntaxin-1AB protein.  
 
Correspondingly, BoNT/C-mediated proteolysis of Syntaxin produced an exact phenocopy of the 
Munc18-1 mutant docking phenotype in chromaffin cells but not at neuronal synapses 
confirming that Syntaxin-1-Munc18-1 dimer forms a docking platform for neurosecretory 
vesicles (de Wit et al., 2006). In C. elegans, the protein Unc13 could open the closed conformation 
of wild-type Syntaxin and prevent the cis-interaction of Syntaxin-1 N-terminal Habc domain and 
the SNARE complex (Hammerlund et al., 2007). The Unc13-deficient mutants exhibited 
pronounced docking deficit in ACh and GABAergic motor neuronal synapses analyzed by high-
pressure freezing, which was eliminated only by over-expression of open Syntaxin and not its 
wild-type variant (Hammerlund et al., 2007). In mice, deletions of the homologous SNAREs 
Syntaxin-1, SNAP-25 and Synaptobrevin-2 caused a partial reduction in the number of 
membrane tethered synaptic vesicles in the respective mutant embryonic hippocampal slices, 
implying that these proteins are essential for morphological docking of vesicles on the 




1.4.2.   Priming of synaptic vesicles - The RRP 
 
Early studies delineated docking and priming to be intrinsically distinct processes essential for 
vesicle mobilization and fusogenicity, occurring in a sequential fashion. Vesicles in close 
apposition (<40 nm) to the plasma membrane have typically been considered morphologically 
docked (Imig et al., 2014). Molecular factors such as phosphoinositides, ATP-dependent NSF 
activity and protein kinases were thought to be essential in rendering the docked vesicles fusion 
competent in PC12 and neuroendocrine cells  (reviewed by Klenchin and Martin, 2000). Many 
studies have now proven that SNARE regulatory proteins such as Munc13s, and CAPS are 
indispensable ‘priming factors’ that maintain a readily releasable pool (RRP) of vesicles at 
synapses.  
 
The RRP of vesicles ready for release can be depleted and replenished rapidly at a synapse. 
Superfusion of dendrites with a hyperkalemic solution caused an initial increase in the quantal 
release rate followed by an exponential decline - this form of synaptic release was estimated to 
correspond to the depletion of the vesicle pool and subsequent refilling (Stevens and Tsujimoto, 
1995). Later, a hypertonic solution was employed to study the kinetics of the transient exocytotic 
burst. Tonicity of the solution is a crucial determinant of the quantal release rate as high 
osmolarity of a solution could prevent the synaptic depolarization induced by the hyperkalemic 
solution. A hypertonic solution such as 500 mOsm Sucrose effectively depletes all the readily 
releasable vesicle pool independent of Ca2+ influx at the synapse and also clearly delineates the 
refilling quanta (Rosenmund and Stevens, 1996).  
 
                                              
Figure 5. Readily releasable pool (RRP) of synaptic vesicles. The readily 
releasable quanta at the presynaptic terminal can be completely depleted 
by application of a hypertonic solution of 500 mM Sucrose. The charge of 
the transient component depicts all the vesicles that are released and the 
sustained component indicates the refilling quanta. 
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However, another method for depletion of the RRP is to stimulate the synapse at high 
frequencies. High-frequency stimulation of synapses depletes the RRP, which causes a 
depression of the PSC amplitudes (Dobrunz and Stevens, 1997). A synapse is considered to be 
plastic when the synaptic strength dynamically varies on distinctive time scales due to prolonged 
activity. Short-term synaptic plasticity refers to variations in synaptic output over a time span of 
a few milliseconds to a few minutes.  
 
Depression of a synapse refers to the progressive decline in the amplitudes of evoked responses 
elicited by repetitive high-frequency stimuli (Zucker, 1989). A fast-depressing synapse is 
typically thought to indicate a high vesicular release probability. Presynaptic Ca2+ influx was 
found to have a positive effect on the release probability of a synapse - a high external Ca2+ 
concentration accelerated vesicle depletion and consequent depression synaptic currents 
(Dittman and Regehr, 1998). However, synaptic depression may also occur due to reduced 
quantal size as well as the quantal content (Scheuss et al., 2002). It was also shown that cross-
linking of surface GluR2-AMPA receptors increased paired pulse depression, which was thought 
to occur as a result of presynaptic glutamate release and consequent desensitization of the 
agonist bound AMPA receptors (Heine et al., 2008). Contrary to depression, high frequency 
stimulation may also result in prominent enhancement of synaptic responses. Synaptic 
facilitation is clearly observable with pairs of stimuli, wherein the amplitude of the latter post-
synaptic current is larger compared to the former. Repetitive pairs of stimulations can also cause 
buildup and decay of synaptic facilitation within a few milliseconds at synapses with a low initial 
release probability (reviewed by Zucker and Regehr, 2002). 
 
  6.A.         6.B. 
        
Figure 6. Short-term synaptic plasticity. (A) Depression of EPSC amplitudes 
observed under stimulation at high frequency of 10 Hz, indicative of high 
vesicular release probability. (B) Initial facilitation of the EPSC amplitudes 
(2nd EPSC > 1st EPSC) a high frequency stimulation of 10 Hz, typically 
observed in neurons with low vesicular release probability. 
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Another form of synaptic enhancement that persists on a time scale of a few seconds is 
augmentation. It occurs owing to slow clearance of residual Ca2+ accumulating in the synaptic 
terminal after repetitive high frequency stimulation. Initially, augmentation was believed to 
reflect a transient increase in the overall size of the readily releasable vesicle pool. Patch-clamp 
studies on solitary hippocampal neurons revealed that a moderate reduction in the relative 
vesicle pool size, but a huge increase in the size of an action-potential induced synaptic current 
implying a surge in the average quantity of neurotransmitter released at augmented synapses 
(Stevens and Wesseling, 1999). Later, it was shown that increased rate of Ca2+-dependent 
priming (increase in RRP) causes augmentation (Junge et al., 2004).  
 




The mammalian Munc13 proteins were first discovered to have a high degree of amino acid 
sequence homology to the Unc13 family in C. elegans (Brose et al., 1995). Three isoforms have 
been identified in the brain, namely Munc13-1, two splice variants of Munc13-2 - the 
ubiquitously expressed ubMunc13-2 and the brain-specific bMunc13-2, and Munc13-3, each of 
which have conserved C1 and C2 (C2B and C2C) domains, Ca2+-Calmodulin binding motifs within 
an amphipathic helix comprised of basic, hydrophobic residues, and a large MUN domain 
(Augustin et al., 1999a; Augustin et al., 1999b, Betz et al., 2001; Junge et al., 2004).  
 
Presynaptic expression of both Munc13-1 and Munc13-2 is crucial for glutamatergic synaptic 
vesicle maturation to fusion competence and release (Varoqueaux et al., 2002). Munc13-1 and 
Munc13-2 dependent synapses exhibit variability in short-term plasticity - the synapses 
expressing only Munc13-1 depress rapidly but those devoid of Munc13-1 but expressing 
Munc13-2 show a marked augmentation that is attributed to increases in intracellular Ca2+ 
concentration and releasable vesicle pool size (Rosenmund et al., 2002).  
 
Munc13s also distinctively bind β-phorbol esters and diacylglycerol at the C1 domain, which is 
thought to be involved in their regulation by second messengers (Rhee et al., 2002). Inactivation 
of the DAG/β-PE binding site in Munc13-1 due to a point mutation H567K, did not affect basal 
synaptic transmission or the RRP size in neurons (Rhee et al., 2002). However, DAG/β-PE 
induced synaptic potentiation of evoked transmitter release was completely abolished (Rhee et 
al., 2002). Point mutation of the Ca2+-CaM binding motif on Munc13-1 (W464R) and ubMunc13-2 
(W383R) abolishes calmodulin binding and impairs Ca2+-dependent short-term plasticity, but 
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does not affect initial vesicular release probability and Ca2+-independent RRP refilling (Junge et 
al., 2004). Therefore, CaM binding to Munc13s is essential for maintaining a Ca2+-dependent 
priming of synaptic vesicles. The MUN domain of Munc13s is an independently folding domain 
essential for vesicle priming and regulated exocytosis, as well as for opening the Munc18-
Syntaxin closed conformation to facilitate docking (Basu et al., 2005; Ma et al., 2011), while the 
C2B domain of Munc13 is a Ca2+ and phospholipid-binding module that controls Munc13 activity 




Ca2+-dependent activator proteins for secretion, also known as CAPSs form a family of proteins 
with two main isoforms CAPS1 and CAPS2. These proteins share a 79% sequence homology. 
CAPS1 expression is predominant across all brain regions, whereas CAPS2 expression is strong 
only in the cerebellum and the adrenal glands (Speidel et al., 2003). CAPS proteins share limited 
homology with Munc13s due to the presence of the MUN domain in their structure. Therefore, 
the effects of CAPS proteins on exocytosis of synaptic vesicles and secretory vesicles were 
studied to great detail in CAPS-1/2 double knockout mice. With respect to synaptic vesicles in the 
mutant mice, 39% neurons elicited no EPSCs in response to low-frequency stimulations, and 
showed a parallel reduction in the RRP size, and the frequency of miniature EPSCs (Jockusch et 
al., 2007). These results clearly indicated a severe deficit in vesicle priming, and reduced 
transmitter content in vesicles, although the priming deficit could be transiently bypassed by an 
increase in intracellular Ca2+ (Jockusch et al., 2007). Similarly, the RRP size of the large dense 
core vesicles was dramatically reduced in chromaffin cells from CAPS-1/2 mutant mice (Liu et al., 
2008). Also, the sustained component of release, representative of the priming of vesicles during 
stimulation, was virtually absent when measured in the mutant cells (Liu et al., 2008). Thus, 
CAPS proteins play a highly significant role in vesicle priming. 
 
In recent electron microscopy based studies of synaptic vesicle localization in hippocampal 
slices, it has been shown that the number of membrane tethered or docked vesicles are 
dramatically reduced in the absence of Munc13s or CAPS (Siksou et al., 2009; Imig et al., 2014). 
Taken together, the ultrastructural and electrophysiological data affirm that docking and priming 





1.5.   Ca2+-mediated vesicle fusion - role of Cognate SNAREs 
 
1.5.1.  Synaptobrevin-2 
 
Synaptobrevin-2 is the main vesicle associated SNARE isoform expressed in the forebrain. 
Deletion of VAMP2 lowers the rate of synaptic quantal transmitter release by ten-fold compared 
to controls, and completely abolishes the Ca2+-triggered evoked release in the mouse brain 
(Schoch et al., 2001). Sequence insertions to increase the intramolecular distance between the 
SNARE binding motif and transmembrane region of VAMP2 caused a pronounced and length-
dependent reduction of evoked release and the vesicular release probability (Deak et al., 2006), 
alluding to a more preferential role of VAMP2 in catalyzing Ca2+-dependent vesicle fusion via a 
tight molecular link between its complex forming SNARE motif and TMR (Guzman et al., 2010). 
 
1.5.2.  Syntaxin-1 
 
Syntaxin in its open conformation was found essential for vesicle docking in C. elegans 
(Hammerlund et al., 2007). In mice, the closed or open state of Syntaxin, did not dramatically 
affect synaptic vesicle docking but a perpetual open conformation of Syntaxin due to a point 
mutation on one of its splice variant Syntaxin-1B, accelerated spontaneous synaptic vesicle 
fusion, moderately reduced the RRP and significantly enhanced short-term depression leading to 
fulminant epileptic seizures in the mutant mice (Gerber et al., 2008). However, a hypomorphic 
mutation of Syntaxin-1B coupled with homozygous deletion of Syntaxin-1A not only caused an 
overall decrease in the expression levels of Syntaxin alongside the formation of fewer SNARE 
complexes but also reduced various synaptic parameters such as AP-evoked release, 
spontaneous release, the size of RRP, and the rate of RRP refilling (Arancillo et al., 2013). These 
results have led to the conclusion that conformational changes in Syntaxin mediate vesicle 
docking and differentially regulate vesicle fusogenicity. 
 
1.5.3.  SNAP-25 and paralogs                                              
 
SNAP-25 is known to have additional neuronal homologs namely SNAP-23, SNAP-47 and SNAP-
29 in mammals. Targeted genetic ablation of SNAP-25 does not cause morphological 
abnormalities in the mouse brain; mutant neurons develop normal neurite extensions and 
immature synapses until 8 days in low-density cultures but subsequently degenerate 
(Washbourne et al., 2001). All parameters such as AP-evoked, sucrose-evoked and spontaneous 
release at excitatory synapses were severely impaired in SNAP-25 deletion mutant neurons in 
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culture associating a critical role for SNAP-25 in mediating neuronal exocytosis  (Tafoya et al., 
2006; Bronk et al., 2007). Similarly, in SNAP-25 mutant chromaffin cells, secretion triggered by 
UV flash photolysis of caged Ca2+ was impaired but rescued by over-expression of SNAP25 




Although SNAP-25 is expressed only in neuronal and neuroendocrine cells, one of its paralogs 
SNAP-23 is expressed also in non-neuronal tissues. SNAP-23 was first discovered in a human B 
lymphocyte cDNA library screen, and shares 79% amino acid sequence identity with SNAP-25. 
In-vitro fusion assays identified SNAP-23 to bind Syntaxin-1, -2, -3, and -4 as well as VAMP-1 and 
-2 (Ravichandran et al., 1996). In congruence with its SNARE binding abilities, SFV-mediated 
dramatic over-expression of SNAP-23 in chromaffin cells expressing endogenous SNAP-25 
caused a considerable reduction in the exocytotic burst and overall secretion indicating that 
overexpressed SNAP-23 likely competes with SNAP-25 for cognate SNARE binding (Sørensen et 
al., 2003). However, lentiviral mediated expression of SNAP-23 in endogenous SNAP-25 
expressing wild-type neurons did not modify evoked release significantly, implying that SNAP-25 
is preferentially used by SNAREs for neurotransmission (Delgado-Martinez et al., 2007). With 
respect to subcellular distribution, endogenous SNAP-23 is enriched at excitatory synapses in 
dendritic spines, and perisynaptic co-localization of SNAP-23 and NMDA receptors is observable. 
Likewise, in terms of functional characteristics, shRNA mediated knockdown of SNAP-23 caused 
a significant reduction in the amplitudes of NMDA-receptor mediated EPSCs suggesting that 




SNAP-47, a member of the SNAP-25 subfamily was first identified from proteomic analysis of 
synaptic vesicle associated peptides that were purified by subcellular fractionation. Expression of 
murine SNAP-47 is developmentally regulated in the brain, with maximal expression levels 
observable already at embryonic day 18. Its expression is also detectable in various other organs 
such as liver, kidneys, lungs, spleen and testis (Holt et al., 2006). As SNAP-47 was identified as a 
Qbc-SNARE, reconstitution of proteoliposomes with SNAP-47, Syntaxin-1A and Synaptobrevin-2 
caused ternary complex formation preceding liposome fusion (Holt et al., 2006). As in-vitro data 
suggested that SNAP-47 might be functionally important for synaptic transmission, it was 
corroborated recently in a study where shRNA-mediated knockdown of SNAP-47 prevented the 
glycine induced increase in surface expression of GluA1 receptor levels in cultured neurons and 
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impaired LTP in acute hippocampal slices - this deficit could be rescued only in the presence of 
an shRNA resistant wild-type SNAP-47 with its intact functional SNARE complex-interacting C-




SNAP-29 is a ubiquitously expressed variant of SNAP-25 that has not been extensively studied in 
well-controlled model systems up until now. SNAP-29 was primarily discovered using the yeast 
two-hybrid screen approach to identify novel interaction partners of Syntaxin-3. The yeast two-
hybrid cDNA clone sequentially matched a 258 a.a. ORF in the human brain cDNA library, 
encoding a protein of about 28.9 kDa in size, which shared 17% sequence identity with SNAP-25 
(Steegmaier et al., 1998). SNAP-29 corresponds to GS32, a ubiquitous SNARE localized to the 
Golgi apparatus found in both cytosolic and membrane fractions of homogenized NRK cells 
(Wong et al., 1999). In-vitro binding assays showed promiscuous binding of SNAP-29 to GST-
fused Syntaxin-1A, -3, -4, -7, -13 and -17, which are expressed on the plasma membrane, Golgi 
apparatus and late endosomes (Steegmaier et al., 1998). Similarly, transient over-expression of 
SNAP-29, Syntaxin-4, and Syntaxin-6 in HeLa cells allowed the formation of binary t-SNARE 
complexes between SNAP-29 and Syntaxins in-vivo, which was augmented by co-expression of 
VAMPs (Hohenstein et al., 2001).  
 
Members of the SNAP-25 family lack transmembrane domains in their structure but possess 
coiled coil motifs. The structure of SNAP-29 comprises of an NPF (asparagine-proline-
phenylalanine) motif at the N-terminal end, two coiled-coil domains at the N-terminal and C-
terminal, each preceded by proline rich regions. However, it lacks a stretch of conserved cysteine 
residues that are present in the other isoforms and are essential for palmitoylation - a post-
translational modification of the protein required for subcellular targeting and membrane 
association (Steegmaier et al., 1998).  
 
In 2005, Sprecher and colleagues made the remarkable discovery that the neurocutaneous 
CEDNIK syndrome manifests in humans as a result of homozygous deletion of the pyrimidine 
nucleotide ‘G’ at position 220 on the SNAP-29 cDNA. The deletion causes premature termination 
of translation 28 amino acids downstream of the mutation and results in a severely truncated 
SNAP-29 protein. Prominent symptoms associated with the disease at the tissue level are 
reduced conductance from peripheral retina, abnormal lamellar granule maturation and 
secretion, while at the organ level include macular atrophy, facial dysmorphism, severe 
psychomotor retardation, palmoplantar keratoderma (Sprecher et al., 2005). Another CEDNIK 
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mutation was identified as a homozygous purine nucleotide ‘A’ insertion at position 486 of the 
SNAP-29 cDNA, which results in premature termination of translation 5 amino acids downstream 
of the mutation (Fuchs-Telem et al., 2010). The mutated SNAP-29 sequence was cloned into a 
pEGFP construct, transfected into HeLa cells and compared with non-transfected and wild type 
SNAP-29 transfected cells using confocal microscopy. A punctate pattern of localization was 
observable along the perinuclear zone of the cells expressing wild-type SNAP-29 - reminiscent of 
a distribution pattern with Golgi associated proteins, while expression of the mutated SNAP-29 
was diffuse in the nucleus and cytosol (Fuchs-Telem et al., 2010). In the rodent brain, SNAP-29 
and Rab3A interact in a GTPγS dependent manner, co-express in myelinating glia, and regulate 
the trafficking of myelin proteolipid protein to the plasma membrane (Schardt et al., 2009). In 
HEK cells, an exclusive perinuclear co-localization of the two proteins is observable (Schardt et 
al., 2009).  
 
Because of its affinity to Golgi-associated Syntaxins, researchers believed that SNAP-29 might 
play a modulatory role in synaptic transmission. Whole-cell patch clamp experiments performed 
on wild-type rat hippocampal neurons subjected to viral over-expression of SNAP-29 showed 
that the synaptic vesicle turnover was significantly reduced after repetitive stimulations at 0.1 Hz 
and 1 Hz. Such an inhibitory effect was eliminated and the synaptic vesicle turnover after 
repetitive firing was increased upon siRNA-mediated knockdown of endogenous SNAP-29 (Pan 
et al., 2005).  
 
Loss of SNAP-29 has been shown to critically affect phagocytic and secretory pathways in non-
cranial organs such as in mast cells, fibroblasts, intestinal epithelium, and oocytes, which is not 
uncommon for a ubiquitously expressed protein (Rapaport et al., 2010; Sato et al., 2011; 
Wesolowski et al., 2012). The role of SNAP-29 has been predominantly studied in non-
mammalian model systems such as C. elegans and Drosophila. However, a systematic and well-










1.6.   Aim1: Biochemical and functional study of SNAP-29  
 
The first aim of my study was to investigate the role of SNAP-29 in mediating synaptic 
transmission in mice. Although the physiological effects of the other SNAP-25 paralogs have been 
extensively studied at central synapses, the precise function of SNAP-29 has remained an enigma 
due to the lack of adequate tools. Over-expression of SNAP-29 was shown to negatively modulate 
neurotransmitter release at excitatory neurons by inhibiting SNARE disassembly and reducing 
synaptic vesicle turnover (Pan et al., 2005). While one could agree on a dominant negative effect 
that may arise due to abundant SNAP-29 binding to the SNARE complex competitively, the roles 
of endogenous SNAP-29 and the other SNAP-25 paralogs in these neurons remained unexplained. 
Therefore, in my study, I aimed to characterize the function of SNAP-29 using mice that carried 


























1.7.  Ca2+-mediated fusion - role of Complexin  
 
1.7.1.   Complexin structure and homology 
 
Complexins (Cplx) are a family of small, cytosolic, highly charged, SNARE-associated proteins 
found in a number of eukaryotic organisms. In mammals, there are four known members of the 
Complexin gene family, namely Cplx1, Cplx2, Cplx3, and Cplx4, which are differentially expressed 
across various organs. Cplx1 and Cplx2 proteins are 134 amino acid long and expressed 
predominantly in several regions of the brain (McMahon et al., 1995), whereas Cplx3 with 158 
amino acids is relatively less abundant in the brain but more strongly expressed in the retina, 
along with Cplx4 consisting of 160 amino acids (Fig.7.) (Reim et al., 2005). Cplx2 is detectable in 
the mammalian adrenal glands (Archer et al., 2002; Cai et al., 2008) and peripheral tissues, 
suggestive of a ubiquitous role. Complexins are evolutionarily conserved across different species 
with variable sequence identities. For example, Complexin homologs known as Synaphins, are 
found in the electromotor nerve cell bodies innervating the cartilaginous fish, Narke japonica 
(Ishizuka et al., 1997). Similarly, C. elegans and Drosophila melanogaster each have homologs of 
Complexin with an approximate 39% sequence identity with murine Cplx1 (Fig.8.) (Hobson et al., 
2011). 
 
Database searches to compare vertebrate and invertebrate orthologs of Complexins revealed a 
highly conserved region covering amino-acid residues 34-77 at the centre of the protein (Pabst et 
al., 2000). NMR and CD spectroscopic analysis of recombinant rat Cplx1 confirmed that a 
substantial part (35-40%) of the protein sequence forms a α-helical structure between amino-
acid residues 26 and 83 (flanked by the N- and C-terminus) and stoichiometrically binds to the 
SNARE complex (Pabst et al., 2000). In Cplx3 and Cplx4, a unique CAAX motif at the C-terminal 
end was discovered to represent the consensus sequence for farnesylation - a form of 
posttranslational modification that allows the protein to be targeted to membranes (Fig.7.) (Reim 




Figure 7.  Domain structure of the Complexin protein family. The  
Complexin proteins have a general structure with four important 
domains, shown here in Cplx1. The N-terminus of the Cplx proteins spans 
amino acid residues 1 to 26, and is essential for the facilitatory function of 
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Complexins (Xue et al., 2010). The accessory α-helix spans residues 27 to 
47, and has been shown to inhibit vesicle fusion by preventing the 
complete zippering of the SNARE complex (Xue et al., 2010). The central 
α-helix is essential for Complexin binding to the SNARE complex, and the 
loss-of-function of this domain impairs release (Xue et al., 2007). The C-
terminus has been shown to have different functions, partly depending on 
the model system - in Cplx1, for example, the C-terminus stimulates 
liposome fusion in-vitro (Malsam et al., 2009), but is essential for vesicle 
priming and clamping spontaneous vesicle fusion in cortical neurons 
(Kaeser-woo et al., 2012). The CAAX motif at the end of the C-terminus is a 
unique site for post-translational farnesylation present only on Cplx3 and 




Figure 8.  Amino acid sequence homology between mouse, worm  
and fly Cplx1. The murine Cplx1, C. elegans Cplx1 and Drosophila Cplx are 
similar in size. Their overall sequence identity is 39% with maximal 
sequence conservation in the central α-helical domain (Adapted from 
Hobson et al., 2011).  
 
1.7.2.  Complexin - SNARE interactions 
 
Mammalian Cplx1 and Cplx2 were first discovered in a syntaxin co-immunoprecipitation of the 
synaptic SNARE complex from rat brain homogenate, and were shown to bind to the SNARE 
complex with nanomolar affinity in-vitro (McMahon et al., 1995). Biophysical studies attempted 
to resolve the structure of Complexins and its association with the SNARE complex. Cplx1 and 
Cplx2 preferentially bound only to preassembled ternary SNARE complex reconstituted on 
proteoliposomes with a 1:1 stoichiometry via their central α-helical region (Pabst et al., 2000).  
 
Resolution of the three-dimensional crystal structure of the Complexin26-83/SNARE complex in 
squids and mammals revealed four parallel, highly twisted α-helices formed by the SNARE motifs 
of Synaptobrevin-2, Syntaxin-1, SNAP-25A, SNAP-25B and a fifth slightly twisted α-helix 
corresponding to Cplx (Fig.9.) oriented in an anti-parallel fashion within the groove of the ‘trans-
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SNARE’ complex, stabilizing the interface between Synaptobrevin and Syntaxin as well as likely 
counteracting the repulsive forces of the opposing vesicle- and plasma-membranes (Chen et al., 
2002; Bracher et al., 2002).  
 
9.A.         9.B. 
 
 
Figure 9. Interaction of the Complexin-SNARE Complex. (A) Ribbon diagram 
illustrates the orientation of helices of the SNAREs and Complexin. Colour 
code is as follows: Yellow - Syntaxin, Red - Synaptobrevin, Blue - SNAP-25 
N-terminal SNARE motif, Green - SNAP-25 C-terminal SNARE motif, Pink - 
Complexin. (B) Interaction between lysine (K69) and tyrosine (Y70) 
residues of Complexin with Aspartate (D218) of Syntaxin is shown. 
Hydrogen bond is formed between Y70 and D218, whereas a salt bridge is 
formed between K69 and D218. Oxygen atoms are indicated in red, and 
nitrogen atoms are indicated in blue (Adapted from Chen et al., 2002).    
 
In support of these findings, a dramatic increase in fluorescence anisotropy indicated that 
Cplx/SNARE complex binding occurs on a millisecond timescale while EPR and CD spectroscopy 
inferred no major structural changes to the core SNARE machinery due to the rapid reaction 
kinetics (Pabst et al., 2002). In summation, the biophysical findings implied that Complexins 
stabilize the tightly bound ‘metastable state’ of the SNARE complex in an immediate step likely 
preceding the actual fusion (reviewed by Marz and Hanson, 2002). Another important tool used 
in the study of Cplx/SNARE interactions is the single molecule FRET technique. Cplx/SNARE 
complex binding measured on lipid bilayers showed rapid binding kinetics of full-length 
Complexins to the SNARE complex (Bowen et al., 2005; Li et al., 2007). In PC12 cells, Complexins 
demonstrated a high affinity for binding to truncated SNARE complexes mimicking partially 
assembled intermediates, but Complexin affinity was directly proportional to the extent of 
SNARE complex assembly (Liu et al., 2006). Mere presence of the core SNARE components in the 
absence of Complexins aided vesicles to remain in a docked state, however Cplx1 binding to 
trans-SNARE complex lowered the fusion energy barrier, and with the concerted action of Ca2+, 




1.7.3.  Complexin structure - function discrepancy 
 
Complexins are proteins that have often been shown to cause diverse functional phenotypes. 
Their role in synaptic physiology is highly debated due to their paradoxical effects in different 
model systems. 
 
1.7.3.1. Complexin as facilitators of synaptic release  
 
In the past decade, successive studies established a significant role for Complexins in facilitating 
a late-step of neurotransmitter release. Neurons derived from mice carrying constitutive 
deletions of the major brain isoforms Cplx1 and Cplx2 (Cplx DKO) exhibited a dramatic reduction 
in synaptic parameters such as peak amplitude of Ca2+-evoked EPSCs, vesicular release 
probability and the apparent Ca2+-sensitivity of the synchronous component of EPSCs, quite 
contrary to littermate control neurons expressing either or both Cplx variants (Reim et al., 2001). 
Genetic over-expression of full-length Cplx1, Cplx3 and Cplx4 in the Cplx DKO mutant neurons 
caused a significant rescue of the EPSC amplitudes and release probability, implying a positive 
role for Complexins in facilitating exocytosis (Reim et al., 2005). However, the existence of Cplx3 
at low levels in the brain raised questions on residual effects of Cplx3 in release. Individual 
deletion of Cplx3 caused no apparent variations in synaptic parameters compared to wild type, 
and so, a Complexin triple-knock-out (TKO) mouse with constitutive deletions of Cplx1, Cplx2 
and Cplx3 was generated (Xue et al., 2008). The Cplx TKO mice exhibited a similar phenotype as 
observed in Cplx DKO mice including perinatal lethality, and severe deficits in synaptic 
transmission (Xue et al., 2008).  
 
Although the synaptic deficits were attributed to the complete loss of Complexins, further 
structural modifications on the Complexin protein structure divulged interesting physiological 
phenotypes. Point mutations of the arginine (R48), lysine (K69) tyrosines (Y52 and Y70) 
residues on the central α-helix of Cplx1 were shown to disrupt SNARE complex binding and 
cause a dramatic reduction in the amplitudes of Ca2+-evoked EPSCs implying that SNARE binding 
of Cplx1 was essential for release (Fig.9.) (Xue et al., 2007; Maximov et al., 2009). Similarly, 
deletion of the Cplx1 N-terminus (1-15 a.a.) or point mutations of the amino acid residues 3 to 6 
was also shown to impair the facilitatory function of Complexin-1 (Xue et al., 2009; Xue et al., 
2010). Loss of the Cplx1 N-terminus impaired its ability to facilitate synaptic release, but deletion 
of the accessory α-helix (27-40 a.a.) reinstated the facilitatory function of the protein (Xue et al., 
2007). A recent study has claimed that the inhibitory effect of the accessory α-helix is dependent 
on the presence of the negative charge of the helix, and that replacing these with positively 
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charged arginine residues increased the synaptic vesicle fusogenicity (Trimbuch et al., 2014). The 
C-terminus of Complexins is variable in terms of sequence identity and functionality, although 
mammalian Complexins have been shown to possess an amphipathic α-helix on the C-terminus 
(Seiler et al., 2009). The C-terminus of Cplx1 has been shown to stimulate liposome fusion in-
vitro and its functionality was transferable to Cplx3 (Malsam et al., 2009). However, in cultured 
cortical neurons the C-terminus of Cplx1 was found to mediate vesicle priming and clamp 
spontaneous fusion of vesicles (Kaeser-woo et al., 2012). With respect to Cplx3 and Cplx4, the 
unique CAAX motifs on their C-termini allows for their farnesylation and targeting to 
membranes. However, the CAAX motif of only Cplx4 was found to be functionally relevant for 
Ca2+-triggered release from hippocampal neurons (Reim et al., 2005). 
 
1.7.3.2. Complexins as Fusion Clamps in various models 
 
Albeit contradictory, some studies showed that Complexins might also have an inhibitory role in 
exocytosis. Over-expression of mammalian Cplx2 in adrenal chromaffin cells caused a significant 
reduction in the charge released during single vesicle fusion events indicating premature 
termination of release events (Archer et al., 2002). Later, new evidence surfaced in in-vitro 
functional reconstitution assays, and functional studies on C. elegans, Drosophila as well as in 




In cell fusion assays with HeLa cells expressing v- and t-SNAREs on their surface along with 
membrane anchored recombinant Cplx1-GPI, showed that Cplx1 inhibits fusion of the cells due to 
high local concentration; fusion robustly recovered upon PI-PLC based cleavage of the Cplx1-GPI 
anchor, and this effect was further enhanced in the presence of the calcium sensor protein - 
Synaptotagmin-1 (Syt-1), as well as free Ca2+ of 200 μM  (Giraudo et al., 2006). Research on 
liposome-fusion showed that Complexin-mediated ‘hemifusion arrest’ could be relieved by Ca2+-
Syt-1. Since SNARE-mediated aqueous content mixing is contributed by initial mixing of lipids on 
outer monolayer of lipids (hemifusion), and is then followed by mixing of the lipids on the inner 
leaflet (full fusion), the individual effects of Complexins and Synaptotagmin were studied in this 
process. Drosophila Complexin (dmCplx) and mammalian Cplx4 apparently inhibited inner leaflet 
mixing and caused a 46% reduction of total fusion, which could be restored only upon addition of 
the calcium binding C2AB domain of Syt-1 along with 500 μM Ca2+ (Schaub et al., 2006). These 
findings in-vitro supported the notion that Complexins may curb release, and further studies 
examined the role of Complexin homologs in different species and in models of higher 
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physiological relevance.  
 
Complexins in C. elegans 
 
In C. elegans, Complexin homologs cpx-1 and cpx-2 were found to have distinctive roles in 
cholinergic release. The worm mutant ok1552 was generated by deletion of a 1.3 kb exon from 
cpx-1, and it displayed severe aldicarb-induced paralysis due to build-up of non-cleaved 
acetylcholine (Martin et al., 2011). Synaptic transmission was affected vividly in the ok1552 
mutant, as the evoked transmitter release was reduced, coupled with a drastic increase in tonic 
release. Similarly, deletion or mutation of the SNARE binding region or the C-terminal domain on 
worm cpx-1 caused a massive increase (>40%) in spontaneous release (Martin et al., 2011) and a 
selective reduction of stimulus evoked release by 94% (Hobson et al., 2011), implying an 
important function of cpx-1 in synchronizing synaptic release and clamping spontaneous fusion. 
Although cpx-1 was found to be highly important for mediating release in C. elegans, cpx-2 had no 




The Drosophila genome encodes for only one Complexin isoform. An intragenic 17-kb deletion of 
the Complexin coding sequence (dmCplxSH1 null mutant) resulted in an enormous surge in the 
frequency of miniature excitatory junction potentials at the NMJ, indicating that dmCplx ‘clamps 
fusion’ at the NMJ of Drosophila and its loss leads to increased spontaneous fusion of vesicles 
(Huntwork and Littleton, 2007). Although spontaneous fusion dramatically increased at the NMJ 
of the cpxSH1 mutants, their Ca2+-evoked amplitudes were significantly reduced, which was 
rescued by over-expressing mammalian Cplx1, Cplx2 and Cplx3 (Cho et al., 2010).  
 
Structure-function analysis showed that the dmCplx could execute its fusion-clamp effect via 
SNARE binding and in the presence of its functional prenylation CAAX motif, as the spontaneous 
release rate was enhanced if the dmCplx SNARE-interacting domain (K75/Y76) and the 
prenylation domain (C155) were mutated (Cho et al., 2010). A number of splice variants were 
predicted from the Drosophila Cpx locus, each having a functional consequence on the fusion-
clamp function. The mutant dmCpx572 generated due to deletion in exon 6 of the dmCplx causing 
premature termination of the C-terminal amino acid sequence showed a marked deficit in 
clamping spontaneous release (Buhl et al., 2012). Likewise, dmCpx1257 generated by a non-sense 
mutation of the terminal amino acid ‘Q’ on the CAAX motif caused a severe deficit in motor co-
ordination of the mutant flies at elevated temperatures, and this phenotype was also 
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corroborated by a pronounced inability to clamp spontaneous fusion (Iyer et al., 2013). These 
studies further emphasized a significant role for CAAX prenylation in mediating the fusion clamp 




Complexins in mice were found to facilitate synaptic release, based on constitutive in 
endogenous Complexin knockout models. However, the shRNA-mediated knockdown of Cplx1 
and Cplx2, strongly inhibited the protein expression, increased the frequency of miniature 
excitatory postsynaptic currents and reduced AP-evoked release in cultured cortical neurons 
(Maximov et al., 2009). Expression of N- and C-terminal deletion mutants of Cplx1 in the Cplx 
knockdown caused a significant increase in frequency of mEPSCs alluding to requirement of the 
N- and C-terminal domains for clamping spontaneous release. Mutation of the SNARE binding 
domain on murine Complexins or prevention of Complexin/SNARE complex binding by 
substitutions on the Synaptobrevin-2 SNARE motif and subsequent lentiviral expression of the 
mutant genes in neurons caused a surge in spontaneous release indicating that Complexin-
SNARE complex interaction was essential for the apparent ‘clamping effect’ of murine 
Complexins (Maximov et al., 2009; Kaeser-Woo et al., 2012). Although Cplx/SNARE complex 
binding is an integral part of the fusion apparatus (Pabst et al., 2002; Chen et al., 2002), the 
physiological effects of various Cplx homologs in different model systems have been conflicting.  
 
1.7.4.  Complexin-Synaptotagmin interactions 
 
Synaptotagmin was first discovered as a synaptic vesicle protein that acts as a cooperative Ca2+ 
receptor for exocytosis in a phospholipid dependent manner (Brose et al., 1992). Synaptotagmin 
comprises a transmembrane region and two C2 domains, C2A and C2B, both of which have been 
shown to bind phospholipids in a Ca2+-dependent manner (Zhang et al., 1998; Fernandez et al., 
2001). A loss-of-function study on Synaptotagmin-1 revealed that Syt-1 deficiency selectively 
impairs Ca2+-dependent synchronous transmitter release in neurons, but does not play a role in 
maintenance of the synaptic structure or postsynaptic density (Geppert et al., 1994). A single 
point mutation on the C2A domain (R233Q) of Syt-1 close to the Ca2+ binding sites caused strong 
reduction in the overall Ca2+-affinity, the EPSC amplitudes, the vesicular release probability as 
well as the Ca2+-responsiveness of the synaptic vesicles (Fernandez-Chacon et al., 2001). These 
studies concluded that Synaptotagmin-1 is the primary calcium sensor protein mediating the 
Ca2+-triggered synchronous fusion of vesicles.  
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Both Synaptotagmin and Complexins have been shown to individually affect the Ca2+-dependent 
transmitter release process, and the nature of interaction between Complexins and 
Synaptotagmin-1 has been explored in a few studies. In-vitro experiments assessing the role of 
Complexins and Synaptotagmins in stimulating cell-cell fusion found that Complexin-GPI anchor 
mediated fusion block could be removed by PI-PLC cleavage, but full fusogenicity was accelerated 
upon addition of 200 μm Ca2+ and Syt-1 (Giraudo et al., 2006). Similar results were obtained in 
liposome fusion assays where inhibition of fusion by Complexins was alleviated upon addition of 
Syt-1 and Ca2+ (Schaub et al., 2006).  
 
Some studies have shed light on Complexin and Synaptotagmin acting as competitors while some 
others have shown that Complexins and Synaptotagmin co-operatively function in vesicle 
release. In-vitro co-sedimentation assays showed that native Syt-1 bound SNARE complexes at 
physiological ionic strengths in a Ca2+-dependent manner, and Syt-1 bound to SNARE complexes 
was quantitatively displaced by full length Complexin (Tang et al., 2006). These results suggested 
that Complexin and Syt-1 compete for SNARE binding. However, evoked EPSCs generated in Cplx 
DKO+Syt-1 KO autaptic neurons were dramatically reduced compared with EPSCs in Cplx 
DKO+Syt-1 WT neurons, implying that Cplxs and Syt-1 are required and cooperatively interact to 
mediate transmitter release (Xue et al., 2010). A more recent study corroborated this finding by 
employing size-exclusion chromatography and isothermal titration calorimetry to study Syt-1-
Cplx1 interactions and found that the Syt-1 eC2AB fragment and Cplx1 protein (full length or 26-
83 fragment) simultaneously bound SNARE complexes but not each other (Xu et al., 2013).  
 
1.8.  SNARE disassembly and synaptic vesicle recycling  
 
In order to maintain fast synaptic neurotransmission during sustained periods of activity, the 
intracellular machinery has evolved specialized apparatus to support SNARE disassembly and a 
fast recovery of synaptic vesicles for subsequent fusion. The disassembly of SNARE complex is 
essential so that the SNARE components can be reused in the subsequent vesicle fusion events. 
Disassembly of binary and ternary SNARE complexes is driven by concerted action of α-SNAP 
binding and the NSF ATPase activity (reviewed by Hanson et al., 1997). The tight coupling of 
synaptic vesicle exocytosis and endocytic membrane retrieval was first described in the frog 
motor nerve terminals. Stimulation of the frog sartorius muscle nerves at high-frequency caused 
transient depletion of synaptic vesicles, balanced by parasynaptic cisternal projections, which 
reappeared in a few minutes as new synaptic vesicles (Heuser and Reese, 1973). Recent studies 
have shown that different pathways of endocytosis may be adapted depending on the type of 
activity sustained at the synapse. Two fast pathways have been attributed to cause rapid vesicle 
 45 
recycling for low frequency stimulations. One allows for vesicles to remain at the active zones for 
refilling while the other recycles locally - also known as ‘kiss and run’ (reviewed by Südhof, 
2004). At high stimulation frequencies, a slow endosomal-recycling pathway is thought to be 
involved in vesicle endocytosis. In this scenario, vesicle endocytosis is predominantly mediated 
by clathrin and dynamin dependent pathways involving endocytic protein scaffolds (reviewed by 
































1.9.  Aim2: To study Complexin structural domains in transmitter release 
 
The second objective of my work was to systematically ascertain the functional 
similarity/variability of the four mammalian Complexin paralogs in the physiological context, by 
introducing point mutations on the SNARE-binding domains and farnesylation domains of each 
of the proteins, and assessing their functional characteristics. For this purpose, I used the 
autaptic Cplx TKO neurons and genetically re-introduced the mutants alongside the wild type 
variants (via lentiviruses). I studied if the physiological functions of the SNARE binding domains 
and farnesylation domains are related. This aim was to provide a perspective on the phenotypic 

































2.  Materials and Methods 
 
2.1.   Materials 
 
2.1.1.   Buffers  
 
    Buffers       Constituents & Supplier                       Final Concentration 
 
10X TBE               Tris (Sigma)                            89 mM 
                Boric Acid (Merck)             89 mM 
                EDTA (Flyka Analytical)                            2 mM 
Diluted to 1X using ddH2O 
  
10X PBS   NaCl (Merck)               1.37 M 
    KCl (Merck)                         26.8 mM 
    NaH2PO4.2H2O (Merck)         80.9 mM 
    KH2PO4 (Merck)          17.6 mM 
Diluted to 1X using ddH2O and pH adjusted to 7.4 with NaOH 
 
10X Running Buffer  Tris                            25 mM 
    Glycine (Sigma Aldrich)         190 mM 
    SDS                       1% 
Diluted to 1X using ddH2O 
 
10X TBS   Tris                                                   0.2 M 
(Western Blot)                              NaCl                1.37 M 
Diluted to 1X using ddH2O and pH adjusted to 7.6 with HCl 
 
10X TBS (for Lentivirus) Tris                      20 mM 
    NaCl            150 mM 
Diluted to 1X using ddH2O, pH adjusted to 7.6 with HCl, and stored at 4°C. 
 
Odyssey Blocking Buffer TBS                       1X 
    Milk Powder (Reformhaus)                  5% 
    Goat Serum (Gibco)                   5% 
Freshly prepared. 
 
Odyssey Antibody Buffer TBS                       1X 
                                              Milk Powder                                        5% 
    Goat Serum (Gibco)                    5% 
    Tween-20                  0.1% 
Freshly prepared.  
 
Odyssey Wash Buffer                PBS                                                               1X 
    Tween-20                  0.1% 
Freshly prepared. 
 
Blocking Solution                         PBS                                                                                                 1X 




Permeabilization                          PBS                                                                                            1X 
solution (For ICC)                        Triton-X 100 (Roche Diagnostics)                                 0.2% 
                                                           Goat Serum                                                                           10% 
Freshly prepared. 
 
Laemmli Buffer  SDS              10% 
                                                           Tris-HCl              0.5 M
                               EDTA                                                               0.1 M  
                                                           Sucrose (Merck)            30% 
                                                           Bromophenol Blue (Pierce)          0.2% 
 
1 part of 1.5 M DTT (Biomol) added to 9 parts of laemmli buffer, aliquot and stored at  
-20°C. 
 
Transfer Buffer  Trizma          25 mM 
    Glycine        190 mM 
    Methanol (Chemie Vertrieb Hannover)          20% 
                                              ddH2O 
Freshly prepared and stored at 4°C. 
 
Wash Buffer 1                 NaH2PO4 (Sodium dihydrogen phosphate)             20 mM 
    NaCl         500 mM 
    Imidazole (AppliChem)        10 mM 
    Urea (Roth)                8 M 
                                                           ddH2O 
Freshly prepared. 
 
Wash Buffer 2                 NaH2PO4         20 mM 
    NaCl        500 mM 
    Imidazole          20 mM 
    Urea                 8 M 
                                                            ddH2O 
Freshly prepared. 
 
Elution Buffer   NaH2PO4         20 mM 
    NaCl         500 mM 
    Imidazole       300 mM 
    Urea                 8 M 
                                                           ddH2O 
Freshly prepared. 
 
ECL Blot Buffer A  TBS                   1X 
    Milk Powder                                                 5% 
    Goat Serum (Gibco)               5% 
    Tween-20             0.1% 
Freshly prepared. 
 
ECL Blot Buffer B   TBS                   1X 
    Milk Powder                 5% 






2.1.2.  Gel Solutions 
 






ECL Blot Buffer C   TBS                      1X 
    Tween-20                0.1% 
Freshly prepared. 
 




Aprotinin   Aprotinin (Roth)        1 mg/ml 
    ddH2O 
Stored at -20°C. 
 
Leupeptin     Leupeptin (Pepta Nova)    0.5 mg/ml 
     ddH2O 
Stored at -20°C. 
 
PMSF     PMSF  (Sigma)                               17.4 mg/ml 
                                                             Isopropanol 
Stored at -20°C. 
  
Cell Lysis Buffer                 PBS        1X 
     Aprotinin                                                      1:1000 
     Leupeptin            1:1000 
     PMSF                                         1:1000 
Freshly prepared and stored on ice. 
 
Tissue Homogenizing Buffer   PBS                                                                                              1X 
                                  Sucrose                                                                                0.32 M 
                                                       Aprotinin                                                      1:1000 
                   Leupeptin            1:1000 
      PMSF                                         1:1000 
Freshly prepared and stored on ice. 
 
Agarose Gel   Agarose (AppliChem)                                                 1% 
    TBE          1X 
    Gel Red (Biotium/VWR)                      1:20,000 
 
Solution boiled for 3 min, incubated at 50°C for 45 min, poured on to  





2.1.3.  Reagents 
 
Reagents          Constituents & Supplier                       Final Concentration 
 
 
Coomassie Stain Solution      Coomassie Brilliant Blue (Biomol)          0.15% 
         Acetic Acid (Merck)               10% 
         Isopropanol (Merck)              25% 
                      ddH2O       
Stored at RT. 
 
Destain Solution       Methanol (Chemie Vertrieb Hannover)            30% 
         Acetic Acid (Merck)               15% 
         ddH2O                                                                        55% 
Stored at RT. 
 
Ponceau S Stain Solution       Ponceau S (Sigma)               0.1% 
          Glacial Acetic Acid                   5% 
          ddH2O 
Filtered and stored at RT. 
 
IPTG                                     IPTG                                            1 M 
Stored at -20°C.       ddH2O 
 
TCA         Trichloroacetic acid (Merck)                         20% 
         ddH2O                            80% 
Stored at RT. 
Acetone         Acetone (Merck)             80% 
 
12% Resolving Gel  30% Bis-Acrylamide (National Diagnostics)               6.0 ml 
 (SDS-PAGE)   1.5 M Tris-Hcl pH 8.8 (Sigma)                                        3.8 ml 
    10% SDS (Roche)           0.15 ml 
    10% Ammonium persulphate (Sigma)                       0.15 ml   
    TEMED (Serva)                                                                0.006 ml 
    ddH2O                                                                                      4.9 ml 
 
4.9 ml of gel poured into a cassette, layered with a few drops of H2O: Butanol mix to  
prevent air bubbles, and allowed to solidify. 
  
5% Stacking Gel                 30% Bis-Acrylamide                                                      0.67 ml 
(SDS-PAGE)   1 M Tris-Hcl pH 6.8 (Sigma)             0.5 ml 
                 10% SDS              0.04 ml 
    10% Ammonium persulphate                          0.04 ml  
    TEMED                                                                                0.004 ml 
     ddH2O                                                                                      2.7 ml 
 
Comb inserted gently after pouring 2 ml of the stacking gel over the solidified  
resolving gel.  
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Stored at 4°C.         ddH2O                                          20% 
 
Triton-X 100      Triton-X 100                                                                        10% 
       ddH2O 
Stored in the dark at 4°C. 
 
4% PFA                                                Paraformaldehyde (Serva)                                           4 gms 
                                                                ddH2O                                                                                 60 ml 
 
Heat to 50°C stirring continuously, add few drops of 10 N NaOH to obtain clear solution.  
Cool down to 4°C and add 4 gms Sucrose. For 100 ml, add 7.74 ml of 1M Na2HPO4  
and 2.26 ml of 1M NaH2PO4, make up to 100 ml with ddH2O. Aliquot and store at -20°C.  
 
Coating Solution      PBS (Gibco)                     1X 
(For petridishes)      Poly-L-Lysine (Sigma Aldrich)               1:12 
Freshly prepared. 
 
Stamping Solution      17 mM Acetic Acid (Merck)          3 parts 
(for Astrocytes)      1 mg/ml Collagen (BD Biosciences                     1 part 
       0.5 mg/ml Poly-D-Lysine (Sigma Aldrich)          1 part 
Freshly prepared.  
 
Ethanol      Ethanol (Sigma Aldrich)               70% 
Stored at RT.      ddH2O                 30% 
 
Bradford’s Reagent      Dye reagent (Bio-rad)            1 part 
        ddH2O                          4 parts 
Stored in the dark at 4°C. 
 
BSA         10 mg/ml BSA (New England Biolabs)      1 mg/ml  
         ddH2O 
Freshly diluted from -20°C stock. 
 
 
2.1.4.  Cell Culture Media 
 
Media                                     Constituents & Supplier                             Final Concentration 
  
 
Luria-Bertani Medium                    Bacto-Tryptone (Difco)                  1% 
(pH 7.5)       Yeast Extract (Difco)                  0.5% 
        NaCl (Merck)                   1%  
                                                               Bacto-Agar (BD) 
                                                               ddH2O 
Autoclaved and stored at RT. 
 
Complete Medium      DMEM (Gibco)       1X 
(HEK cell culture)      FBS (Gibco)                   10% 
       Pen-Strep (Gibco)      1% 
        L-Glutamine (Gibco)                    1% 
                     NEAA (Gibco)                    1% 
       Geneticin (Calbiochem)     1% 
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Stored at 4°C. 
 
 
OptiMEM Medium             OptiMEM (Gibco)    1X 
(For Lentivirus)             FBS (Gibco)                              10% 
Stored at 4°C. 
 
Changing Medium             DMEM (Gibco)                   1X 
(For Lentivirus)             FBS (Gibco)     2% 
Stored at 4°C.              Pen-Strep (Gibco)                 1% 
               Sodium Butyrate (Merck)                                       2 mM 
 
Freezing Medium             Complete Medium                           90% 
(For HEK Cells)             DMSO (Sigma)                            10% 
Stored at 4°C. 
 
FBS Medium               DMEM                    1X 
(For Astrocytes)              FBS                              10% 
                                                  GlutaMax (Gibco)                              1% 
                                          MITO (BD)              0.1% 
Stored at 37°C. 
 
NBA Medium              NBA Medium (Gibco)    1X 
(For neurons)              B-27 (Gibco)     2% 
Stored at 4°C.                           GlutaMax      1% 
               Pen-Strep (Gibco)                            0.2% 
 
 
2.1.5.  Reagents for Electrophysiology 
 
Reagents                          Constituents & Supplier                     Final Concentration 
 
 
10X ATP/GTP Energy Stock                ATP-Mg Salt (Sigma Aldrich)                                 40 mM 
(pH 7.5, 370 mOsm/L)                         GTP-Na salt (Sigma Aldrich)                                     3 mM 
                                                                     MgCl2.6H2O                                                                    6 mM 
                                                                     Creatine phosphate – Na2 (Sigma)                     150 mM 
                                                                     Creatine phosphokinase                                       50 U/ml 
Stored at -20°C. 
 
CaCl2             1M CaCl2 (Merck)                        100 mM 
(For intracellular Soln.)                        ddH2O 
 
Stored at -20°C. 
 
EGTA-AM                                                  EGTA-AM (Calbiochem)                                          7.5 mM 
                                                                     DMSO 
Stored at -20°C. 
 
Sucrose                                                  Sucrose (Sigma)                                                                  1 M 
                                                                 1X Base + 
 
 53 
Stored at -20°C, diluted to 0.5 M in 1X Base+ for experimental use. 
 
Tetrodotoxin                                       Tetrodotoxin (Tocris)                                                3 mM 
                                                                 ddH2O 
 
Stored at -20°C, diluted to 300 nM in 1X Base+ for experimental use. 
 
1X Base +                                             KCl           2.4 mM 
(pH 7.4, 310-320 mOsm/L)       NaCl        140 mM 
(External Solution)                      HEPES                        10 mM 
                        D-Glucose (Sigma)                       10 mM 
          CaCl2                           4 mM 
          MgCl2                           4 mM 
                                                                 ddH2O 
Freshly prepared. 
 
Intracellular Solution                      KCl          136 mM 
(pH 7.4, 320 mOsm/L)                      HEPES        17.8 mM 
                        K-EGTA           0.1 mM 
                                                                 10X ATP/GTP energy stock                                              1X    
Stored at -20°C. 
 
 
2.1.6.  Antibiotics, Media Supplements and Solutions 
 
Supplements                                     Constituents & Supplier                      Final Concentration 
 
 
Ampicillin (1000X)  Ampicillin (Sigma)          50 mg/ml 
(Amp)    ddH2O  
Stored at -20°C.         
 
Kanamycin (400X)  Kanamycin (Sigma)        10 mg/ml 
(Kan)    ddH2O 
Stored at -20°C. 
 
Geneticin                                         Geneticin (Calbiochem)                                               50 mg/ml 
                                                           PBS                                                                                             1X 
Stored at -20°C. 
 
MITO    DMEM + GlutaMax (Gibco)                            1X 
                               MITO serum extender (BD)                            1% 
Stored at -20°C. 
 
Pen-Strep (100X)  Pen-Strep (Gibco)            0.2% 
Stored at -20°C. 
 
Trypsin-EDTA (1X)  Trypsin-EDTA (Gibco)                                     0.05% 
Stored at -20°C. 
 
HBSS    HBSS w/o Ca and Mg (Gibco)                             1X 




Papain Solution    DMEM                                                               1X 
      CaCl2 (Merck)                1 mM 
                    EDTA (Flyka Analytical)           0.5 mM 
       L-cysteine (Sigma)          1.65 mM 
 
Papain solution was filter sterilized through a 0.22 μm filter and stored at -20°C.  
To 1 ml of thawed papain solution, 25 units of Papain enzyme  
(Worthington Biochem. Corp.) was added and bubbled with Carbogen for 20 min,  
to obtain a clear solution.  
The solution was filter sterilized and incubated at 37°C until further use in cell culture.  
 
STOP Solution                      DMEM                                  1X 
         FBS (PAA)                                    10% (v/v) 
         Albumin (Sigma)        2.5 mg/ml 
         Trypsin Inhibitor (Sigma Aldrich)        2.5 mg/ml 
 
Filter sterilized through a 0.22 μm filter and stored at -20°C.  
 
 
2.1.7. Antibodies for Western Blotting and Immunocytochemistry 
 
Table 1  Primary Antibodies  
 
Antibody name  Antibody working concentration 
mCPX I/II 94.2 (SySy) 
Rabbit Polyclonal C-terminus 
1:1000 
mCPX III SA1896 (SySy) 
Rabbit Polyclonal 
1:500 
mCPX IV SA1897 (SySy) 
Rabbit Polyclonal 
1:500 







Purified Rabbit Polyclonal 
1:1000 
SNAP29 (SySy) 
Affinity-Purified Rabbit Polyclonal 
1:1000 (for WB)/1:500 (for ICC) 
Synaptobrevin-2 69.1 (SySy) 
Mouse Monoclonal 
1:7500 













Table 2  Secondary Antibodies  
 











(GαR - GFP channel) 
1:1000 
Alexa-555 (SySy) 
(GαGP - Cy5 channel) 
1:1000 
 
2.1.8.   Primer sequences, PCR reaction mix and programs 
 
Cplx1 Genotyping PCR 
 
Table 3 Primer Sequences for Cplx1 
 
Primer no. Gene of interest Sequence 
1118 Cplx1 WT 5'-AGTACTTTTGAATCCCCTGGTGA -3' 
1119 Cplx1 WT 5'-TAGCTATCCCTTCTTGTCCTTGTG -3' 
1111 Cplx1 KO 5'-CGCGGCGGAGTTGTTGACCTCG -3' 
1112 Cplx1 KO 5'-CTGGCTTGTCCCTGAATCCTGTCC -3' 
 
 
Table 4 PCR reaction mix for Cplx1 WT 
 
Constituents Reaction vol. (in μl) 
10X RedTaq Buffer 2 
2.5 mM dNTPs 1 
10 pM/μl Primer 1118 1 
10 pM/μl Primer 1119 1 





Table 5 PCR reaction mix for Cplx1 KO  
 
Constituents Reaction vol. (in μl) 
10X RedTaq Buffer 2 
2.5 mM dNTPs 1 
10 pM/μl Primer 1111 1 
10 pM/μl Primer 1112 1 





Table 6  PCR program for Cplx1 
 
Steps Temp (°C) Time (min:sec) 
1 94 03:00 
2 94 00:30 
3 60 00:30 
4 72 01:00 
5 Go to Step 2, Repeat steps 2-3-4 30 times 
6 72 07:00 
7 10 Forever 
 
 
Nex-Cre SNAP29 KO Genotyping PCR 
 
Table 7  Primer sequences for Nex-Cre SNAP29 
 
Primer no. Gene of interest Sequence 
20172 SNAP-29 (WT/floxed) 5'-CCACATGTAACCACCAGCCCTC -3' 
20173 SNAP-29 (WT) 5'-GTTCTAGGACTCCTCGCTGCCG -3' 
20176 SNAP-29 (floxed) 5'-CTTGCTATCCACCTGCCTTAG -3' 
 
 
Table 8  PCR reaction mix for Nex-Cre SNAP29 KO  
 
Constituents Reaction vol. (in μl) 
10X RedTaq Buffer 2 
2.5 mM dNTPs 2 
10 pM/μl Primer 20172 0.5 
10 pM/μl Primer 20173  0.5 




Table 8.1  PCR program for Nex-Cre SNAP29 KO () 
 
Steps Temp (°C) Time (min:sec) 
1 95 03:00 
2 55 00:45 
3 72 01:00 
4 95 00:30 
5 Go to Step 2, Repeat steps 2,3,4 35 times 
6 55 01:00 
7 72 10:00 





Table 9 PCR reaction for Nex-Cre SNAP29 KO  
 
Constituents Reaction vol. (in μl) 
10X RedTaq Buffer 2 
2.5 mM dNTPs 2 
10 pM/μl Primer 20172 0.5 
10 pM/μl Primer 20176 0.5 





Table 9.1 PCR program for Nex-Cre SNAP29 KO 
 
Steps Temp (°C) Time (min:sec) 
1 95 03:00 
2 49 00:30 
3 72 01:00 
4 95 00:30 
5 Go to Step 2, Repeat steps 2,3,4 39 times 
6 55 01:00 
7 72 10:00 
8 10 Forever 
 
Constitutive SNAP29 KO Genotyping PCR 
 
Table 10 Primer sequences for Constitutive SNAP29 KO 
 
Primer no. Gene of interest Sequence 
20174 SNAP-29 (WT/floxed) 5'-CACACCTCCCCCTGAACCTGAAAC -3' 
20175 SNAP-29 (WT) 5'-GCAGCGTCTGCATTGGATAC -3' 
20176 SNAP-29 (floxed) 5'-CTTGCTATCCACCTGCCTTAG -3' 
 
 
Table 11 PCR reaction mix for SNAP29 KO  
 
Constituents Reaction vol. (in μl) 
10X RedTaq Buffer 2 
2.5 mM dNTPs 2 
10 pM/μl Primer 20174 0.5 
10 pM/μl Primer 20175 0.5 
10 pM/μl Primer 20176 0.5 












































Steps Temp (°C) Time (min:sec) 
1 95 03:00 
2 49 00:30 
3 72 01:00 
4 95 00:30 
5 Go to Step 2, Repeat steps 2,3,4 39 times 
6 55 01:00 
7 72 10:00 
8 10 Forever 
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2.2.  Methods 
 
2.2.1.   Transformation of plasmid DNA into competent bacteria 
 
The plasmid DNA transformation was performed according to the protocol detailed in 
Endofree Plasmid Maxi Kit from Qiagen. The plasmid DNA was diluted to a concentration of 
100 ng/μl in order to transform into a selective strain of bacteria E.coli. For transformations, 
one aliquot containing 50 μl of competent bacteria was thawed on ice, and 1 μl of diluted DNA 
was added. The content was transferred to the Gene Pulser® cuvette and electroporated at 
1.8 mV. The electroporated bacteria were collected in 1 ml plain LB medium and allowed a 
recovery time of 1 hr at 37°C in a shaker. After recovery, 100 μl of transformed bacteria was 
plated on to an LB plate containing selective antibiotic and incubated at 37°C for up to 12 
hours to obtain confluent bacterial growth on the plate.   
 
2.2.2.   Plasmid DNA “Maxi” purification 
 
 Plasmid DNA purification was performed according to the protocol detailed in Endofree 
Plasmid Maxi Kit from Qiagen. The Endofree procedure prevents co-purification of 
endotoxins, which strongly decrease transfection efficiency of DNA in primary cells. In order 
to purify the plasmid DNA, a single colony of transformed bacteria was picked inoculated in 2 
ml of Luria Bertani (LB) medium containing selective antibiotic. The starter culture was 
incubated for 8 hrs at 37°C with vigorous shaking and then diluted 1/1000 in selective LB 
medium for 12-16 hrs at 37°C with vigorous shaking (300 rpm). Thereafter, the bacterial cells 
were harvested by centrifugation at 3500 rpm for 15 min at 4°C. The bacterial cell pellet was 
resuspended in 10 ml of cold Buffer P1 containing RNase A. To the suspension, 10 ml of 
buffer P2 was added and mixed thoroughly by inverting the tube 4-6 times. The mixture was 
incubated at RT for 5 min. In the meantime, QIAfilter catridge was placed in a 50 ml falcon. 
Next, 10 ml of Buffer P3 was added to the lysate and mixed thoroughly. The lysate was 
poured on to the QIAfilter catridge and incubated at RT for 10 min. The plunger was then 
gently inserted into the catridge to filter the lysate in the falcon tube. To the filtered lysate, 
2.5 ml of Buffer ER was added and mixed well. The mixture was incubated on ice for 30 min. 
The OIAGEN-tip 500 column was equilibrated by applying 10 ml of Buffer QBT and emptied 
by gravity flow. The filtered lsate was applied to the column and allowed to pass through the 
resin through gravity flow. The column was washed twice with 30 ml of Buffer QC. The DNA 
was eluted from the resin into a 50 ml falcon using 15 ml of Buffer QN. The DNA was 
precipitated by adding 10.5 ml of Isopropanol and mixed well. The solution containing the 
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DNA was centrifuged at 3500 rpm for 45 min at 4°C. Thereafter, the supernatant was 
carefully removed and the DNA pellet was washed with 1 ml of 70% Ethanol. The mix was 
centrifuged at 15000 rpm for 10 min and the supernatant was discarded. The DNA pellet was 
air dried for 10 min, re-dissolved in 100 μl of endotoxin free Buffer TE and stored at -20°C.  
 
2.2.2.1. Determination of yield of purified DNA 
 
 To determine the yield, the DNA concentration was measured using the UV 
spectrophotometer. The DNA can be quantified at wavelength 260 nm and 280 nm because a 
solution of DNA with an optical density of 1.0 will have a concentration of 50 μg/ml (using a 
10 mm pathlength cell). The A260/A280 absorbance ratio for a pure DNA solution will be 1.8, 
enabling an assessment of the purity and quality of the preparation. The purified DNA 
samples were diluted 1:100 in ddH2O. For reference, a blank solution containing pure ddH2O 
was used. The A260/A280 absorbance ratio and concentration of each of the sample was 
thereafter recorded.  
 
2.2.3.   Recombinant protein purification 
 
2.2.3.1.  Equilibration of beads 
 
 First, 2x6 ml of 50% Ni-NTA agarose solution (Qiagen) was transferred into a 50 ml falcon 
tube. The solution was centrifuged at 1000xg for 1 min. The beads were washed with 40 ml of 
the wash buffers 1 and 2 as well as the elution buffer for 5 min each, using a rotating wheel at 
RT. The beads were transferred in a final volume of 10 ml into small falcon tubes and washed 
once again. Both the aliquots were combined, the beads were finally re-suspended in a 
volume of 6 ml of wash buffer 1 and stored at 4°C. 
  
2.2.3.2.  IPTG Induction 
 
 A single colony of bacteria transformed with pET-28a plasmid containing the gene of interest 
was inoculated in 100 ml of LB-KAN medium and incubated overnight at 37°C in a shaker. 
The following day, 50 ml of the overnight culture was inoculated in 1 l of LB-KAN medium 
incubated for 1 hr at 37°C and subsequently for 30 min at RT, in a shaker. IPTG was added to 
a final concentration of 1 mM to the bacterial culture to induce protein production. The 
culture was further incubated at RT for 4 to 6 hrs in a shaker. The bacterial cells were 
collected by centrifugation at 4000 rpm for 20 min at 4°C. The pellet was washed once with 
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30 ml of 1X PBS and the cell suspension was collected in a 50 ml falcon tube, centrifuged at 
3500 rpm for 20 min at 4°C. The supernatant was discarded and the pellet was stored at -
80°C.  
   
2.2.3.3.  Preparation of protein extract and binding of protein to beads 
 
 The pellet was thawed and re-suspended in 10 ml of wash buffer 1 (without urea; containing 
protease inhibitors) on ice. The suspension was sonicated three times for 20 sec each and 
centrifuged at 15000 rpm for 30 min at 4°C. The supernatant was transferred into a fresh 50 
ml falcon tube to which urea was added at a final concentration of 8 M and the volume was 
made up to 50 ml using wash buffer 1. Then, 2 ml of the equilibrated beads was added and 
the solution was incubated overnight at RT on a rotating wheel.  
 
2.2.3.4.  Wash and protein elution 
 
 The solution was centrifuged at 1000 rpm for 5 min at RT. The beads were washed three 
times with 40 ml of wash buffer 1 and wash buffer 2 for 5 min each respectively. The protein 
was finally eluted three times using 1 ml of elution buffer for 10 min each respectively. The 
supernatant containing the protein was flash frozen in liquid Nitrogen and stored at -80°C.  
   
2.2.3.5.  Protein precipitation  
 
 One volume of 20% precooled TCA was added to one volume of eluted protein solution and 
the mix was incubated at -80°C for 30 min. The solution was then transferred into a 
polycarbonate tube and ultra-centrifuged at 80000 rpm for 25 min. The supernatant was 
removed and the pellet was washed with 80% precooled Acetone and transferred into an 
eppendorf tube. The sample was subjected to centrifugation at 15000 rpm for 30 min. The 
supernatant was discarded while the pellet was dried and re-suspended in 1X PBS containing 
Triton X-100 at a concentration of 0.1%. The precipitated protein was stored at -80°C.  
 
2.2.4.   Genotyping of DNA samples from tissues 
 
2.2.4.1.  Equilibration of nexttec™ cleanplate96 
 
 350 μl of Prep Buffer was added on to each well of nexttec™ cleanplate96, incubated at RT for 
5 min and centrifuged at 350x g for 1 min.  
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2.2.4.2.  Lysis 
 
 To each sample of tissue, 265 μl Buffer G1, 10 μl Buffer G2 and 25 μl Buffer G3 was added and 
incubated at 61°C, 1100 rpm for 1 hr.  
 
2.2.4.3.  Purification of genomic DNA 
 
 Upon lysis, 120 μl of each of the lysates was transferred to the equilibrated nexttec™ 
cleanplate96 and incubated for 3 min at RT. The plate was centrifuged at 700x g for 1 min and 
the eluate contained the purified DNA.  
 
2.2.5.   Polymerase Chain Reaction 
 
 The purified DNA was incorporated into the reaction mix for PCR amplification and the PCR 
reaction was carried out in a PTC-225 Peltier Thermal Cycler (Tables 4, 5, and 6 for Cplx1, 
tables 8, 8.1, 9, and 9.1 for Nex-Cre SNAP-29 and tables 11, 11.1 for constitutive SNAP-29 KO).  
 
2.2.6.   Agarose Gel Electrophoresis 
 
 In order to analyze DNA samples and determine the genotype of the animals, the DNA 
samples obtained after PCR amplification were subjected to electrophoresis on a 1% Agarose 
gel. First, the PCR DNA samples were diluted in gel loading buffer. The gel was prepared by 
adding 1 g Agarose to 100 ml of 1X TBE Buffer, and the solution was microwaved at 900W for 
3 min. The gel solution was incubated in a water bath at 50°C for 45 min and then poured on 
to the holding cassette after addition of GelRed in a final concentration of 1:20,000. The 
samples were then loaded on the solidified agarose gel along with the 100 bp ladder. The gel 
was run for 45 min at 115 V and visualized under UV illumination and the band sizes were 
documented. Depending on the size and presence or absence of the bands, the DNA sample 
was verified as knockout, heterozygous or homozygous control (Fig.10. Cplx1 PCR products, 
and Fig.11. SNAP29 PCR products). 
 
2.2.6.1.  Genotyping results from PCR and agarose gel electrophoresis 
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I performed PCR amplification of the genomic DNA isolated from tail biopsies of mice, to 
identify the KO and littermate heterozygote/wild type animals. PCR amplification was 




Parent mice used for breedings were Cplx1 (+/-) and Cplx2 (-/-) and Cplx3 (-/-). The tail DNA 
samples were subjected to electrophoresis, and genotyping results yielded a Cplx1 WT band 
at 333 bp, and Cplx1 KO band at 425 bp.  
  
     10.A.     10.B. 
                            
 
Figure 10 Genotyping results for Cplx1 PCR. (A) and (B) Cplx1 WT and Cplx1 
KO PCRs respectively (Tables 4, 5 and 6) for DNA samples from P0 or 
E18 animals.  DNA sample 1 lacks WT fragment of 333 bp, but contains 
Cplx1 KO fragment at 425 bp. Hence, DNA sample 1 is a Cplx1 
knockout (-/-). DNA sample 2 contains a WT fragment of 333 bp and a 




SNAP-29 conditional and constitutive KO mice were generated by Nex-Cre and EIIa-Cre 
mediated deletion of exon-2 on the SNAP-29 gene, respectively (Appendix 6.1.). In case of the 
Nex-Cre SNAP-29 KO, the exon-2 of SNAP-29 was flanked by two LoxP cassettes to obtain a 
floxed target allele. Nex-Cre mediated recombination of the target allele resulted in deletion 
of exon-2, loss of SNAP-29 protein expression. Cross-breeding mice carrying a floxed target 
allele and mice expressing cre-recombinase under the Nex promoter resulted in litters of 
animals that were wild type (620 bp), or floxed/wild-type heterozygotes (765 bp/620 bp), or 
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floxed/floxed KO (765 bp). Cre-recombination could be confirmed by the presence of a 450 
bp fragment. Similarly, crossing mice carrying the targeted KO allele with mice expressing 
Cre-recombinase under the EIIa promoter, resulted in litters of animals that were 
homozygous SNAP-29 KO (-/-) (430 bp), or wild type (+/+) (343 bp), or heterozygous for 
SNAP-29 (+/-) (343 bp /430 bp). 
 
     11.A.      11.B. 
                       
 
Figure 11 Genotyping results for SNAP-29 conditional and constitutive 
deletion. (A) Floxed SNAP-29 gene is 765 bp in size, while SNAP-29 
wild type is 620 bp is size. Nex-Cre mediated recombination results in 
loss of SNAP-29 exon-2 yielding a 450 bp fragment. Since Cre-
recombinase targets the gene in the presence of LoxP sites, no 
recombination is observed in case of SNAP-29 wild type (+/+). (B) 
EIIa-Cre mediated recombination results in the constitutive loss of 
SNAP-29 exon-2. SNAP-29 homozygous knockouts (-/-) are 430 bp in 
size, while the wild type is 343 bp in size. 
 
2.2.7.   SDS - Polyacrylamide Gel Electrophoresis 
 
 SDS-Polyacrylamide Gel Electrophoresis is a technique used to separate a complex mixture of 
proteins, and to verify the homogeneity of samples. In order to ensure dissociation of 
proteins into their individual polypeptide subunits and to minimize aggregation, a strongly 
reducing agent such as SDS is added to aid the migration of the SDS-polypeptide complexes 
according to the size of the polypeptide through the pores formed via cross-linking of the 
polymerized bisacrylamide (Laemmli, UK, 1972).  
 
2.2.7.1.  Preparation of SDS-Polyacrylamide Gels 
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 The glass plates were first assembled according to manufacturer’s instructions. The 
appropriate volume of resolving gel was prepared and poured in between the plates, leaving 
sufficient space for the stacking gel and space for the comb. The gel solution was overlaid 
with water-saturated Butanol. After 30 min, the Butanol was poured off and the solidified gel 
surface was washed with water. Next, the appropriate volume of stacking gel was prepared 
and poured over the polymerized resolving gel. A Teflon comb was immediately inserted into 
the stacking gel solution to create wells for loading samples.  
 
2.2.7.2.  Preparation of samples 
 
 All samples were heated at 100°C for 5 min in laemmli buffer prior to loading on SDS-gels in 
order to denature the proteins and ensure optimal band resolution.  
 
2.2.7.3.  Electrophoresis of gels 
 
 After the polymerization of the stacking gel, the comb was removed and the wells were 
washed with water. The gel was mounted on the electrophoresis apparatus and the running 
buffer was added to the top and bottom reservoirs. The samples were loaded on to the wells 
using a Hamilton micorlitre syringe. The electrophoresis apparatus was attached to a power 
supply and a current of 25 mA was applied to one gel until the samples reached the bottom of 
the resolving gel. Thereafter, the power supply was turned off, and the gel plates were 
disassembled to obtain the electrophoresed gel for staining or blotting purposes.  
 
2.2.8.   Coomassie Staining of proteins in SDS-PAGE gels 
 
 The Coomassie Brilliant Blue staining procedure helps in easy and rapid detection of proteins 
on the gel. For staining, the gel was placed in a plastic container, covered with 5 volumes of 
Coomassie staining solution and agitated on an orbital shaker for 20 min. Thereafter, the 
solution was discarded and the gel was covered with destaining solution for 2 hrs. The 
destaining solution was changed several times to obtain a clear background against the 
protein bands.  
 
2.2.9.   Western Blotting 
 
2.2.9.1.  Protein transfer from gel to nitrocellulose membrane 
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 After completion of electrophoresis, the gel sandwich was disassembled and the stacking gel 
was discarded. The transfer sandwich comprised of nitrocellulose membrane of precut size in 
contact with the resolving gel, both surrounded by whatmann papers of precut size, porous 
pads and plastic supports. The transfer was performed with the gel towards the cathode in a 
tank containing two electrode panels. The transfer of proteins from gel to the nitrocellulose 
membrane was achieved by applying a current of 250 mA for 2 hrs or 40 mA overnight at 4°C 
(Towbin et al., 1979).  
 
2.2.9.2.  Ponceau S staining of proteins 
 
 Upon completion of protein transfer, the nitrocellulose membrane was carefully removed 
from the transfer sandwich. It was stained with Ponceau S for a few minutes at RT. Thereafter 
the membrane was washed with water to destain Ponceau S and air-dried at RT. 
 
2.2.9.3.  Immunoblotting for ECL analysis 
 
 The Enhanced Chemiluminescence (ECL) Western Blotting analysis system is a non-
radioactive method used for detection of antigen epitopes on the immobilized target protein, 
conjugated directly or directly with horseradish peroxidase (HRP)-labelled antibodies. In this 
procedure, the non-specific binding sites on the nitrocellulose membrane anchoring the 
proteins were blocked by immersing the membrane in 10 ml of blocking buffer (buffer A) for 
30 min on an orbital shaker. The primary antibody was diluted in fresh buffer A at the 
appropriate concentration, after which it was added on to the membrane and incubated for 1 
hr at RT. Next, the membrane was washed 5 times for 5 min each with buffer B at RT. The 
HRP-labelled secondary antibody was diluted in buffer B and incubated on the membrane for 
1 hr at RT. The membrane was washed 4 times for 5 min each wit buffer B at RT. Then the 
membrane was washed with buffer C and buffer D once each for 5 min at RT. The membrane 
was placed on a glass plate with the protein side upwards and the excess buffer was drained 
off. The detection reagents were mixed in a 1:1 proportion and added to the surface of the 
membrane. The reagent mixture was incubated for 1 min at RT without any agitation, and 
then drained off. The membrane was covered with a transparency and air bubbles were 
smoothed out. The membrane was exposed to sheets of Hyperfilm ECL for different time 
periods ranging from 5 sec to 5 min in the dark room. The films were removed and developed 
in the developer.  
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2.2.9.4.  Immunoblotting for Odyssey® analysis 
 
 The Infrared Imaging system Odyssey® developed by LI-COR Biosciences is a widely used 
protein detection system, which employs Infrared fluorescence dyes IRDye® coupled 
secondary antibodies to label proteins. The system uses the digital software Image Studio™ 
Lite, for quantitative analysis of Western Blots thereby eliminating the need for films, dark 
rooms and associated costs yet providing a sensitive and accurate method for detecting 
strong as well as weak protein bands. This procedure involved the following steps.  
 
The non-specific sites on the nitrocellulose membrane were blocked using the blocking buffer 
for 1 hr at RT. The primary antibody was diluted in the required concentration in the 
antibody buffer and added to the membrane after removal of blocking buffer. The membrane 
was slowly agitated on an orbital shaker for 1 hr at RT. Then, the membrane was washed 5 
times for 5 min each with the wash buffer. The IRDye® coupled secondary antibody was 
diluted in fresh antibody buffer at required concentration and incubated on the membrane 
for 1 hr at RT in the dark in order to prevent photobleaching of the fluorescent IRDye®. The 
membrane was then washed 3 times for 5 min each with the wash buffer in the dark and 
subsequently washed 2 times for 5 min each with 1X PBS. The membrane was then analyzed 
with Odyssey®.  
   
2.2.10.  Growth and maintenance of HEK293FT cell line 
 
 The growth and maintenance of the HEK293FT cell line was done in accordance with the 
protocol from Invitrogen. 
 
2.2.10.1.  Thawing cells 
 
 One vial of HEK293FT cells was thawed in a 37°C water bath. The vial was decontaminated 
on the outside with 70% Ethanol and the cells were transferred to a 15 ml sterile tube 
containing 1X PBS. The cells were briefly centrifuged at 150-200 xg and resuspended in 2 ml 
of complete medium lacking Geneticin®. The cells were transferred into a T-75 cm2 flask 
containing 10 ml of complete medium lacking Geneticin®. The flask was incubated overnight 
at 37°C to allow the cells to attach to the base of the flask. The medium was aspirated the 
following day and replaced with fresh complete medium containing Geneticin®. The flask was 
incubated at 37°C until the cells were 80-90% confluent.  
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2.2.10.2.  Subculturing cells 
 
 The cells were passaged when they were at least 80% confluent. The medium from the flask 
was aspirated and the cells were washed once with 10 ml of 1X PBS to remove any excess 
medium. Then 2 ml of Trypsin-EDTA was added to the monolayer of cells and incubated for 1 
min at 37°C for the cells to detach from the base of the flask. About 8 ml of complete medium 
containing Geneticin® was added and the cell suspension was transferred to a 15 ml sterile 
conical tube. The total cell count was determined using a hemocytometer. The cells were 
seeded at recommended densities after diluting in pre-warmed medium. The cells were 
maintained in adherent monolayer cultures over a few passages before transfections.  
 
2.2.10.3.  Freezing cells 
 
 The HEK293FT cells were grown to 90% confluency after which the medium was aspirated 
and the cells were washed once with 10 ml of 1X PBS to remove any excess medium. Then 2 
ml of Trypsin-EDTA was added to the monolayer of cells and incubated for 1 min at 37°C for 
the cells to detach. About 8 ml of complete medium containing Geneticin® was added and the 
cell suspension was transferred to a 15 ml sterile conical tube. The total cell count was 
determined using a hemocytometer. The cell suspension was centrifuged at 250 xg for 5 min 
at RT. The medium was carefully aspirated and the cell pellet was re-suspended in a pre-
determined volume of chilled freezing medium comprising of 90% complete medium and 
10% DMSO. The suspension was dispensed as aliquots in cryovials and the cells were frozen 
at a density of 3 x 106 viable cells per ml in a controlled-rate freezing apparatus where the 
freezing rate was decreased at 1°C per minute. The vials were transferred into liquid nitrogen 
for long-term storage.  
 
2.2.11.  Lentivirus Production 
 
 The protocol for lentivirus production was optimized from the standard protocol offered by 
Invitrogen. 
 
2.2.11.1.  Coating dishes 
 
 For coating 15 cm dishes, a mixture of Poly-L-Lysine and PBS was used in a ratio of 1:11 
respectively. The mixture was mixed well and added to 15 cm dishes to cover the surface. The 
plates were incubated at 37°C for at least 1 day for the PLL to layer coat the plate entirely.  
 69 
 
2.2.11.2.  Transfection into HEK293FT cells  
 
 About 1.6 x 107 cells were seeded on day 1 on a PLL-coated 15 cm dish containing OptiMEM 
medium with 10% FBS. After 24 hours on day 2, the cells were 90% confluent and were used 
for transfections with the plasmid DNA of interest. First, a mixture of 60 μl Lipofectamine® 
2000 and 6 ml plain OptiMEM medium was prepared. Simultaneously, 25 μg the DNA of 
interest was added to 6 ml of plain OptiMEM medium along with 6 μg of the enveloping DNA 
and 6 μg of packaging DNA and incubated at RT for 5 min. The Lipofectamine® 2000 and DNA 
mixtures were combined and incubated at RT for 1 hr. The mixture was then added to the 
dish containing the HEK293FT cells and 10 mM of Sodium Butyrate was added to inhibit 
further cell proliferation and induce expression of the DNA of interest. The cells were 
incubated at 37°C for 7 hours, after which the medium was replaced with fresh DMEM 
medium containing FCS, Pencillin-Streptomycin, and Sodium Butyrate. 
 
2.2.11.3.  Harvesting Lentivirus 
 
 Lentiviruses were produced according to S2 level biosafety regulations from HEK293FT cells. 
After 48 hours of transfection, the cells were found to detach from the plate surface 
implicating virus production and consequent cell death. The virus containing medium from 
the dish was transferred into a 50 ml falcon tube and centrifuged at 2000 rpm for 5 min at 
4°C. The supernatant was filtered through a Luer-Lock syringe system and a 0.45 μm filter 
into a fresh 50 ml falcon tube and the cell pellet was discarded. 10 ml of the filtered 
supernatant solution was transferred into an AMICON filter system tube. The solution was 
centrifuged at 4300 rpm for 10 min at 4°C and the flow-through was discarded. The 
procedure was repeated for the remaining supernatant solution and the virus was washed 
twice with 10 ml of plain Neurobasal medium. Subsequently, the virus was washed twice with 
5 ml of 1X TBS and the virus was concentrated to 500 μl in the filter. The lentivirus was 
dispensed as aliquots in cryovials, flash-frozen in Liquid Nitrogen and stored at -80°C for 
long-term use. 
 
2.2.11.4.  Lentiviral Infections in neurons 
 
 The lentivirus prepared was thawed to RT and added to neurons at DIV 2 for the optimal 
infection and protein expression.  
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2.2.12.  Mouse Strains 
 
 The respective mutant and control mice for individual neuron culture experiments were 
obtained from one litter. Cplx TKO mice (Xue et al., 2008) were generated by interbreeding 
Cplx I+/- Cplx II-/- Cplx III-/- parent mice. Littermates Cplx I+/- Cplx II-/- Cplx III-/- served as 
controls for some experiments. Nex-Cre SNAP29 KO mice (Goebbels et al., 2006) and 
constitutive SNAP-29 KO mice were generated by Dr Sandra Goebbels and Georg Wieser (MPI 
Experimental Medicine, Göttingen, Germany).  
   
2.2.13.  Autaptic Neuron Culture 
 
 The autaptic neuron culture was prepared according to standard published protocol 
(Burgalossi et al., 2012). 
 
2.2.13.1.  Preparation of glass coverslips 
 
 The glass coverslips were immersed in a glass beaker containing 1N HCl and swirled gently 
overnight. The HCl was drained and any debris was rinsed off using distilled water. The 
coverslips were then washed twice for 10 min in 70% Ethanol and once for 10 min in 100% 
Ethanol. The coverslips were then stored in 100% Ethanol.  
 
2.2.13.2.  Preparation of plates  
 
 The coverslips were taken one at a time and placed slanted towards the wall of the well in 
order to allow them to dry off the Ethanol. This procedure was done on the sterile bench and 
the coverslips were air-dried for at least 15 min before being placed horizontally on the well 
surface. A solution of 0.15% Agarose was made in water and microwaved for 3 min for 
complete dissolution. About 2 ml of the Agarose solution was added to each well and 
removed after 10 sec. The coating of Agarose was allowed to air dry for 15 min after which 
the plates were sterilized under UV for 30 min.  
 
2.2.13.3.  Stamping the agarose coated coverslips 
 
 In order to stamp the agarose coated coverslips, a mixture of 3 parts acetic acid, one part 
collagen and one part PDL was used for preparation of a stamping medium. About 1.5 ml of 
the medium was added on to small folded tissues and the stamp was dipped on this stamping 
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pad to get just enough medium on. The agarose layer on the well was gently stamped and the 
procedure was repeated to stamp all the wells. The plates were allowed to air dry for 20 min 
and sterilized under UV for 30 min. The plates were ready to be used for cultures. 
 
2.2.13.4.  Culturing Cortical Astrocytes in T-75 cm2 flasks 
 
 The cortical astrocytes adhere well to the PDL-Collagen stamp islands to form a feeder layer 
for the growth of autaptic neurons. To culture cortical astrocytes, the cortices from the P0 
mouse brain were dissected in ice-cold HBSS removing the meninges and hippocampi. The 
cortices were transferred into 1 ml of 0.05% Trypsin-EDTA and were incubated on a shaker 
at 450 rpm for 15 min at 37°C. The solution was then discarded and the cortices were washed 
twice with 500 μl of FBS medium. Then cortices were dissociated by trituration for about 30 
times in 500 μl of FBS medium. About 13 ml of FBS medium was added to the T-75 cm2 and 
the triturated cortices were added to the flask and mixed gently. The flask was incubated at 
37°C, 5% CO2 and the medium was changed to fresh FBS after 24 hours to allow the growth of 
astrocytes. The astrocytes were ready to use after 1 week when they were 70% confluent.  
 
2.2.13.5.  Preparation of astrocyte micro-islands 
 
 The stamped culture plates were sterilized for 1 hour under UV. The T-75 cm2 was removed 
and vortexed for 2 min at high speed. The medium containing all detached non-astrocytic 
cells was removed. The astrocytes were rinsed twice with 10 ml of sterile PBS. 5 ml of 0.05% 
Trypsin-EDTA was added to the astrocytes for 30 sec and removed. The flask was incubated 
for 10 min at 37°C, 5% CO2. Simultaneously, the sterile culture plates were filled with 2 ml of 
FBS per well. After 10 min, the trypsinization was stopped in the flask using 10 ml of FBS; the 
astrocytes were carefully washed down the flask and removed into a 50 ml falcon. The cells 
were triturated using a 10 ml pipette and counted using a hemocytometer. Upon counting, 
the astrocyte cells were seeded on to the wells of the plates at an appropriate density 
depending on the stamp size. The plates were shaken for about 2 min in order to ensure 
homogenous distribution of cells. The plates were kept in the incubator for up to 2 days and 
used for neuron culture.  
 
2.2.13.6.  Preparation of neurons for autaptic culture 
 
 For neuron culture, the hippocampi were dissected from the brain of a E18/P0 mouse and 
placed in 500 μl of papain solution in a 1.5 ml eppendorf tube. They were digested for 1 hour 
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at 37°C under constant agitation at 450 rpm. Next, the papain solution was removed and 500 
μl of the STOP solution was added and incubated for 15 min at 37°C, 450 rpm. The STOP 
solution was removed and the hippocampi were washed twice with 500 μl of NBA medium. 
The hippocampal neurons were then gently triturated in 200 μl of NBA medium and the tube 
was kept undisturbed for 1 min to allow the cell debris to settle at the bottom of the tube. The 
cell supernatant was extracted and mixed with 1 ml of fresh NBA medium. The neurons were 
counted using a hemocytometer and seeded at the appropriate density on to the plates. 
 
2.2.14.  Electrophysiology of autaptic neurons 
 
 Whole-cell voltage clamp measurements were performed on single neurons over astrocyte 
microislands (autapses) using Multiclamp 200B (Molecular devices) under the control of 
Clampex 10.1 (Molecular devices). Neurons were clamped at -70 mV, the series resistance 
was compensated and action-potential (AP) induced evoked responses were triggered by a 2 
ms somatic depolarization to 0 mV. Neurons were stimulated at 0.2 Hz to measure basal 
evoked responses (EPSCs/IPSCs) in the standard external solution. A perfusion system was 
used to apply hypertonic sucrose solution directly on the patched neuron for duration of 5 s 
in order to measure the size of the readily releasable vesicle pool from the charge transfer of 
the sucrose-induced transient synaptic current. Evoking 50 and 100 synaptic responses at 
high-frequency stimulations of 10 Hz and 40 Hz respectively determined the short-term 
synaptic plasticity. Quantal release (mEPSCs and mIPSCs) was measured for duration of 100 s 
by directly perfusing standard external solution containing 300 nM TTX on to the neuron. In 
order to detect miniature events, traces were digitally filtered at 5 kHz offline and events 
were automatically detected using a defined template function in Axograph 1.0. All data were 
analyzed offline using Axograph 1.0 (Axograph Scientific) and Kaleidagraph (Synergy 
Software). Statistical significance was tested using Student’s t-test.  
 
2.2.15.  Collagen-PDL coating of 24 well plates and 6 cm dishes 
 
 A combination of Acetic acid, Collagen and Poly-D-Lysine at predetermined concentrations 
was prepared and mixed well. The solution was uniformly spread on to the surface of the 
wells using a cotton swab. The plated were air-dried and UV-sterilized for 1 hr under the 
airflow hood. The plates were closed and stored at RT and UV-sterilized for 1 hr before use.  
 
2.2.16.  Continental Neuron Culture 
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 In order to make continental cultures of neurons, the brain of a Embryonic day 18 (E18) or 
Postnatal day 0 (P0) mouse pup was dissected to remove the hippocampi. Both the 
hippocampi were incubated in 500 μl of papain solution for 45 min or 1 hr respectively at 
37°C with constant agitation at 450 rpm after which the solution was removed and 500 μl of 
the STOP solution was added. The hippocampi were incubated for 15 min at 37°C in a shaker 
at 450 rpm. The STOP solution was removed and the hippocampi were washed twice with 
500 μl of NBA+B27 medium. Then, 200 μl of the NBA+B27 medium was added and the 
hippocampi were gently triturated for 20 times. The cell debris was allowed to settle for 1 to 
2 min. About 180 μl of the supernatant containing the neurons was removed and added to 1 
ml of fresh NBA+B27 medium. The cell suspension was mixed well by inversion and the total 
cell count was determined using a hemocytometer. After determination of the cell count, the 
neurons were plated out at a density of 1,000,000 cells per 6 cm coated dish in order to 
obtain a confluent continental neuron culture. The media in the wells was changed after 48 
hours to remove cell debris.  
 
2.2.17.  Immunocytochemistry of continental neuron cultures 
 
 Neurons cultured on 24-well coverslips were used after 14 days in-vitro for 
immunocytochemical staining. The medium was aspirated and the cells were briefly washed 
with 1X PBS. 4% PFA containing sucrose in PB buffer was added to RT and incubated at RT 
for 7 min. The cells were washed for 4 times, 5 min each with 1X PBS. The cells were 
permeabilized using PBS solution containing goat serum and Triton-X 100 for 30 min. The 
cells were washed twice with 1X PBS. The blocking solution made of 1X PBS and goat serum 
was added to the cells and incubated for 30 min. The blocking solution was aspirated and 
fresh blocking solution containing the primary antibodies were added and incubated 
overnight at 4°C. The cells were washed 3 times the next day with 1X PBS. The Alexa-
fluorophore labeled secondary antibodies were diluted in the blocking solution and added to 
cells. The cells were incubated for 90 min in the dark at RT, and were further washed 3 times 
with 1X PBS. The coverslips were mounted onto glass slides using the aquamount solution 
and analyzed using an epifluorescent microscope.   
 
2.2.18.  Harvesting proteins from continental neuron cultures 
 
 After 14 days of neuron growth, the medium from the plate was aspirated and the neurons 
were washed once with 1X PBS to remove any excess medium. Then, 30 μl of PBS containing 
a cocktail of protease inhibitors was added to one well and the cells were vigorously scraped 
 74 
using a cell scraper. The cell suspension was transferred into a small eppendorf tube and 
briefly homogenized using a 30G needle and a 1 ml syringe. A small aliquot of the 
homogenized cell suspension was taken for estimation of the protein concentration using 
Bradford’s assay and the remaining sample was stored at -80°C.  
 
2.2.19.  Bradford’s Assay  
 
 The Bradford’s assay was performed for all samples such as cortical homogenates, cell lysates 
and recombinant proteins to ascertain the concentration of proteins in a given volume of 
sample. BSA was used as protein standard in concentrations of 0, 0.025, 0.05, 0.075, 0.1, 
0.125 μg/ml in a total volume of 200 μl of ddH2O. The dye reagent was diluted 5 times in 
ddH2O, filtered and stored in the dark at 4°C. The samples were diluted in the ratios of 1:100 
and 1:200 in 200 μl of ddH2O. The wavelength for absorbance was set at 595 nm in the 
spectrophotometer. Each of the standards was mixed with 800 μl of the dye reagent and the 
mixture was transferred into disposable plastic cuvettes of 1 ml capacity. The absorbance 
was recorded in the spectrophotometer and the procedure was repeated for the protein 
samples. A hyperbolic graph was obtained plotting the absorbance values at 595 nm against 
the protein concentrations. The slope of the graph was used to determine the protein 






















3.  Results 
 
3.1.  Results - SNAP-29 
 
3.1.1.  Insights into the role of SNAP-29 at neuronal synapses 
 
SNAP-29, as many studies have indicated, is a ubiquitously expressed protein and also a 
closely related paralog of neuronal SNAP-25. In my study, I investigated the physiological role 
of SNAP-29 at synapses in the mouse brain. 
 
For this purpose, two genetic mouse mutants of SNAP-29 were generated (See Appendix 6.1). 
First, targeted deletion of the SNAP-29 gene from forebrain glutamatergic neurons was 
performed via Nex-Cre (Goebbels et al., 2006) driven recombination of a conditional SNAP-29 
KO allele. The conditional loss of SNAP-29 from the hippocampus and the cerebral cortex did 
not cause any morphological or behavioral abnormalities in newborn mice. Subsequently, 
SNAP-29 constitutive KO mice were generated. These mice exhibited a strong keratoderma 
phenotype, as observed in patients suffering from the CEDNIK syndrome, and survived only a 
few hours after birth. The perinatal lethality was thus an intriguing characteristic that 
motivated my study on synaptic function in SNAP29 KO neurons. 
 
3.1.1.1. Protein composition in the Nex-Cre SNAP-29 KO mice 
 
I prepared cortical homogenates and neuronal lysates from KO and WT littermate animals for 
biochemical studies. Using Western blotting and enhanced chemiluminescence (ECL), I 
analyzed the expression levels of SNAP-29 and the SNARE proteins namely SNAP-25, 
Syntaxin-1, and Synaptobrevin-2. I found that the expression of SNAP-29 was strongly 
reduced in Nex-Cre KO cortex when compared with littermate WT cortex (Fig.12.A.) however, 
expression of other SNARE proteins was unaltered (Fig.12.C.). Furthermore, I analyzed the 
protein expression levels in cultured hippocampal neurons and found that the KO neurons 
exhibited a clear reduction in SNAP-29 (Fig.12.B.). In all cases, β-Tubulin was used as loading 





Figure  12.  Biochemical analysis of the protein composition in the  
Nex-Cre SNAP-29 KO neurons. (A) Expression levels of SNAP-29 
(~29 kDa) in the cortex of 3 WT and 2 NexCre SNAP29 KO animals as 
assessed by Western blotting (B) Expression levels of SNAP-29 in 
cultured hippocampal neurons of 2 WT and 2 NexCre SNAP29 KO 
animals as assessed by Western blotting (C) Expression levels of 
SNAP-29 and neuronal SNARE proteins SNAP-25 (25 kDa), Syntaxin-
1AB (~35 kDa), and Synaptobrevin-2 (15 kDa) in the cortex of WT and 
NexCre SNAP29 KO mice. KO animals exhibited a strong reduction in 
SNAP-29 levels in cortex and hippocampal neurons. Loading control β-
Tubulin (55 kDa) was used for all experiments. 
 
3.1.1.2. Normal glutamatergic synaptic transmission in Nex-Cre SNAP29 KO mice 
 
Exogenous addition and over-expression of SNAP-29 was previously shown to inhibit 
synaptic release in neurons in an activity dependent manner (Su et al., 2001; Pan et al., 2005). 
However, several questions were raised on the role of endogenous SNAP-29. As the Nex-Cre 
mediated deletion of SNAP-29 drastically lowered the endogenous SNAP-29 protein levels in 
the forebrain, I studied the basic parameters of synaptic transmitter release by performing 
whole-cell patch clamp recordings in autaptic hippocampal neurons from NexCre SNAP29 KO 
mice and WT littermates. The amplitudes of evoked excitatory post-synaptic currents (EPSC), 
the size of the readily releasable pool of vesicles and the vesicular release probability in KO 
and WT neurons were not significantly different (Fig.13. A. B. and C.). 
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Figure 13.  Normal excitatory synaptic transmission in hippocampal  
neurons of Nex-Cre SNAP-29 KO. (A) Mean EPSC amplitude of WT 
and SNAP29 deficient neurons was similar (B) Mean RRP size 
measured as charge triggered by the application of 0.5 M sucrose 
solution was similar (C) Mean vesicular release probability estimated 
as the ratio of charge of the evoked EPSC to the charge of the RRP was 
similar. Error bars indicate standard error of mean. Numbers of 
neurons analyzed are indicated on bars. Absolute values are indicated 
in Table 12. No statistically significant differences were observed 
(Students t-test). 
 
I measured the short-term plasticity by applying stimulations of 10 Hz and 40 Hz, but found 
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Figure 14.  Normal short-term plasticity in hippocampal neurons of  
Nex-Cre SNAP-29 KO. (A) and (B) Normalized synaptic responses 
observed upon stimulation of WT and SNAP29 deficient neurons at 
frequencies of 10 Hz and 40 Hz, respectively. 
 
Down-regulation of SNAP-29 was indicated to increase the rate of turnover of the vesicle pool 
(Pan et al., 2005). In order to test this claim, I measured the spontaneous release by 
exogenous application of 300 nM TTX immediately after a train stimulation of 40 Hz. Since 
high-frequency stimulations increase residual calcium in the terminal, spontaneous release of 
release-ready vesicles increases manifold as newly primed vesicles join the pool. The 
increased basal Ca2+ does not have an effect on the amplitudes of spontaneous miniature 
events. In my study, I found that immediately after stimulation at 40 Hz, the frequency of 
mEPSC events increased approximately three-fold (compared to the mEPSC frequency at 
resting conditions) in both the WT and KO neurons (Fig.15.A.) and no significant differences 
observable. The frequency of spontaneous miniature currents measured at resting conditions 
was similar in WT and KO neurons (Fig.15.B.). The mEPSC amplitudes remained unchanged 
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Figure 15.  Normal mEPSC release in excitatory hippocampal  
neurons of Nex-Cre SNAP-29 KO. Miniature responses measured in 
the presence of 300 nM TTX to block APs. (A) and (C) Mean mEPSC 
frequency and amplitudes immediately after high-frequency 
stimulation of 40 Hz, (B) and (D) Mean mEPSC frequency and mEPSC 
amplitudes at rest. Error bars indicate standard error of mean. 
Numbers of neurons analyzed are indicated on bars. Absolute values 
are indicated in Table 12. No statistically significant differences were 







Table 12. Synaptic parameters measured from excitatory autaptic hippocampal neurons 
of WT and Nex-Cre SNAP29 KO mice 
 
Parameters WT  Nex-Cre SNAP29 KO 
 
Mean EPSC Amplitudes (nA) 
± S.E.M. 
4.1696 ± 0.24786 
(n=101) 
4.3589 ± 0.31405  
(n=87) 
Mean RRP Size  
(nC) ± S.E.M. 
0.387190 ± 0.05073 
(n=50) 
0.41526 ± 0.046521 
(n=50) 
Mean Pvr  
(%) ± S.E.M. 
8.5279 ± 0.76799 
(n=50) 
7.9025 ± 0.79510  
(n=50) 
Mean mEPSC Frequency 
(After 40 Hz) (Hz) ± S.E.M. 
10.252 ± 1.0882 
(n=56) 
8.3309 ± 0.67503  
(n=53) 
Mean mEPSC Amplitude 
(After 40 Hz) (pA) ± S.E.M. 
22.698 ± 1.2046 
(n=56) 
22.486 ± 1.1481  
(n=53) 
Mean mEPSC Frequency (At 
rest) (Hz) ± S.E.M. 
2.9407 ± 0.47954 
(n=41) 
2.9765 ± 0.28224  
(n=40) 
Mean mEPSC Amplitude (At 
rest) (pA) ± S.E.M. 
24.602 ± 1.6743 
(n=41) 
25.646 ± 1.7048  
(n=40) 
    S.E.M. is standard error of mean     n is total number of cells pooled from  
       multiple cultures. 
 
3.1.1.3. Protein composition in the brain of constitutive SNAP-29 KO mice 
 
As the constitutive SNAP-29 KO mice exhibited the Keratoderma phenotype, they could be 
visually distinguished from WT littermates. I prepared cortical homogenates from the WT 
and KO animals and subjected the samples to biochemical analysis. I found that the 
constitutive deletion of SNAP-29 gene resulted in a complete loss of the SNAP-29 protein 
(also corroborated by tail genotyping and PCR). I tested the expression levels of cognate 
SNAREs and the paralogs of SNAP-29 namely, SNAP-25, SNAP-23 and SNAP-47 and found 
that loss of SNAP-29 did not up-regulate the expression of other paralogs or SNAREs 
(Fig.16.). 
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Figure 16.  Protein composition in SNAP-29 constitutive KO mouse  
brain. Expression levels of SNAP-29 and other candidate proteins in 
WT and constitutive SNAP-29 KO cortical lysates. Complete loss of 
SNAP-29 in the KO cortex but normal expression in WT was observed, 
while Syntaxin-1AB (35 kDa), Synaptobrevin-2 (15 kDa), and SNAP-25 
(25 kDa) were expressed normally, along with SNAP-47 (47 kDa) and 
SNAP-23 (two likely alternative splice variants detected as two bands 
at ~23 kDa) in both WT and KO animals. β-Tubulin (55 kDa) was used 
as loading control.  
 
3.1.1.4. Immunocytochemical analysis of SNAP-29 in hippocampal neurons 
 
SNAP-29 was previously shown to co-localize with the presynaptic marker Synaptophysin 
(Su et al., 2001). However, the corresponding experiments lacked a valid control. In my study, 
I performed immunostaining on cultured hippocampal neurons (DIV: 14) from SNAP-29 KO 
and WT animals to check for presynaptic expression of SNAP-29 in neurons, and used 
VGLUT-1 as a presynaptic marker. Although visibly diffuse expression of SNAP-29 (in green) 
is observable throughout the soma and the neuronal processes in the WT animals, a co-
localization with VGLUT-1 (in red) in the presynaptic compartment was not detectable 








17.A. SNAP-29 WT 
 
17.B. SNAP-29 KO 
 
 
Figure 17.  Immunocytochemical analysis of SNAP-29 localization in  
neurons. (A) WT cultured hippocampal neurons stained for SNAP-29 
(Alexa-488-green) and VGLUT-1 (Alexa-555-red). Visibly diffuse 
SNAP-29 expression is observed in soma, axons and dendrites. (B) KO 
hippocampal neurons stained for SNAP-29 and VGLUT-1, complete 








3.1.1.5. Normal glutamatergic synaptic transmission in Constitutive SNAP-29 KO 
mice 
 
Obvious absence of synaptic deficits in NexCre SNAP29 KO mice and the perinatal lethal 
phenotype of the constitutive SNAP29 KO animals prompted me to verify the synaptic 
parameters in the glutamatergic neurons of the hippocampus of the constitutive SNAP29 KOs. 
In both WT and KO animals, all measured parameters such as evoked EPSC amplitudes, RRP 
size, and vesicular release probability were not significantly different (Fig.18.A. B. and C., 
Table 13). Short-term plasticity measured upon high-frequency stimulation also showed 
normal EPSC depression in both SNAP29 WT and SNAP29 KO neurons (Fig.19.A. and B.). 
 
18.A.                            18.B.                   18.C.  
                 
 
Figure 18.  Normal excitatory synaptic transmission in hippocampal  
neurons of SNAP-29 KO. (A) Mean EPSC amplitude of WT and 
SNAP29 KO neurons was similar (B) Mean RRP size measured as 
charge triggered by the application of 0.5 M sucrose solution was 
similar (C) Mean vesicular release probability estimated as the ratio of 
charge of the evoked EPSC to the charge of the RRP was similar. Error 
bars indicate standard error of mean. Numbers of neurons analyzed 
are indicated on bars. Absolute values are indicated in Table 13. No 








 19.A.              19.B. 
       
 
Figure 19.  Normal short-term plasticity in hippocampal neurons of 
SNAP-29 KO. (A) and (B) Normalized synaptic responses observed 
upon stimulation of WT and SNAP29 KO neurons at frequencies of 10 
Hz and 40 Hz, respectively. 
 
Frequency of spontaneous release measured after high-frequency activity was markedly 
higher (approximately three-fold compared to resting conditions) in both WT and KO 
neurons but did not significantly vary between the genotypes (Fig.20.A. and B., Table 13). 
There were no visible differences in mEPSC amplitudes (Fig.20.C. and D., Table 13). 
 
                                20.A.                 20.C. 





      20.B.             20.D. 
                                          
 
Figure 20.  Normal mEPSC release in excitatory hippocampal  
neurons of SNAP-29 KO. Exogenous application of 300 nM TTX to 
block AP and measure miniature release - (A) and (C) Mean mEPSC 
frequency and amplitudes immediately after high-frequency 
stimulation of 40 Hz, (B) and (D) Mean mEPSC frequency and mEPSC 
amplitudes after low frequency stimulation of 0.2 Hz. Error bars 
indicate standard error of mean. Numbers of neurons analyzed are 
indicated on bars. Absolute values are indicated in Table 13. No 
statistically significant differences were observed (Students t-test 
used to test statistical significance). 
 
Table 13. Synaptic parameters measured from excitatory autaptic hippocampal neurons 
of WT and constitutive SNAP29 KO mice 
 
Parameters WT  SNAP29 KO 
 
Mean EPSC Amplitudes (nA) 
± S.E.M. 
5.9830 ± 0.62848 
(n=31) 
6.1046 ± 0.47024 
(n=52) 
Mean RRP Size  
(nC) ± S.E.M. 
0.55125 ± 0.091682 
(n=22) 
 0.62544 ± 0.075976 
(n=33) 
Mean Pvr  
(%) ± S.E.M. 
 7.3743 ± 1.1273 
 (n=22) 
9.1212 ± 1.2280 
 (n=33) 
Mean mEPSC Frequency 
(After 40 Hz) (Hz) ± S.E.M. 
30.508 ± 2.5736 
(n=20) 
31.613 ± 1.7891 
(n=35) 
Mean mEPSC Amplitude 
(After 40 Hz) (pA) ± S.E.M. 
21.341 ± 1.6585 
(n=20) 
22.628 ± 0.94515 
(n=35) 
Mean mEPSC Frequency (At 
rest) (Hz) ± S.E.M. 
6.7292 ± 0.84912 
(n=13) 
 9.4768 ± 1.3896 
(n=22) 
Mean mEPSC Amplitude (At 
rest) (pA) ± S.E.M. 
 20.843 ± 1.8612 
(n=13) 
 22.602 ± 1.5345 
 (n=22) 
    S.E.M. is standard error of mean     n is total number of cells pooled from  
       multiple cultures. 
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3.1.1.6. Normal GABAergic synaptic transmission in Constitutive SNAP-29 KO 
mice. 
 
Since the excitatory glutamatergic neurons showed no deficits in synaptic release, and 
because inhibitory neurons were reported to express lower levels of SNAP-25 than excitatory 
neurons (Frassoni et al., 2005), I tested the inhibitory neurons in the striatum of the SNAP-29 
KO mice to identify possible functional deficits due to reduced endogenous SNAP-25 levels 
and total loss of SNAP-29. Major synaptic parameters such as evoked IPSC amplitudes, short-
term plasticity and vesicular release probability were similar in WT and KO striatal 
GABAergic neurons (Fig.21.A. and C. and Fig.22.A. and B.). Although the RRP size was 
seemingly larger in the KO neurons than in the WT neurons, the difference was not significant 
(Fig.21.B.). The frequency and amplitude of mIPSCs measured at rest were also similar 
between the WT and KO neurons (Fig.23.A. and B.). 
 
  21.A.      21.B.    21.C. 
                        
 
Figure 21. Normal inhibitory synaptic transmission in striatal neurons of 
SNAP-29 KO. (A) Mean IPSC amplitude of WT and SNAP29 deficient 
neurons was similar (B) Mean RRP size measured as charge triggered 
by the application of 0.5 M sucrose solution was similar (C) Mean 
vesicular release probability estimated as the ratio of charge of the 
evoked EPSC to the charge of the RRP was similar. Error bars indicate 
standard error of mean. Numbers of neurons analyzed are indicated 
on bars. Absolute values are indicated in Table 14. No statistically 






 22.A.                 22.B. 
       
 
 
Figure 22.  Normal short-term plasticity in striatal neurons of SNAP-29 KO.  
(A) and (B) Normalized synaptic depression observed upon 
stimulation of WT and SNAP29 KO neurons at high-frequencies of 10 
Hz and 40 Hz, respectively. 
 
   23.A.                                                    23.B. 
                                                 
 
Figure 23.  Normal miniature release in inhibitory striatal neurons of  
SNAP-29 KO. Exogenous application of 300 nM TTX to block AP and 
measure miniature release (A) and (B) Mean mIPSC frequency and 
amplitudes after low-frequency stimulation of 0.2 Hz. Error bars 
indicate standard error of mean. Numbers of neurons analyzed are 
indicated on bars. Absolute values are indicated in Table 14. No 
statistically significant differences were observed (Students t-test 





Table 14. Synaptic parameters measured from inhibitory autaptic striatal neurons of 
WT and constitutive SNAP29 KO mice 
 
Parameters WT  SNAP29 KO 
 
Mean IPSC Amplitudes (nA) ± 
S.E.M. 
 4.6467 ± 0.38514 
(n=27) 
4.1507 ± 0.49095 
(n=17) 
Mean RRP Size  
(nC) ± S.E.M. 
0.68431 ± 0.06837 
(n=21) 
0.91578 ± 0.27234 
(n=12) 
Mean Pvr  
(%) ± S.E.M. 
28.183 ± 2.5166 
(n=21) 
23.141 ± 2.3342 
(n=12) 
Mean mIPSC Frequency (At 
rest) ± S.E.M. 
9.1420 ± 1.9316 
(n=5) 
6.0012  ± 1.3180 
(n=8) 
Mean mIPSC Amplitude (At 
rest) (pA) ± S.E.M. 
35.206 ± 8.0420 
(n=5) 
24.403 ± 2.5223 
(n=8) 
    S.E.M. is standard error of mean             n is total number of cells pooled from  



























3.2.  Results - Complexins  
 
3.2.1.  Wild-type mammalian Complexins facilitate glutamatergic synaptic  
transmission 
 
Multiple studies have extensively discussed the role of Complexins in different model 
systems. The mammalian Complexins are the most intriguing due to the presence of different 
paralogs, variations in their structures, and different affinities to the neuronal SNAREs. In the 
literature, mammalian Complexins have been shown to facilitate Ca2+-evoked transmitter 
release but a systematic comparative structure-function analysis of the various paralogs has 
never been done. Also, the role of Complexins in synchronizing vesicle fusion and release has 
not been clearly defined. In my study, I performed a comparative and detailed analysis of the 
various Complexin paralogs and examined the differences in their efficacies to modulate 
neurotransmitter release at central glutamatergic synapses.  
 
3.2.1.1. Endogenous Complexin-1 is essential for Ca2+-triggered release of 
vesicles but not for vesicle priming 
 
Many previous studies have shown that mammalian Complexin-1 (Cplx1) is an effective 
facilitator of synaptic release (Reim et al., 2001; Xue et al., 2008). I have been able to confirm 
these results using the Cplx-TKO autaptic neuron culture system, in which I performed 
whole-cell patch clamp recordings to measure transmitter release in a homogenous 
population of synapses. As control (Cplx-CTRL), I used neurons from littermate Cplx1 
heterozygotes (Cplx1 +/- Cplx2 -/- Cplx3 -/-), which share the same phenotype as wild-type 
animals. Also, as a part of my study, I analyzed the kinetics of EPSCs in these neurons to 
better understand the role of Complexins in synchronizing vesicle fusion. 
 
I measured the amplitudes of AP-evoked EPSCs in Cplx-CTRL and Cplx-TKO neurons and 
found that the absence of Complexins resulted in a 50% reduction of the peak EPSC 
amplitudes (mean EPSC: 4.195 ± 0.595 nA) compared to control neurons expressing Cplx1 
(mean EPSC: 2.032 ± 0.38 nA) (Fig.24.A.). However, the size of the readily releasable primed 
pool of vesicles was similar at synapses of Cplx-CTRL (mean RRP: 0.28 ± 0.068 nC) and Cplx-
TKO neurons (mean RRP: 0.27 ± 0.079 nC) (Fig.24.B.). A deficit in Ca2+-triggered release in 
the absence of Cplx despite the presence of a normal releasable vesicle pool implied a 
reduction in the vesicular release probability (Pvr) at the affected synapses. The vesicular 
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release probability in Cplx-TKO neurons (mean Pvr: 9.54 ± 0.953%) was reduced by 60% 
compared to Cplx-CTRL (mean Pvr: 3.38 ± 0.382%) (Fig.24.C.). 
 
                                        24.A.              
                                                
24.B.                    24.C. 
     
 
Figure 24.A.,B.,C. Evoked synaptic transmission in autaptic hippocampal  
neurons of Cplx CTRL and Cplx TKO mice. Cplx CTRL (Cplx1+/-, 
Cplx2-/-, Cplx3-/-) and Cplx TKO (Cplx1-/-, Cplx2-/-, Cplx3-/-) 
cultured neurons were used in the study. (A) Mean excitatory post-
synaptic current (EPSC) amplitudes ± S.E.M. of CTRL and TKO neurons 
- EPSC was reduced by 50% in the absence of Complexins, **p<0.01 
compared with Cplx CTRL, representative traces for Cplx CTRL and 
TKO are included. (B) Mean RRP size ± S.E.M. measured as charge 
elicited due to release of the primed vesicle pool, induced by 
application of 0.5 M sucrose solution - RRP size was unaltered in CTRL 
and TKO neurons, representative traces for Cplx CTRL and TKO are 
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included. (C) Mean vesicular release probability (Pvr) ± S.E.M. in CTRL 
and TKO neurons estimated as the percentage ratio of charge of the 
evoked EPSC to the charge of the RRP – Pvr was reduced by 60% in 
the absence of Complexins, ***p<0.001 compared with Cplx CTRL. 
Error bars indicate standard error of mean (S.E.M.). Numbers of 
neurons analyzed are indicated on bars. Students t-test was used to 
test statistical significance. 
   
Short-term plasticity analysis further corroborated the reduced vesicular release probability 
in the absence of Complexins. A high initial facilitation of EPSCs was observed in the Cplx-
TKO neurons at high-frequency stimulation (10 Hz and 40 Hz), indicative of low initial 
vesicular release probability when compared to a fast depression of EPSCs in the Cplx-CTRL 
neurons (Figs.24.D. and 24.E.).  
 
             24.D. 
              
           24.E. 
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Figure 24.D.,E. Short-term plasticity in autaptic hippocampal neurons of Cplx 
CTRL and Cplx TKO mice. (D) and (E) Amplitudes of the synaptic 
responses evoked by a train of stimulation at 10 Hz and 40 Hz (for 
EPSCs) were normalized to the amplitude of the first response and 
plotted against the stimulus number. Representative traces for Cplx 
CTRL and TKO are included for 10 Hz stimulation. Data are expressed 
as mean ± S.E.M. Numbers of neurons analyzed are indicated. 
Normalized EPSC depression observed in CTRL neurons implies high 
initial vesicular release probability, while initial facilitation of 
normalized EPSC amplitudes in TKO neurons indicates lower initial 
release probability. 
 
3.2.1.2. Loss of Complexins does not dramatically affect spontaneous vesicle 
fusion.  
 
I measured the frequency and amplitudes of miniature excitatory post-synaptic currents 
(mEPSC) spontaneously occurring at the Cplx-CTRL and Cplx-TKO neuronal synapses (by 
blocking action-potentials using TTX). The mEPSC frequency was reduced to a small extent in 
the absence of Complexins (mean mEPSC frequency: 3.19 ± 0.483 Hz) compared to the 
controls (mean mEPSC frequency: 4.858 ± 0.593 Hz), although the amplitude of miniature 
release was not significantly different between the Cplx-CTRL (mean mEPSC Amplitude: 
25.644 ± 2.727 pA) and Cplx-TKO (mean mEPSC Amplitude: 18.64 ± 2.5 pA)  (Fig.24.F. and 
24.G.). 
 
24.F.                  24.G. 
 
 
Figure 24.F.,G. Spontaneous neurotransmitter release (mEPSC) in autaptic 
hippocampal neurons of Cplx CTRL and Cplx TKO mice. 300 nM 
Tetrodotoxin was exogenously applied using the fast perfusion system 
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to neurons in order to block Na+-channel driven action potentials 
while measuring miniature excitatory post-synaptic currents. (F) 
Mean mEPSC frequency - a small but significant reduction of mEPSC 
frequency was observed in the Cplx TKO neurons, *p<0.05 compared 
with CTRL; representative traces for Cplx CTRL and TKO are included. 
(G) Mean mEPSC amplitudes of Cplx CTRL and Cplx TKO - no 
significant differences were observed. Error bars indicate standard 
error of mean. Numbers of neurons analyzed are indicated on bars. 
Students t-test was used to test statistical significance. 
 
3.2.1.3. Role of endogenous Complexin-1 in synchronous and asynchronous 
vesicle release. 
 
Integral of the average EPSC charge clearly delineates the two kinetic phases of release - the 
fast synchronous phase and the slower asynchronous phase. Previously, it was shown that 
loss of Cplx1 and Cplx2 reduced the synchronous component of release while the 
asynchronous component of release was unchanged (Reim et al., 2001). This finding led to 
the conclusion that Complexins do not play a role in mediating asynchronous release of 
vesicles. I analyzed the two components of the cumulative and normalized EPSC charge in 
Cplx CTRL as well as TKO neurons to confirm the previously published effects. I found that in 
the absence of Complexins, the synchronous component of release is reduced, while the 
asynchronous component persists at similar levels I observed in the presence of Complexins 
(Fig.25.A. and 25.B.). 
 
25.A.      25.B. 
      
 
Figure 25.A.,B. Asynchronous neurotransmitter release in autaptic hippocampal 
neurons of Cplx CTRL and Cplx TKO mice. (A) and (B) Cumulative 
and normalized integrals of the EPSC charge versus time, respectively. 
The fast rising component indicates synchronous release of vesicles 
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and the slowly rising component indicates the asynchronous 
component of release. Synchronous release is higher in CTRL neurons 
when compared with TKO neurons, but the asynchronous component 
persists in both CTRL and TKO neurons. Numbers of neurons analyzed 
are indicated. 
 
Next, I attempted to find out if and why the loss of Complexins has little effect on the 
asynchronous release of vesicles. For this purpose, I exogenously applied the slow Ca2+-






Figure 25.C. Representation of synchronous and asynchronous 
neurotransmitter release under the effect of exogenously applied 
EGTA-AM in autaptic hippocampal neurons of Cplx CTRL and Cplx 
TKO mice. When an AP arrives at the presynaptic terminal, Ca2+-influx 
releases a fraction of the primed vesicles resulting in the excitatory 
post-synaptic current that typically reflects two kinetic components of 
release - a fast synchronous release phase occurring within tens of 
milliseconds, and a slow asynchronous phase (or delayed release) 
occurring for a few hundred milliseconds as the Ca2+ in the terminal is 
cleared. Application of EGTA-AM, a slow Ca2+-binding buffer chelates 
the Ca2+ ions that cause delayed release. In Cplx CTRL neurons, the 
synchronous release is not affected but the asynchronous phase is 
selectively reduced 4 minutes upon application of EGTA-AM, whereas 
EGTA-AM does not affect the release kinetics of Cplx TKO neurons.  
 
In the Cplx CTRL neurons, no reduction in the synchronous and asynchronous release was 
observable within one minute after perfusion of EGTA-AM. After four minutes of application, 
the asynchronous component of release was reduced while the synchronous component 
remained unaltered (Fig.25.D.). In the Cplx TKO neurons, one minute after perfusion, EGTA-
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AM did not alter the synchronous and asynchronous release. Four minutes after perfusion of 
EGTA-AM also resulted in no changes to both the asynchronous and synchronous 
components of release (Fig.25.E.) indicating that the loss of Complexins likely causes 
desynchronization of vesicle fusion.  
 




Figure 25.D.,E. Synchronous and asynchronous neurotransmitter release under 
the effect of exogenously applied buffer EGTA-AM in autaptic 
hippocampal neurons of Cplx CTRL and Cplx TKO mice. Integral of 
normalized EPSC charge versus time shows a fast rising component 
indicating synchronous release of vesicles and a slowly rising 
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component for the asynchronously released vesicles. (D) Cplx CTRL - 
EPSC charge integral 1 min after application of EGTA-AM (in blue) and 
4 min after application of EGTA-AM (in green) - the synchronous 
component of release is increased and asynchronous release is 
decreased in CTRL neurons (E) Cplx TKO - EPSC charge integral 1 min 
after application of EGTA-AM (in red) and 4 min after application of 
EGTA-AM (in green) - no changes of the synchronous and 
asynchronous component is apparent in TKO neurons. Numbers of 
neurons analyzed are indicated. 
 
3.2.1.4. Lentiviral expression of wild-type Complexins can restore efficient 
transmitter release in Cplx-TKO neurons 
 
The Cplx-DKO mutant neurons derived from the Cplx-DKO mice (lacking Cplx1 and Cplx2) 
exhibited similar deficits in synaptic parameters as the Cplx-TKO mice (Reim et al., 2001; Xue 
et al., 2008). Over-expression of three Complexin paralogs - Cplx1, Cplx3 and Cplx4 - via 
Semliki-Forest-virus (SFV) transduction in Cplx-DKO mutant neurons could efficiently 
restore the EPSC amplitudes and the vesicular release probability (Reim et al., 2005).   
 
I decided to conduct a detailed comparative analysis of the functions of all mammalian 
Complexins, which had not been done before. For this purpose, I used the lentiviral delivery 
system for expression of the different Cplx paralogs. This approach circumvents the 
notorious toxicity and possible overexpression artifacts of the SFV system that was used in 
the previous studies. All the lentiviral expression constructs used in the present study were 
kindly prepared by Dr. Kerstin Reim. The pFUGW-lentiviral vector was used for expressing 
the Cplx genes under the control of a Synapsin promoter for neuronal expression, and the 
vector contained a reporter gene (EGFP) insert expressed under the control of a ubiquitin 
promoter. Unlike the SFV-mediated over-expression, lentiviral transduction of neurons 
causes integration of the gene of interest into the host genome and typically results in protein 
expression at levels comparable to the endogenous proteins. In the present study, the 
autaptic Cplx TKO neurons were infected with the lentiviruses and were allowed to grow up 
to 10 days in-vitro (DIV) for gene integration and protein expression. The neurons were used 
for whole-cell patch clamp recordings after visible expression of EGFP between DIV 10 and 
14.  
 
I found that all wild type Complexins were able to efficiently rescue the synchronous Ca2+-
triggered EPSCs in the Cplx TKO neurons. Expression of all Cplx-WTs in the Cplx TKO neurons 
resulted in more than a 65% increase of the EPSC peak amplitudes as compared to TKO 
neurons expressing only EGFP (Fig.26.A.). Analysis of the kinetics of EPSCs substantiated 
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further that the synchronous component of release was higher in the presence of the Cplx-
WT isoforms, whereas the asynchronous component remained unaltered for all conditions 
(Fig.26.B.).  
 
26.A.           26.B. 
             
 
Figure 26.A.,B. Evoked EPSC amplitudes and synchronous release in autaptic 
hippocampal Cplx TKO neurons expressing Cplx wild type 
proteins (A) Mean excitatory post-synaptic current (EPSC) 
amplitudes. Peak EPSC amplitudes were completely rescued in the 
presence of all Complexin wild type paralogs, ***p<0.0001, **p<0.001 
compared with TKO neurons transduced with EGFP. Absolute values 
are included in Table 15. Error bars indicate standard error of mean. 
Numbers of neurons analyzed are indicated on bars. Students t-test 
was used to test statistical significance. (B) Synchronous and 
asynchronous release depicted as integral of EPSC charge - The 
synchronous component of EPSCs is enhanced in Cplx TKO neurons 
expressing the various wild type Complexins.  
 
The size of the primed vesicle pool ready for release was similar in all cases (Fig.26.C.). The 
vesicular release probability at synapses was diminished in the absence of Complexins but 
significantly increased in neurons expressing Cplx1, Cplx2, Cplx3 and Cplx4 (Fig.26.D.). Cplx-
TKO neurons expressing the wild-type Complexins exhibited faster depression of EPSCs 
under high frequency stimulations, indicative of higher initial vesicular release probability in 
the presence of Complexins (Fig.26.E. and 26.F.). A small increase in the frequency of 
miniature EPSCs was observable in Cplx-TKO neurons expressing Cplx1, but not in the 
presence of the other Cplx paralogs (Fig.26.G.), whereas the amplitudes of the miniature 
EPSCs were unaltered in the presence of all the Cplx isoforms (Fig.26.H.).  
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26.C.           26.D. 
          
Figure 26.C.,D. RRP size and vesicular release probability in autaptic 
hippocampal Cplx TKO neurons expressing Cplx wild type 
proteins (C) Mean RRP size was measured as charge elicited due to 
release of the primed vesicle pool, induced by application of 0.5 M 
sucrose solution – RRP size was unaltered in TKO neurons 
irrespective of the construct expressed (D) Mean vesicular release 
probability (Pvr) was estimated as the ratio of charge of the evoked 
EPSC to the charge of the RRP - Pvr was enhanced in the presence of 
all wild type Complexins, ***p<0.0001, **p<0.001, *p<0.05 compared 
with TKO neurons expressing EGFP. Absolute values are included in 
Table 15. Error bars indicate standard error of mean. Numbers of 
neurons analyzed are indicated on bars. Students t-test was used to 
test statistical significance. 
 
26.E.          26.F.  
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Figure 26.E.,F. Short-term plasticity in autaptic hippocampal Cplx TKO neurons 
expressing Cplx wild type proteins (E) and (F) Amplitudes of the 
synaptic responses evoked by a train of stimulation at 10 Hz and 40 
Hz (for EPSCs) were normalized to the amplitude of the first response 
and plotted against the stimulus number. Data are expressed as mean 
± S.E.M. Numbers of neurons analyzed are indicated. EPSC depression 
was observed in TKO neurons expressing Cplx wild type paralogs 
implying high initial vesicular release probability, while high initial 
facilitation of EPSC amplitudes was observed in TKO neurons 
expressing EGFP indicating lower initial release probability. 
 
26.G.           26.H. 
          
 
Figure 26.G.,H. Spontaneous neurotransmitter release (mEPSC) in autaptic 
hippocampal Cplx TKO neurons expressing EGFP and Cplx wild 
type proteins. 300 nM Tetrodotoxin was exogenously applied to 
neurons in order to block Na+-channel driven action potentials while 
measuring miniature excitatory post-synaptic currents. (G) Mean 
mEPSC frequency - a small but significant increase of mEPSC events 
was observed only in the Cplx TKO neurons expressing Cplx1-WT 
protein, *p<0.05 compared with Cplx TKO (H) Mean mEPSC 
amplitudes of Cplx TKO neurons expressing Cplx wild type paralogs – 
no significant differences were observed. Absolute values are included 
in Table 15. Error bars indicate standard error of mean. Numbers of 
neurons analyzed are indicated on bars. Students t-test was used to 







Table 15. Synaptic parameters measured from excitatory Cplx TKO neurons 
expressing EGFP and Cplx1, Cplx2, Cplx3, Cplx4 WT lentiviral proteins.  
 
Parameter 
(Mean ± S.E.M.) 
Cplx TKO (+) 





























































 S.E.M. is standard error of mean                n is number of cells pooled from multiple cultures 
 
3.2.2. Mutation of the SNARE-binding domain and Farnesylation domain in 
Complexins impedes glutamatergic synaptic transmission. 
 
The Complexin domain structure is intriguing with different parts of the protein accounting 
for different functions. In this study, I have investigated the central α-helical SNARE binding 
domain and the farnesylation domains of the various Complexins. Multiple studies have 
examined deletions or point mutations on these domains to comprehend their role in the 
Ca2+-triggered and constitutive transmitter release processes. The central α-helical SNARE 
binding domain from amino acid residues 48-70 is highly conserved across the various 
Complexin paralogs and among different species (Reim et al., 2005; Xue et al., 2007). Point 
mutation of an Arginine residue at position 63, Lysine residue at position 69 and Tyrosine 
residue at position 70 on Cplx1 were previously shown to completely abolish SNARE complex 
binding in co-sedimentation assays (Xue et al., 2007). Of particular interest was the double 
point mutation of lysine and tyrosine residues on Cplx1, which not only abolished Cplx1 
binding to the SNARE complex but also failed to rescue synaptic transmission upon SFV-
mediated over-expression in Cplx-DKO neurons. Although the lysine-tyrosine amino acid duo 
is conserved across the Complexin homologs in many species, this double point mutation was 
previously tested only on Cplx1. Therefore, I assessed the effect of double point mutations of 
lysine (K) to alanine (A) and tyrosine (Y) to alanine (A) in the SNARE-binding central α-
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helical on all four Complexins: Cplx1-K69A/Y70A, Cplx2-K69A/Y70A, Cplx3-K79A/Y80A, and 
Cplx4-K80A/Y81A. Also, one cysteine (C) to serine (S) point mutation was introduced in the 
farnesylation ‘CAAX’ motif of both Cplx3 (C155S) and Cplx4 (C157S) to block farnesylation. In 
order to systematically compare the physiological effects of all the Complexin mutants at the 
Cplx-TKO synapses, I used the respective Complexin wild type and mutant lentiviruses to 
infect Cplx-TKO neurons and perform whole-cell patch clamp recordings on the neurons 
expressing the proteins. 
 
3.2.2.1. Rescue efficacies of Complexin-1 wild type (Cplx1-WT) and Complexin-1 
SNARE binding domain mutant (Cplx1-K69A/Y70A) proteins in Cplx TKO 
neurons. 
 
SFV-mediated over-expression of the SNARE binding domain mutant of Cplx1 was unable to 
rescue the deficits in synaptic transmission in Cplx-DKO neurons, while similar over-
expression of Cplx1-WT did rescue the deficits (Xue et al., 2007). Given the possible problems 
associated with SFV mediated overexpression, I set out to assess the role of the α-helical 
SNARE binding domain of the different Complexins, using lentiviral delivery. I first tested the 
efficacies of Cplx1-WT and Cplx1-K69A/Y70A proteins in rescue of the Cplx-TKO phenotype. 
In this experiment, I found that the peak amplitude of EPSC elicited by the expression of 
Cplx1-WT in the Cplx-TKO neurons was significantly higher when compared with the EPSCs 
elicited after expression of Cplx1-K69A/Y70A (Fig.27.A.). This was further corroborated by a 
clear augmentation in the synchronous component of release in the neurons expressing 
Cplx1-WT measured by the integral of the EPSC charge (Fig.27.B.).  
 
27.A.                 27.B. 
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Figure 27.A.,B. Evoked EPSC amplitudes and synchronous release in autaptic 
hippocampal Cplx TKO neurons expressing Cplx1-WT and Cplx1-
K69A/Y70A proteins. (A) Mean excitatory post-synaptic current 
(EPSC) amplitudes. Peak EPSC amplitude in Cplx TKO neurons 
expressing Cplx1-K69A/Y70A was dramatically reduced compared 
with neurons expressing Cplx1-WT, ***p<0.0001 between the neurons 
of the groups compared. Absolute values are included in Table 16. 
Representative traces are included. Error bars indicate standard error 
of mean. Numbers of neurons analyzed are indicated on bars. Students 
t-test was used to test statistical significance. (B) Synchronous and 
asynchronous release depicted as integral of EPSC charge - 
Synchronous component of EPSC is decreased in Cplx TKO neurons 
expressing Cplx1-K69A/Y70A compared with Cplx1-WT; the 
asynchronous component was unaltered. Numbers of neurons 
analyzed are indicated.  
 
As the readily releasable vesicle pool size was nearly equal in neurons expressing the Cplx1 
WT and Cplx1 SNARE binding mutant (Fig.27.C.), the vesicular release probability in the 
Cplx1-WT expressing neurons was 90% higher when compared to the neurons expressing 
Cplx1-K69A/Y70A, implying that the SNARE binding domain mutant of Cplx1 was unable to 
alleviate the deficits in the release of vesicles at Cplx-TKO synapses (Fig.27.D.). Similarly, the 
short-term plasticity at synapses expressing Cplx1-WT showed a marked depression of the 
EPSC amplitudes while those expressing the SNARE mutant showed a dramatic facilitation of 
initial EPSCs indicative of high and low initial release probabilities, respectively (Fig.27.E. and 
27.F.). The miniature EPSC frequency and amplitude were similar in neurons expressing 
Cplx1-WT and Cplx1-K69A/Y70A (Fig.27.G. and 27.H.).  
 
27.C.            27.D. 
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Figure 27.C.,D. RRP size and vesicular release probability in autaptic 
hippocampal Cplx TKO neurons expressing Cplx1-WT and Cplx1-
K69A/Y70A proteins. (C) Mean RRP size was measured as charge 
elicited due to release of the primed vesicle pool, induced by 
application of 0.5 M sucrose solution - RRP size was unaltered in TKO 
neurons irrespective of the construct expressed, representative traces 
are included. (D) Mean vesicular release probability (Pvr) estimated 
as the ratio of charge of the evoked EPSC to the charge of the RRP – 
Pvr was reduced by 50% in the neurons expressing Cplx1-K69A/Y70A 
compared with Cplx1-WT expressing neurons, ***p<0.0001 between 
the neurons of the groups compared. Absolute values are included in 
Table 16. Error bars indicate standard error of mean. Numbers of 
neurons analyzed are indicated on bars. Students t-test was used to 
assess statistical significance. 
 
                  27.E. 
                        
                   27.F. 
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Figure 27.E.,F. Short-term plasticity in autaptic hippocampal Cplx TKO neurons 
expressing Cplx1-WT and Cplx1-K69A/Y70A proteins. (E) and (F) 
EPSC amplitudes of the synaptic responses evoked by a train of 
stimulation at 10 Hz and 40 Hz (for EPSCs) were normalized to the 
amplitude of the first response and plotted against the stimulus 
number. Representative traces of EPSCs at the beginning of the 10 Hz 
stimulation train are shown. Data are expressed as mean ± S.E.M. 
Numbers of neurons analyzed are indicated. Depression of EPSCs was 
observed in TKO neurons expressing Cplx1-WT, and initial facilitation 
of EPSCs was observed in TKO neurons expressing Cplx1-K69A/Y70A, 
indicating high and low initial release probabilities, respectively. 
 
       27.G.       27.H. 
        
 
Figure 27.G.,H. Spontaneous neurotransmitter release (mEPSC) in autaptic 
hippocampal Cplx TKO neurons expressing Cplx1-WT and Cplx1-
K69A/Y70A proteins. 300 nM Tetrodotoxin was exogenously applied 
to neurons in order to block Na+-channel driven action potentials 
while measuring miniature excitatory post-synaptic currents. 
Representative traces are included (G) Mean mEPSC frequency, and 
(H) Mean mEPSC amplitudes in Cplx TKO neurons expressing Cplx1-
WT and Cplx1-K69A/Y70A - no significant differences were observed. 
Absolute values are included in Table 16. Error bars indicate standard 
error of mean. Numbers of neurons analyzed are indicated on bars. 








Table 16. Synaptic parameters measured from excitatory Cplx TKO neurons 
expressing Cplx1-WT and Cplx1-K69A/Y70A lentiviral proteins.  
 
Parameter 
(Mean ± S.E.M.) 
Cplx TKO (+) 
Cplx1-WT Cplx1-K69A/Y70A 
EPSC Amplitude (nA) 3.99±0.339 (n=75) 1.53±0.192 (n=53) 
RRP Size (nC)  0.372±0.059 (n=36) 0.373±0.060 (n=38) 
Pvr (%)  7.747±0.813 (n=35) 4.148±0.537 (n=37) 
mEPSC Frequency (Hz)  6.72±1.03 (n=24) 4.65±0.74 (n=24) 
mEPSC Amplitude (pA) 20.075±1.25 (n=24) 17.214±0.74 (n=24) 
  S.E.M. is standard error of mean              n is number of cells pooled from multiple cultures 
 
3.2.2.2. Rescue efficacies of Complexin-2 wild type (Cplx2-WT) and Complexin-2 
SNARE binding domain mutant (Cplx2-K69A/Y70A) proteins in Cplx TKO 
neurons. 
 
Complexin-2 is the other major Complexin paralog present in the brain. Loss of Cplx2 has 
been shown to impair long-term potentiation of synapses in the CA1 stratum radiatum and 
CA3 mossy-fibre terminals of the hippocampus with no effect on short-term plasticity 
(Takahashi et al., 1999). In adrenal chromaffin cells, large dense-core vesicle (LDCV) 
secretion triggered by UV-flash photolysis of caged-Ca2+ was dramatically reduced in the 
absence of Cplx2, implying that Cplx2 is essential for secretion in chromaffin cells (Cai et al., 
2008). In the same study, it was also found that mutation of the lysine (K69) and tyrosine 
(Y70) residues on the SNARE-binding domain of Cplx2 blocked Cplx2 activity, indicating a 
key role of Cplx2-SNARE binding in LDCV exocytosis.  
 
I expressed the Cplx2-WT and its SNARE binding domain mutant Cplx2-K69A/Y70A in Cplx 
TKO neurons to determine the effect on synaptic release. In presence of Cplx2-WT, the Ca2+-
evoked EPSCs in Cplx-TKO neurons are significantly higher compared to neurons expressing 
Cplx2-K69A/Y70A (Fig.28.A.). Correspondingly, the synchronous component of EPSCs was 
higher in presence of Cplx2-WT while the asynchronous component of release was similar in 
presence of both Cplx2 variants (Fig.28.B.). The RRP size was unchanged between neurons 
expressing wild type Cplx2 and SNARE domain mutant Cplx2; however, the vesicular release 
probability was significantly higher in the former (Fig.28.C. and 28.D.). Consistent with the 
release probability features, neurons expressing Cplx2-WT exhibited fast depression of EPSCs 
when stimulated at high frequencies, but those expressing the Cplx2-K69A/Y70A exhibited 
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an initial facilitation (Fig.28.E. and 28.F.). In the presence of Cplx2-WT and the Cplx2-
K69A/Y70A, the frequency and the average amplitude of miniature EPSCs were at 
comparable levels (Fig.28.G. and 28.H.).  
 
28.A.           28.B.  
    
Figure 28.A.,B. Evoked EPSC amplitudes and synchronous release in autaptic 
hippocampal Cplx TKO neurons expressing Cplx1-WT and Cplx1-
K69A/Y70A proteins. (A) Mean excitatory post-synaptic current 
(EPSC) amplitudes. Peak EPSC amplitude in Cplx TKO neurons 
expressing Cplx2-K69A/Y70A was dramatically reduced compared 
with neurons expressing Cplx2-WT, ***p<0.0001 between the neurons 
of the groups compared. Absolute values are included in Table 17. 
Representative traces are included. Error bars indicate standard error 
of mean (S.E.M.). Numbers of neurons analyzed are indicated on bars. 
Students t-test was used to test statistical significance. (B) 
Synchronous and asynchronous release depicted as Integral of EPSC 
charge – The synchronous component of EPSC is lower in Cplx TKO 
neurons expressing the Cplx2-K69A/Y70A compared with Cplx2-WT; 
the asynchronous component was unaltered. Numbers of neurons 















                     28.C.            28.D. 
                                 
 
Figure 28.C.,D. RRP size and vesicular release probability in autaptic 
hippocampal Cplx TKO neurons expressing Cplx2-WT and Cplx2-
K69A/Y70A proteins (C) Mean RRP size measured as charge elicited 
due to release of the primed vesicle pool, induced by application of 0.5 
M sucrose solution – RRP size was unaltered in neurons irrespective 
of the construct expressed; representative traces are included. (D) 
Mean vesicular release probability (Pvr) estimated as the ratio of 
charge of the evoked EPSC to the charge of the RRP - Pvr was reduced 
by 50% in the neurons expressing Cplx2-K69A/Y70A compared with 
Cplx2-WT expressing neurons, ***p<0.0001 between the neurons of 
the groups compared. Absolute values are included in Table 17. Error 
bars indicate standard error of mean (S.E.M.). Numbers of neurons 
analyzed are indicated on bars. Students t-test was used to assess 
statistical significance. 
 
     28.E.  
                  
          
 
 108 
          28.F. 
                   
 
Figure 28.E.,F. Short-term plasticity in autaptic hippocampal Cplx TKO neurons 
expressing Cplx2-WT and Cplx2-K69A/Y70A proteins. (E) and (F) 
Amplitudes of the synaptic responses evoked by a train of stimulation 
at 10 Hz and 40 Hz (for EPSCs) were normalized to the amplitude of 
the first response and plotted against the stimulus number. 
Representative traces of EPSCs at the beginning of the 10 Hz 
stimulation train are shown. Data are expressed as mean ± S.E.M. 
Numbers of neurons analyzed are indicated. Depression of EPSCs was 
observed in TKO neurons expressing Cplx2-WT, and initial facilitation 
of EPSCs was observed in TKO neurons expressing Cplx2-K69A/Y70A 
indicating high and low initial release probabilities, respectively. 
 




Figure 28.G.,H. Spontaneous neurotransmitter release (mEPSC) in autaptic 
hippocampal Cplx TKO neurons expressing Cplx2-WT and Cplx2-
K69A/Y70A proteins. 300 nM Tetrodotoxin was exogenously applied 
to neurons in order to block Na+-channel driven action potentials 
while measuring miniature excitatory post-synaptic currents. 
Representative traces are included (G) Mean mEPSC frequency, and 
(H) Mean mEPSC amplitudes in Cplx TKO neurons expressing Cplx2-
WT and Cplx2-K69A/Y70A - no significant differences were observed. 
Absolute values are included in Table 17. Error bars indicate standard 
error of mean. Numbers of neurons analyzed are indicated on bars. 
Students t-test was used to test statistical significance. 
 
Table 17. Synaptic parameters measured from excitatory Cplx TKO neurons 
expressing Cplx2-WT and Cplx2-K69A/Y70A lentiviral proteins.  
 
Parameter 
(Mean ± S.E.M.) 
Cplx TKO (+) 
Cplx2-WT Cplx2-K69A/Y70A 
EPSC Amplitude (nA) 4.924±0.416 (n=58) 2.036±0.267 (n=43) 
RRP Size (nC)  0.465±0.058 (n=31) 0.469±0.108 (n=30) 
Pvr (%)  5.66±0.49 (n=31) 2.79±0.452 (n=30) 
mEPSC Frequency (Hz)  4.295±0.667 (n=24) 4.022±0.857 (n=15) 
mEPSC Amplitude (pA) 21.225±1.278 (n=24) 18.193±0.773 (n=15) 
  S.E.M. is standard error of mean               n is number of cells pooled from multiple cultures 
 
3.2.2.3. Rescue efficacies of Complexin-3 wild type (Cplx3-WT), Complexin-3 
SNARE binding domain mutant (Cplx3-K79A/Y80A) and Complexin-3 
Farnesylation domain mutant (Cplx3-C155S) proteins in Cplx TKO 
neurons. 
 
Complexin-3 is prominently expressed in the retina; low Cplx3 expression is detectable in the 
cortex and hippocampus of murine brain (Reim et al., 2005), but not in cultured cortical or 
hippocampal neurons. Although hardly via biochemical methods, the possibility that Cplx3 
may affect release at neuronal synapses could not be disregarded. The binding affinity of 
Cplx3 to the cognate SNARE complex is lower as compared to Cplx1 and Cplx2. However, the 
lysine and tyrosine residues essential for binding to the SNARE complex are conserved. 
Furthermore, Cplx3 contains a CAAX motif on the C-terminal end that is farnesylated 
(addition of a 15-carbon moiety to translated protein product) in-vivo and targets Cplx3 to 
membranes (Reim et al., 2005). Hence, I compared the rescue efficacies of the Cplx3-WT 
against its SNARE binding domain mutant (Cplx3-K79A/Y80A) and farnesylation domain 
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mutant (Cplx3-C155S) by lentiviral expression of the respective proteins in Cplx-TKO 
neurons. As a negative control, I also used Cplx-TKO neurons infected with an EGFP 
expressing lentivirus.  
 
I found that lentiviral expression of Cplx3-WT in the Cplx-TKO neurons efficiently rescued the 
evoked EPSC amplitudes, vesicular release probability and short-term plasticity. However, 
expression of the Cplx3-K79A/Y80A and Cplx3-C155S did not rescue the transmitter release 
deficits in the Cplx-TKO neurons. Also, compared to Cplx3-WT, the evoked EPSCs in cells 








Figure 29.A.,B. Evoked EPSC amplitudes and synchronous release in autaptic 
hippocampal Cplx TKO neurons expressing EGFP, Cplx3-WT, 
Cplx3-K79A/Y80A and Cplx3-C155S proteins. (A) Mean excitatory 
post-synaptic current (EPSC) amplitudes. Peak EPSC amplitudes in 
Cplx TKO neurons expressing Cplx3-WT were significantly higher 
when compared with neurons expressing EGFP, Cplx3-K79A/Y80A 
and Cplx3-C155S. ***p<0.0001 between the neurons of the groups in 
comparison. Absolute values are included in Table 18. Representative 
traces are included. Error bars indicate standard error of mean 
(S.E.M.). Numbers of neurons analyzed are indicated on bars. Students 
t-test used to test statistical significance. (B) Synchronous and 
asynchronous release depicted as integral of EPSC charge – The 
synchronous component of EPSCs was lower in Cplx TKO neurons 
expressing EGFP, Cplx3-K79A/Y80A and Cplx3-C155S compared with 
Cplx3-WT; the asynchronous component was unaltered. Numbers of 
neurons analyzed are indicated.  
 
Likewise, the vesicular release probability of TKO neurons expressing Cplx3-K79A/Y80A and 
Cplx3-C155S was low compared to data from cells expressing Cplx3-WT although the RRP 
sizes were relatively similar (Fig.29.C. and 29.D.).  
 
29.C.               29.D. 
        
 
Figure 29.C.,D. RRP size and vesicular release probability in autaptic 
hippocampal Cplx TKO neurons expressing EGFP, Cplx3-WT, 
Cplx3-K79A/Y80A and Cplx3-C155S proteins (C) Mean RRP size 
measured as charge elicited due to release of the primed vesicle pool, 
induced by application of 0.5 M sucrose solution - RRP size was 
unaltered in neurons irrespective of the construct expressed, 
representative traces are included. (D) Mean vesicular release 
probability (Pvr) estimated as the ratio of charge of the evoked EPSC 
to the charge of the RRP - Pvr was enhanced by 30% in the neurons 
expressing Cplx3-WT compared with neurons expressing EGFP, Cplx3-
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K79A/Y80A and Cplx3-C155S, *p<0.05 between the neurons of the 
groups compared. Absolute values are included in Table 18. Error bars 
indicate standard error of mean. Numbers of neurons analyzed are 
indicated on bars. Students t-test was used to assess statistical 
significance. 
 
High frequency stimulations at 10 Hz and 40 Hz resulted in EPSC depression in neurons 
expressing Cplx3-WT and a marked initial facilitation in neurons expressing the Cplx3 SNARE 







Figure 29.E.,F. Short-term plasticity in autaptic hippocampal Cplx TKO neurons 
expressing EGFP, Cplx3-WT, Cplx3-K79A/Y80A and Cplx3-C155S 
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proteins. (E) and (F) Amplitudes of the synaptic responses evoked by 
a train of stimulation at 10 Hz and 40 Hz (for EPSCs) were normalized 
to the amplitude of the first response and plotted against the stimulus 
number. Representative traces of EPSCs at the beginning of the 10 Hz 
stimulation train are shown. Data are expressed as mean ± S.E.M. 
Numbers of neurons analyzed are indicated. Depression of EPSCs was 
observed in TKO neurons expressing Cplx3-WT indicating high initial 
release probability, while initial facilitation of EPSCs was observed in 
TKO neurons expressing EGFP, Cplx3-K79A/Y80A and Cplx3-C155S 
indicating low initial release probabilities. 
 
The miniature EPSCs frequency and amplitude elicited by the neurons expressing the 
different Cplx3 variants remained unaltered (Fig.29.G. an 29.H.). 
 
 29.G.            29.H. 
 
Figure 29.G.,H. Spontaneous neurotransmitter release (mEPSC) in autaptic 
hippocampal Cplx TKO neurons expressing EGFP, Cplx3-WT, 
Cplx3-K79A/Y80A and Cplx3-C155S proteins. 300 nM Tetrodotoxin 
was exogenously applied to neurons in order to block Na+-channel 
driven action potentials while measuring miniature excitatory post-
synaptic currents. Representative traces are included. No significant 
differences were found in (G) Mean mEPSC frequency, and (H) Mean 
mEPSC amplitudes in any of the groups compared. Absolute values are 
included in Table 18. Error bars indicate standard error of mean. 
Numbers of neurons analyzed are indicated on bars. Students t-test 





Table 18. Synaptic parameters measured from excitatory Cplx TKO neurons 
expressing EGFP, Cplx3-WT, Cplx3-K79A/Y80A, and Cplx3-C155S 
lentiviral proteins.  
 
Parameter 
(Mean ± S.E.M.) 


















































  S.E.M. is standard error of mean               n is number of cells pooled from multiple cultures 
 
3.2.2.4. Rescue efficacies of Complexin-4 wild type (Cplx4-WT), Complexin-4 
SNARE binding domain mutant (Cplx4-K80A/Y81A) and Complexin-4 
Farnesylation domain mutant (Cplx4-C157S) proteins in Cplx TKO 
neurons. 
 
Complexin-4 is exclusively expressed in the mammalian retina. It is found at the rod 
photoreceptor (in the outer plexiform layer) and bipolar cell (in the inner plexiform layer) 
ribbon synapses (Reim et al., 2005). SFV-mediated over-expression of wild type Cplx4 in 
Cplx-DKO neurons could partly restore the amplitudes of evoked EPSCs and the vesicular 
release probability to levels comparable to that of Cplx1 SFV-mediated over-expression 
(Reim et al., 2005). Previously, it was shown that Cplx4 possesses a farnesylation motif 
similar to Cplx3, and SFV-mediated over-expression of non-farnesylated mutant Cplx4 could 
not rescue the deficits in EPSC amplitudes as well as the release probability in Cplx-DKO 
neurons (Reim et al., 2005). Although the interaction of Cplx4 with the native SNARE complex 
in the neurons is not detectable (Appendix 6.2.), I studied the functional effects of the lysine-
tyrosine double point mutation in the conserved central α-helical domain (Cplx4-
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K80A/Y81A) of Cplx4 and I also examined the effect of the farnesylation domain of Cplx4 
(Cplx4-C157S) in regulating transmitter release.  
 
I found that the evoked EPSC amplitudes in the Cplx-TKO neurons expressing Cplx4-WT were 
significantly higher compared to the EPSCs evoked in Cplx-TKO neurons expressing EGFP, 
Cplx4-K80A/Y81A and Cplx4-C157S, respectively (Fig.30.A.). In congruence, the synchronous 





Figure 30.A. Evoked EPSC amplitudes in autaptic hippocampal Cplx TKO 
neurons expressing EGFP, Cplx4-WT, Cplx4-K80A/Y81A and 
Cplx4-C157S proteins. Mean excitatory post-synaptic current (EPSC) 
amplitudes. Representative traces are included. Peak EPSC amplitude 
in Cplx TKO neurons expressing Cplx4-WT was significantly higher 
when compared with neurons expressing EGFP, Cplx4-K80A/Y81A 
and Cplx4-C157S. ***p<0.0001 between the neurons of the groups in 
comparison. Absolute values are included in Table 19. Error bars 
indicate standard error of mean. Numbers of neurons analyzed are 












Figure 30.B. Synchronous release in autaptic hippocampal Cplx TKO neurons 
expressing EGFP, Cplx4-WT, Cplx4-K80A/Y81A and Cplx4-C157S 
proteins. Synchronous and asynchronous release depicted as integral 
of EPSC charge – The synchronous component of EPSC was lower in 
Cplx TKO neurons expressing EGFP, Cplx4-K80A/Y81A and Cplx4-
C157S compared with Cplx4-WT; the asynchronous component was 
unaltered. Numbers of neurons analyzed are indicated.  
 
The RRP size was not significantly different in the neurons irrespective of the constructs 
expressed (Fig.30.C.). However, the vesicular release probability was significantly higher in 
TKO neurons expressing Cplx4-WT, which also exhibited faster EPSC depression at high-
frequency stimulation. To the contrary, the vesicular release probability in neurons 
expressing Cplx4-K80A/Y81A or Cplx4-C157S was nearly the same as in TKO neurons 
expressing EGFP. Also, an initial facilitation under high frequency stimulation implied the 









30.C.            30.D. 
  
 
Figure 30.C.,D. RRP size and vesicular release probability in Cplx TKO neurons 
expressing EGFP, EGFP, Cplx4-WT, Cplx4-K80A/Y81A and Cplx4-
C157S proteins. (C) Mean RRP size measured as charge elicited due 
to release of the primed vesicle pool, induced by application of 0.5 M 
sucrose solution - RRP size was unaltered in neurons irrespective of 
the construct expressed, representative traces are included. (D) Mean 
vesicular release probability (Pvr) estimated as the ratio of charge of 
the evoked EPSC to the charge of the RRP - Pvr was enhanced by 30% 
in the neurons expressing Cplx4-WT compared with neurons 
expressing EGFP, Cplx4-K80A/Y81A and Cplx4-C157S, *p<0.05 
between the neurons of the groups compared. Absolute values are 
included in Table 19. Error bars indicate standard error of mean 
(S.E.M.). Numbers of neurons analyzed are indicated on bars. Students 








Figure 30.E.,F. Short-term plasticity in autaptic hippocampal Cplx TKO neurons 
expressing EGFP, Cplx4-WT, Cplx4-K80A/Y81A and Cplx4-C157S 
proteins. (E) and (F) Amplitudes of the synaptic responses evoked by 
a train of stimulation at 10 Hz and 40 Hz (for EPSCs) were normalized 
to the amplitude of the first response and plotted against the stimulus 
number. Representative traces of EPSCs at the beginning of the 10 Hz 
stimulation train are shown. Data are expressed as mean ± S.E.M. 
Numbers of neurons analyzed are indicated. Depression of EPSCs was 
observed in TKO neurons expressing Cplx4-WT indicating high initial 
release probability, while initial facilitation of EPSCs was observed in 
TKO neurons expressing EGFP, Cplx4-K80A/Y81A and Cplx4-C157S 
indicating low initial release probabilities. 
 
The mEPSC frequency elicited by the neurons expressing the different Cplx4 variants 
remained unaltered (Fig.30.G.). To a small extent, the miniature amplitude was reduced in the 
neurons expressing the SNARE-domain mutant Cplx4-K80A/Y81A and increased in the 












30.G.         30.H. 
 
 
Figure 30.G.,H. Spontaneous neurotransmitter release (mEPSC) in autaptic 
hippocampal Cplx TKO neurons expressing EGFP, Cplx4-WT, 
Cplx4-K80A/Y81A and Cplx4-C157S. 300 nM Tetrodotoxin was 
exogenously applied to neurons in order to block Na+-channel driven 
action potentials while measuring miniature excitatory post-synaptic 
currents. (G) Mean mEPSC frequency - no significant differences were 
found in within all the groups compared, representative traces are 
included. (H) Mean mEPSC amplitudes - no significant variation 
between EGFP and Cplx4-WT expressing neurons but a slight decrease 
of mEPSC amplitude in the Cplx4-K80A/Y81A SNARE mutant 
expressing neurons and a small increase in mEPSC amplitude in the 
Cplx4-C157S farnesylation mutant expressing neurons, was apparent. 
*p<0.05 compared with EGFP and Cplx4-WT, respectively. The 
Absolute values are included in Table 19. Error bars indicate standard 
error of mean. Numbers of neurons analyzed are indicated on bars. 
Students t-test was used to assess statistical significance. 
 
Table 19. Synaptic parameters measured from excitatory Cplx TKO neurons 
expressing EGFP, Cplx4-WT, Cplx4-K80A/Y81A, and Cplx4-C157S 
lentiviral proteins.  
 
Parameter 
(Mean ± S.E.M.) 






















Pvr (%)  4.39±0.508 5.83±0.374 4.54±0.364 3.970±0.709 
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 S.E.M. is standard error of mean                n is number of cells pooled from multiple cultures 
 
3.2.3. Lentiviral expression and quantification of wild type and mutant 
Complexin proteins in Cplx-TKO neurons 
 
Lentivirus mediated transduction of genes in non-dividing cells has been shown to cause 
efficient gene integration and expression (Naldini et al., 1996). In the present study, the 
lentiviral pFUGW vector comprising of dual promoters - the neuron-specific Synapsin 
promoter for Complexins and the Ubiquitin promoter for the reporter gene EGFP, was used to 
express the respective Complexin genes upon transduction in neurons (Gascon et al., 2008). 
This lentiviral system of expression allows stable gene expression at moderate levels, and I 
attempted to quantify the protein expression levels from the transduced neurons and 
compare them with endogenous protein levels in wild type neurons. 
 
To estimate the protein expression in the neurons, I prepared recombinant wild type 
Complexin proteins (rCplx1, rCplx2, rCplx3 and rCplx4) (Methods 2.2.3.) that had been 
cloned in the pET-28a vector for a T7 promoter driven bacterial expression of the proteins 
with a His6-tag. Presence of the His6-tag is a useful tool for affinity purification of recombinant 
proteins expressed in E. coli. After preparation of recombinant proteins, I performed SDS-
PAGE and Coomassie staining to verify the purification of recombinant proteins (Fig.31.A. and 












31.A.          31.B. 





Figure 31.A.,B.,C. Recombinant His6-tagged Cplx proteins. Coomassie staining  
of SDS-Gels. (A) Cplx1 and Cplx3 recombinant proteins were prepared 
simultaneously and eluted in three fractions E1, E2 and E3 and tested 
for expression against BSA standards of 1 μg, 2 μg and 3 μg (Refer 
Methods 2.2.3.). (B) Cplx2 and Cplx4 recombinant proteins were 
prepared simultaneously and eluted in three fractions E1, E2 and E3 
and tested for expression against BSA standards of 1 μg, 2 μg and 3 μg 
(Refer Methods 2.2.3.). The four recombinant Cplx proteins had 
molecular mass in the range of 15 kDa to 25 kDa. (C) The recombinant 
proteins rCplx1, rCplx2, rCplx3 and rCplx4 were diluted to various 
concentrations of 50 ng, 25 ng, 10 ng, 5 ng, 2.5 ng and 1 ng and 
subjected to SDS-PAGE and Western blotting. The intensities of the 
protein bands were recorded using the Odyssey Infrared Scanner and 
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a standard curve was generated for each of the four recombinant 
Complexins. 
 
3.2.3.1. Cplx1 protein estimation 
 
Since Cplx1 is prominently expressed in hippocampal neurons, I calculated the protein 
concentrations of Cplx1-WT and Cplx1-K69A/Y70A in infected Cplx-TKO neurons in 
comparison to the endogenous levels of Cplx1 present in wild type hippocampal neurons. I 
used a standard curve of the recombinant Cplx1 protein for estimation of the protein 
concentrations. Linear regression analysis and percentage of transduced cells yielded 
estimates that endogenous Cplx1 is present at 12.25 x 10-5 pmol in a wild-type neuron, while 
Cplx1-WT and Cplx1-K69A/Y70A proteins are expressed at 1.55 x 10-5 pmol and 1.73 x 10-5 
pmol respectively per transduced Cplx TKO neuron (Fig.32. and Table 20.). 
                
 32.A. 
                                         
 32.B. 
                        
 
Figure 32.A.,B. Quantification of endogenous and lentiviral Cplx1   
protein expression. (A) Western blot performed for the standard  























curve of rCplx1 (30 ng, 25 ng. 20 ng, 15 ng, 10 ng, 5 ng). 5 μg of sample 
protein from wild type neuronal extract of total concentration 60 μg 
was used for the blot. Cplx TKO neuron cultures seeded at a density of 
106 cells per 6 cm petridish were infected separately with lentiviruses 
for Cplx1-WT and Cplx1-K69A/Y70A at DIV 2. The infected neurons 
were harvested at DIV 14 and total protein concentration was 
estimated. 10 μg of sample from total lentiviral protein harvest of 56 
μg (Cplx1-WT) and 65 μg (Cplx1-K69A/Y70A) was used for the blot. 
(B) Regression analysis for standard curve and sample Cplx1 proteins. 
In comparison to the rCplx1 standard curve, 5 μg of total protein from 
wild type neurons contains 30.6 ng of Cplx1 protein, while 10 μg 
lentiviral protein from Cplx TKO + Cplx1-WT and Cplx TKO + Cplx1-
K69A/Y70A contained 25 ng and 24 ng of the respective Cplx1 
protein. Molecular weight of Cplx1 is 15.0 kDa. Calculations are shown 
in Table 20. 
 





Number of neurons Cplx1 











200,000 n.a. 30.6 ng in 5 μg of 
analyte (0.6% of 
total protein 
harvest) 




1,000,000 600,000 25 ng in 10 μg of 
analyte (0.25% of 
total protein 
harvest) 





1,000,000 600,000 24 ng in 10 μg 
analyte (0.24% of 
total protein 
harvest) 
10.4 pmol in 
600,000 neurons 
 
3.2.3.2. Cplx2 protein estimation 
 
Since Cplx2 is also prominently expressed in hippocampal neurons, I next calculated the 
protein concentrations of Cplx2-WT and Cplx2-K69A/Y70A in infected Cplx-TKO neurons in 
comparison to the endogenous levels of Cplx2 present in wild type hippocampal neurons. I 
used a standard curve of the recombinant Cplx2 protein for estimation of the protein 
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concentrations. Linear regression analysis and percentage of transduced cells yielded 
estimates that endogenous Cplx2 is present at 13 x 10-5 pmol in a wild-type neuron, while 
Cplx2-WT and Cplx2-K69A/Y70A proteins are expressed at 5.05 x 10-5 pmol and 15.03 x 10-5 
pmol respectively per transduced Cplx TKO neuron (Fig.33. and Table 21.). 
   
         33.A. 
                         
        33.B. 
                         
 
Figure 33.A.,B. Quantification of endogenous and lentiviral Cplx2   
protein expression. (A) Western blot performed for the standard  
curve of rCplx2 (70 ng, 65 ng. 60 ng, 55 ng, 50 ng, 45 ng, 40 ng, 35 ng). 
5 μg of sample protein from wild type neuronal extract of total 
concentration 60 μg was used for the blot. Cplx TKO neuron cultures 
seeded at a density of 106 cells per 6 cm petridish were infected 
separately with lentiviruses for Cplx2-WT and Cplx2-K69A/Y70A at 
DIV 2. The infected neurons were harvested at DIV 14 and total 
protein concentration was estimated. 10 μg of sample from total 
lentiviral protein harvest of 115 μg (Cplx2-WT) and 188 μg (Cplx2-
K69A/Y70A) was used for the blot. 10 μg of each of the infected 
samples was used for the blot. (B) Regression analysis for standard 
curve and sample Cplx2 proteins. In comparison to the rCplx2 





















standard curve, 5 μg of total protein from wild type neurons contains 
33.4 ng of Cplx2 protein, while 10 μg total protein from Cplx TKO + 
Cplx2-WT and Cplx TKO + Cplx2-K69A/Y70A contained 39.6 ng and 
72 ng of the respective Cplx2 protein. Molecular weight of Cplx1 is 
15.3 kDa. Calculations are shown in Table 21. 
 
















200,000 n.a.  33.4 ng in 5 μg 
Analyte (0.67% of 
total protein 
harvest) 




1,000,000 600,000 39.6 ng in 10 μg 
Analyte (0.4% of 
total protein 
harvest) 





1,000,000 600,000 72 ng in 10 μg 
Analyte (0.72% of 
total protein 
harvest) 
90.2 pmol in 
600,000 neurons 
 
3.2.3.3. Cplx3 protein estimation 
 
Cplx3 is faintly expressed in the hippocampus, but more distinctly expressed in the cortex. I 
next attempted to estimate the Cplx3 protein concentration in the cultured cortical neurons. 
However, there was no endogenous Cplx3 protein expression detectable (Fig.34.A). 
Therefore, I calculated the protein concentrations of Cplx3-WT infected Cplx-TKO neurons in 
comparison to the standard curve of the recombinant Cplx3 protein directly. Linear 
regression analysis and percentage of transduced cells yielded estimates that Cplx3-WT 
lentiviral protein is expressed at 0.875 x 10-5 pmol per transduced Cplx TKO neuron 
(Fig.34.B. and 34.C. and Table 22.). The lentiviral protein expression levels of Cplx3-
K79A/Y80A and Cplx3-C155S mutants will be ascertained in future experiments. 





                 34.A. 
                                      
 
Figure 34.A. Estimation of endogenous Cplx3 protein expression.  
Western blot performed for the standard curve of rCplx3 (35 ng, 30 
ng. 20 ng, 15 ng, 10 ng, 15 ng, 5 ng, and 1 ng). 25 μg and 50 μg of total 
protein from wild type cortical neuron lysate were also used for the 
blot. Cplx3 at its molecular weight of 17.6 kDa was undetectable. 
 
    34.B. 
                                        
    34.C. 
                                  













Figure 34.B.,C. Quantification of lentiviral Cplx3-WT protein expression.  
(B) Western blot performed for the standard curve of rCplx3 (35 ng, 
30 ng. 20 ng, 15 ng, 10 ng, 15 ng, 5 ng, and 1 ng. Cplx TKO neuron 
cultures seeded at a density of 106 cells per 6 cm petridish were 
infected with lentivirus for Cplx3-WT at DIV 2. The infected neurons 
were harvested at DIV 14 and total protein concentration was 
estimated. 5 μg and 10 μg of sample from total lentiviral protein 
harvest of 200 μg were used for the blot. (C) Regression analysis for 
standard curve and sample Cplx3 proteins. In comparison to the 
rCplx3 standard curve, 5 μg total protein contained 2.5 ng of Cplx3 
protein, while 10 μg total protein contained 5.13 ng of the Cplx3-WT 
protein. Molecular weight of Cplx1 is 17.6 kDa. Calculations are shown 
in Table 22. 
 
















1,000,000 650,000 2.5 ng in 5 μg 
Analyte (0.05% of 
total protein 
harvest) 




1,000,000 650,000 5.13 ng in 10 μg 
Analyte (0.05% of 
total protein 
harvest) 
5.83 pmol in 
650,000 neurons 
 
3.2.3.4. Cplx4 protein estimation 
 
Since Cplx4 is not expressed in the brain, I calculated the protein expression levels of Cplx4-
WT, Cplx4-K80A/Y81A and Cplx4-C157S infected Cplx-TKO neurons in comparison to the 
standard curve of the recombinant Cplx4 protein. Linear regression analysis and percentage 
of transduced cells yielded estimates that Cplx4-WT, Cplx4-K80A/Y81A and Cplx4-C157S are 
expressed at 0.876 x 10-5 pmol, 0.828 x 10-5 pmol, and 1.64 x 10-5 pmol per transduced Cplx 
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     35.B. 
                                   
 
Figure 35.A.,B. Quantification of lentiviral Cplx4 protein expression. (A) Western 
blot performed for the standard curve of rCplx4 (40 ng, 35 ng. 30 ng, 
25 ng, 20 ng, 15 ng, 10 ng, 5 ng). Cplx TKO neuron cultures seeded at a 
density of 106 cells per 6 cm petridish were infected separately with 
lentiviruses for Cplx4-WT, Cplx4-K79A/Y80A, and Cplx4-C157S at DIV 
2 - 10 μg, 15 μg and 5 μg of the respective proteins harvested at DIV 
14 was used for the blot. (B) Regression analysis for standard curve 
and sample Cplx4 proteins. In comparison to the rCplx4 standard 
curve, 10 μg Cplx TKO + Cplx4-WT, 15 μg Cplx TKO + Cplx4-
K80A/Y81A and 5 μg Cplx TKO + Cplx4-C157S contained 9.62 ng, 10.6 
ng and 12.3 ng of the respective Cplx4 proteins. Molecular weight of 











































1,000,000 600,000  9.62 ng in 10 μg 
Analyte (0.09% of 
total protein 
harvest) 





1,000,000 550,000 10.6 ng in 15 μg 
Analyte (0.07% of 
total protein 
harvest) 




1,000,000 850,000 12.3 ng in 5 μg 
Analyte (0.25% of 
total protein 
harvest) 
























4.   Discussion 
 
4.1.  Discussion - SNAP-29 
 
4.1.1.  SNAP-29 - localization and interactions with presynaptic SNAREs 
 
The expression of SNAP-29 in the cortex and hippocampus of the mouse brain is clearly 
indicative of the fact that SNAP-29 is present in neurons (Fig.12. and 16.), although it is 
unknown if its localization is limited only to a subset of synapses.  
 
The full length protein of SNAP-29 was found to share 17% sequence identity with SNAP-23 
and SNAP-25, with the highest homology existing among the coiled coil domains at the N- and 
C-terminus (Steegmaier et al., 1998). A significant variation in the structure of the SNAP-29 
protein is the complete absence of the conserved cysteine residue stretch that acts as a 
substrate for palmitoylation (Steegmaier et al., 1998). Palmitoylation is a post-translational 
modification that links C16-palmitate residues to the Cysteine residues via a covalent 
thioester bond and co-ordinates the protein sorting to membranes (Veit et al., 1996). Prior 
studies in mammalian cells demonstrated that newly synthesized wild type and non-
palmitoylated mutant SNAP-23 protein could efficiently interact with Syntaxin in-vivo and 
associate to membranes (Vogel and Roche, 1999). Similarly, pulse-chase experiments 
revealed that newly synthesized wild type and non-palmitoylated mutant SNAP-25 is 
localized to Golgi via interactions with the transmembrane domain of Synatxin-1A (Vogel et 
al., 2000). Mutations on the cysteine rich domain of SNAP-25 that prevent palmitoylation did 
not affect membrane association of SNAP-25 in the presence of Syntaxin, whereas non-
palmitoylated mutant SNAP-25 was diffusely distributed in the cytosol in the absence of 
Syntaxin (Washbourne et al., 2001). Interaction with Syntaxins was found to be sufficient for 
membrane association of SNAP-23 and SNAP-25 but palmitoylation likely dictates the precise 
intracellular localization of the proteins (Greaves et al., 2010). The SNAP-47 protein, similar 
to SNAP-29 lacks the palmitoylation site, but co-purifies with synaptic vesicles in subcellular 
fractionation of mouse whole brain homogenate, forms ternary SNARE complex with 
Syntaxin-1A and Synaptobrevin-2 and aids SNARE-mediated liposome fusion (Holt et al., 
2006).  
 
A biochemical study performed by Su et al. (2001) on rat brain homogenates showed that 
Syntaxin-1A was co-immunoprecipitated by anti-SNAP-29 antibodies, and GST-fused SNAP-
29 co-sedimented the native SNARE complex, alluding to a possible interaction between 
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SNAP-29 and the neuronal SNAREs. In-vitro binding assays and transfections in cultured 
mammalian cells revealed that GST-fused SNAP-29 interacts with numerous other Syntaxin 
paralogs such as Syntaxin-1A, -3, -4, -7, -13 and -17, which are present on plasma membrane, 
or intracellular organelles (Steegmaier et al., 1998; Hohenstein et al., 2001). Similarly, 
Drosophila SNAP-29 (also known as ubisnap) has been shown to interact with dSyntaxin-1 
and dSyntaxin-16 in co-immunoprecipitation experiments of cultured Schneider cells derived 
from Drosophila embryos (Xu et al., 2014). A recent study concluded that SNAP-29 exhibits 
high affinity interaction with Syntaxin-17 in-vitro to form a binary t-SNARE complex that is 
stabilized by ATG14 – an autophagy specific regulator promoting fusion of proteoliposomes 
(Diao et al., 2015).  
 
Immunocytochemical analysis of cultured hippocampal neurons previously showed extensive 
co-localization of SNAP-29 with the presynaptic marker Synaptophysin, and subcellular 
fractionation of rat brain synaptosomes revealed an enrichment of SNAP-29 in the synaptic 
vesicle and plasma membrane fractions (Su et al., 2001). In my study, the 
immunocytochemical experiment performed on cultured hippocampal neurons from WT 
mice showed a diffuse pattern of SNAP-29 expression in the soma, axons and dendrites, while 
the KO neurons exhibited a complete absence of SNAP-29 immunostaining (Fig.17.). 
Abundant SNAP-29 was previously found in actively myelinating oligodendrocytes, and 
Schwann cells with perinuclear enrichment on the endoplasmic reticulum (Schardt et al., 
2009). Therefore, the presence of SNAP-29 on the axons is reasonable. However, the absence 
of an endogenous palmitoylation site in SNAP-29 and likely weak interactions with Syntaxins 
may contribute to the diffuse distribution of SNAP-29 in the neuronal soma. Also, co-
localization of the presynaptic vesicle marker VGLUT-1 and SNAP-29 is not detectable at 
synapses of WT neurons. This result does not show an apparent preferential association of 
SNAP-29 to synaptic vesicles. However, confocal or STED imaging could give a better insight 
on the peripheral and subcellular localization of SNAP-29 at presynaptic terminals. 
Additionally, co-immunoprecipitation experiments and proteomic analysis could be 
performed to determine the interactions of neuronal SNAP-29 with other SNAREs, to confirm 
the proportion of the SNAP-29 protein associated to membranes as well as to organelles such 
as Golgi or endosomes, and assess if such subcellular targeting is indeed mediated by 





4.1.2.  SNAP-29 - no key role in synaptic vesicle exocytosis 
 
The proteins SNAP-25, SNAP-23 and SNAP-47 exert positive effect in synaptic vesicle fusion. 
Conversely, SNAP-29 has been shown to negatively modulate neurotransmitter release. 
Initial studies indicated that injection of a high concentration of exogenous SNAP-29 at 
cholinergic synapses of paired SCG neurons gradually reduced the EPSP amplitudes at 
frequencies of 0.05 Hz and 0.2 Hz (Su et al., 2001). Such activity dependent decline of release 
was attributed to inhibition of cis-SNARE disassembly post fusion, as SNAP-29 was found to 
compete with α-SNAP for SNARE binding, ultimately resulting in fewer SNAREs available for 
subsequent rounds of vesicle fusion (Su et al., 2001). A related study also ascribed the over-
expressed SNAP-29 to inhibit release in an activity dependent manner. Over-expression of 
SNAP-29 in cultured hippocampal neuron pairs did not affect evoked post-synaptic currents 
or short-term plasticity but reduced the synaptic vesicle-refilling rate after stimulation at 0.1 
Hz and 1 Hz (Pan et al., 2005). However, synaptic facilitation was observed upon siRNA 
mediated knockdown of endogenous SNAP-29 (Pan et al., 2005). Although the former study 
(Su et al., 2001) analyzed the effects of SNAP-29 over-expression, the contribution of 
endogenous SNAP-29 to synaptic release was neglected. A negative modulatory role for 
SNAP-29 was defined merely based on stimulation-frequency dependent effects, which 
cannot be considered as a sole parameter regulating synaptic release. The latter study (Pan et 
al., 20005) explored additional effects of diminished SNAP-29 expression on synaptic release, 
and concluded that down-regulation of SNAP-29 caused initial facilitation of the EPSC 
amplitudes, increased recovery rate after high-frequency stimulation, and consequently 
enhanced synaptic vesicle turnover. However, the slower synaptic depression or high initial 
facilitation are indicators of lower initial vesicular release probability at the synapse, and the 
effect of SNAP-29 knockdown on the number of release-ready vesicles, and the vesicular 
release probability were unaccounted for in the experiment.  
 
The objectives of my study overrules the disadvantages of the previous studies for various 
reasons: 1) The present study deals with the measurement of synaptic output from an 
“autaptic” cultured neuron, which comprises of a homogenous population of synapses, 
whereas previous studies measured cumulative synaptic release from a varied population of 
synapses existing between multiple neurons. Synapses between different neurons have a 
high degree of variability in terms of vesicle pool and the release probability. Therefore, using 
a well-defined model such as autaptic neurons limits the discrepancies that arise due to 
synaptic variability. 2) The present study involves systematic analysis of various synaptic 
parameters such as single AP-evoked Ca2+-dependent release at low-frequency stimulations, 
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Ca2+-independent release of the primed vesicle pool at the presynaptic terminal (measured 
by application of hypertonic sucrose solution), short-term synaptic plasticity under high-
frequency stimulations, the release probability, the quantal release and its dependence on 
residual Ca2+. This type of analysis provides a comprehensive assessment of synaptic 
functionality. 3) The study utilizes both conditional and constitutive gene knockout animals. 
In this manner, non-specific off-target effects of knockdown approaches or proteins 
generated by incomplete knockdown are circumvented. The parallel use of conditional gene 
knockout circumvents compensatory processes that might arise in the course of constitutive 
gene knockout. 
 
In my study, I found that conditional deletion of SNAP-29 from glutamatergic synapses did 
not significantly alter the AP-evoked Ca2+-triggered release, the readily releasable vesicle 
pool size, or vesicular release probability indicating that SNAP-29 does not contribute to 
vesicle priming or fusion at synapses. The synapses lacking SNAP-29 depressed to a similar 
extent as those containing SNAP-29 under high-frequency stimulations of 10 Hz and 40 Hz. 
This parameter also reflected the high yet unaltered vesicular release probability at the 
synapses devoid of SNAP-29. The quantal release measured after high-frequency stimulations 
showed a residual Ca2+-dependent increase of release events that was relatively similar at 
both WT and KO synapses. These results clearly indicate that SNAP-29 is not required for 
vesicle recovery after depletion. Thus, SNAP-29 does not play a role in modulating Ca2+-
dependent and Ca2+-independent release, at glutamatergic synapses. Although the results 
from the conditional KO are convincing, effects of residual protein expression at these 
synapses could not be accounted for in this data set. Similarly, the role of SNAP-29 at 
GABAergic synapses, which are also abundant in the CNS, could not be studied in the 
conditional KO model used here. In the constitutive SNAP-29 KO, I found no alterations in the 
expression levels of the Syntaxin-1AB, Synaptobrevin-2, SNAP-25, SNAP-23 and SNAP-47 in 
SNAP-29 KO brains (Fig.16.). Therefore, compensatory effects in synaptic transmission due to 
up-regulation of other SNARE proteins are unlikely. Also, I found no significant differences in 
the various synaptic parameters tested, such as peak amplitudes of evoked post-synaptic 
currents, readily releasable primed vesicle pool size, vesicular release probability, or quantal 
release at glutamatergic and GABAergic synapses between the WT and KO. Both synapse 
types exhibited normal short-term synaptic depression indicative of high vesicular release 
probability.  
 
The intact synaptic transmission at synapses devoid of SNAP-29 offers a few rational cues. 
The neuronal SNARE complex, which is essential for mediating vesicle fusion comprises 
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primarily of Syntaxin-1, Synaptobrevin-2 and SNAP-25. These proteins form the four-helical 
bundle essential for vesicle fusion (Fasshauer et al., 1998). The intrinsic stability of the four-
helical bundle is partially due to high affinity interactions between the SNARE motifs of the 
three proteins. Many studies have shown that loss of one of the SNARE proteins severely 
impedes the vesicle fusion process at central synapses.  
 
SNAP-25 deletion causes a dramatic decline in evoked transmitter release, size of the RRP, 
which is also indicated by the decreased number of membrane attached vesicles in 
hippocampal synapses (Bronk et al., 2007; Imig et al., 2014). A small reduction in 
spontaneous release of cultured hippocampal neurons of the SNAP-25 null mutants was 
observable, but all synaptic parameters could be restored upon lentiviral expression of SNAP-
25a, SNAP-25b, and SNAP-23, albeit to variable degrees of significance (Delgado-Martinez et 
al., 2007). Considering the fact that the SNAP-25 null mutant neurons still express 
endogenous SNAP-29, the role of SNAP-29 in synaptic transmission might be minor, which 
agrees with my findings. One cannot presume that the expression of SNAP-29 in cultured 
neurons may be negligible because in my study, expression of SNAP-29 is evident in cultured 
hippocampal neurons (Fig.12.B.). Although SNAP-29 has been shown to interact with 
multiple Syntaxins in in-vitro assays and to also co-sediment the native neuronal SNARE 
complex (Su et al., 2001), the innate interaction between SNAP-29 and the neuronal SNAREs 
could be limited due to low-affinity binding of SNAP-29 and the SNAREs. Such weak affinity 
can be justified due to substantial variations in the sequence and structure of SNAP-29 
compared with SNAP-25. Although the lentiviral expression of SNAP-23 in SNAP-25 null 
mutants predominantly caused asynchronous release, expression of SNAP-23 along with the 
presence of endogenous SNAP-25 did not alter the transmitter release kinetics, indicating a 
preferential use of SNAP-25 for maintenance of synchronous neurotransmission (Delgado-
Martinez et al., 2007). Furthermore, no dramatic synaptic deficits or changes in release 
kinetics were observed in the absence of SNAP-29 in my study.  
 
Thus, it can be concluded that the cognate neuronal SNARE proteins - Syntaxin-1 and 
Synaptobrevin-2 ‘preferentially’ bind SNAP-25 to form the neuronal SNARE core complex and 
mediate subsequent release in neurons, while the binding of SNAP-29 to these SNAREs is 
likely minimal and therefore, SNAP-29 is not required for neurotransmitter release at 




4.1.3.  SNAP-29 - clinical implications due to loss of function  
 
Human patients suffering from the CEDNIK syndrome - a disease characterized by 
neuropathy, ichthyosis, and palmoplantar keratoderma - were found to have a frameshift 
mutation at nucleotide G at SNAP-29 cDNA position 220 leading to premature termination of 
the coding sequence and a severely truncated protein product (Sprecher et al., 2005). A 
similar keratoderma phenotype was observed in the constitutive SNAP-29 KO mice, which is 
likely caused by abnormal lamellar granule maturation in the epidermis and secretion and 
retention of non-hydrolyzed glucosylceramide, resulting in decreased desquamation or 
separation of cells (Sprecher et al., 2005). The SNAP-29 KO mice were susceptible to perinatal 
lethality, which is an apparent clinical consequence of SNAP-29 deletion. CEDNIK syndrome 
patients exhibit severe psychomotor retardation or neuropathy; absence of tendon reflexes 
and macular atrophy were further substantiated by low amplitude responses in peripheral 
nerve conductance studies (Sprecher et al., 2005). Although deficits in synaptic transmission 
at the central synapses can be excluded as a plausible cause for perinatal lethality in SNAP-29 
KO mice, they may suffer due to severe deficits in the functioning of the peripheral nervous 




















4.2.  Discussion - Complexins 
 
4.2.1. Mammalian Complexins improve the release efficacy of vesicles via 
binding to the neuronal SNARE complex 
 
The Complexin family of proteins has distinctively evolved as neuron-specific regulators of 
the synaptic vesicle fusion machinery in higher eukaryotes with nervous systems (Brose, 
2008). The small size and polar charge of Complexins makes them ideal candidates that 
mediate the cardinal process of transmitter release between neurons via a cascade of robust 
protein-protein interactions. In the literature, substantial evidence exists on the positive 
modulatory role of Complexins in synaptic vesicle fusion and release in mouse neurons (Reim 
et al., 2001, Reim et al., 2005; Xue et al., 2007, Xue et al., 2008). Many studies in-vitro, on 
invertebrate models, and in mice using different techniques have also revealed an inhibitory 
role of Complexins in vesicle fusion, confounding the preexisting notions.  
 
In the present study, I have first attempted to comprehend the role of Complexins in 
mediating synchronous release of vesicles. Genetic loss of Cplx1 and Cplx2 in new-born mice 
(Cplx DKO) caused massive perturbations in synaptic neurotransmitter release that were 
apparent as reductions in amplitudes of evoked post-synaptic currents, vesicular release 
probability and apparent Ca2+ sensitivity of neurotransmitter release (Reim et al., 2001). 
Individual loss of Cplx3 had no effects on transmitter release at hippocampal glutamatergic 
and GABAergic synapses (Xue et al., 2008), and Cplx TKO neurons lacking Cplx1, Cplx2 and 
Cplx3 exhibited similar profound deficits in synaptic transmission as the Cplx DKO neurons, 
which I could corroborate as the preliminary findings in my study (Fig.24.).  Cplx TKO 
neurons exhibited highly significant reductions in the Ca2+-triggered EPSC amplitudes and the 
release probability of primed vesicles at their synapses, implying that Complexin facilitates 
release upon influx of Ca2+. Previously, it was shown that loss of Complexins selectively 
reduced the synchronous phase of release but did not cause any alterations in the 
asynchronous release of vesicles (Reim et al., 2001). This finding raised doubts if the 
asynchronous release in neurons is indeed totally independent of Complexins.  
 
The EPSC charge evoked by an action potential can be plotted as a cumulative integral that 
delineates the synchronous and asynchronous phases of release, both of which are dependent 
on Ca2+, albeit with different affinity (Goda and Stevens, 1994). In my study, I found that 
Complexin loss leads to a decreased synchronous component of the EPSC, when compared 
with cells expressing endogenous Cplx1. However, the asynchronous component of release is 
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unaltered. Next, I investigated the cause for the presence of asynchronous release at similar 
levels in both Cplx CTRL and TKO neurons. For this purpose, I used the slow-Ca2+ chelating 
buffer EGTA-AM, which reduces asynchronous release but does not alter synchronous release 
in neurons. Prolonged exogenous application of EGTA-AM reduced the asynchronous 
component in Cplx CTRL neurons but not in the Cplx TKO neurons. Although EGTA-AM may 
still chelate the residual Ca2+ in the terminal and prevent release of the so called 
‘asynchronous pool’ of vesicles in the Cplx TKO neurons, it is obvious that the vesicles that 
belong to the synchronous pool are likely ‘desynchronized’ due to the absence of Complexins. 
Thus, it can be inferred that vesicles from the synchronous pool in the Cplx CTRL neurons 
contributed to the asynchronous component of release in the Cplx TKO neurons.  
 
An important factor that could affect the vesicle release process is the stability of the SNARE 
complex. The core complex formed by SNAP-25, Syntaxin-1 and Synaptobrevin-2 is a 
thermodynamically stable four helical bundle that brings the vesicles in close proximity to 
the presynaptic plasma membrane (Fasshauer et al., 1998). Loss of one of the SNARE 
components dramatically affects Ca2+-triggered exocytosis of synaptic vesicles. Individual 
deletions of the SNAP-25 and Synaptobrevin-2 proteins severely reduced amplitudes of the 
evoked EPSCs and the size of the RRP at the presynaptic active zone (Bronk et al., 2007; Deak 
et al., 2006). These findings imply that in the absence of SNARE components, the SNARE core 
complex required for maintenance of the primed pool of vesicles is disrupted leading to 
severe deficits in the number of primed vesicles competent for fusion and the magnitude of 
Ca2+-evoked transmitter release. The innately stable SNARE complex comprises of the four 
helices contributed by the SNARE components, connected by (leucine) zipper like layers with 
strong hydrophobic interactions between amino acids at the centre of the bundle (Pabst et al., 
2000).  It has been shown that Complexin binds in an anti-parallel orientation within the 
Syntaxin-Synaptobrevin groove of the SNARE complex, and this binding propagates the 
preassembled SNARE complex to a metastable state while reducing steric repulsions between 
the apposing membranes (Chen et al., 2002). Such an assembly is likely a prerequisite for 
greater release efficacy of the highly-fusogenic vesicles awaiting the action potential trigger 
and Ca2+ influx. 
 
Major interactions were found between the central α-helical domain of Complexins and the 
Syntaxin-Synaptobrevin motifs exposed within the groove of the helical bundle. Of particular 
interest are the residues lysine (K) at position 69 and tyrosine (Y) at position 70 on the Cplx1 
(also conserved at the same positions in Cplx2) central α-helix that interact via a salt bridge 
and a hydrogen bond, respectively with an aspartate residue (D) at position 218 of Syntaxin 
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(Chen et al., 2002). Disruption of this interaction due to alanine point mutations 
(K69A/Y70A) abolished Cplx1 binding to the SNARE complex in co-sedimentation assays 
(Xue et al., 2007). Also, SFV-mediated over-expression of Cplx1-K69A/Y70A in the Cplx DKO 
neurons did not rescue the deficits in release (Xue et al., 2007), while expression of a single 
allele of wild type Cplx1, could efficiently mediate transmitter release in response to 
increases in the cytosolic Ca2+ concentration. Another attractive candidate target on the Cplx3 
and Cplx4 sequence is the ‘CAAX’ motif at the C-terminal end, which is required for 
farnesylation (attachment of a 15-Carbon moiety to the translated protein) and targeting to 
membranes in-vivo (Reim et al., 2005). Point mutation of cysteine to serine (Cplx3-C155S, 
Cplx4-C157S) completely eliminated membrane association of the proteins. Thus, the 
presence of multiple paralogs of mammalian Complexins is intriguing in terms of their 
requirement at central synapses. Furthermore, the conservation of the lysine-tyrosine amino 
acid duo among all known Cplx homologs and the unique requirement of the CAAX motif on 
Cplx3 and Cplx4 led to further speculation on the functional role of these residues, and the 
effects of stable long-term expression of the Complexin mutants in the Cplx TKO neurons. 
 
In parallel to the present study, co-sedimentation assays were performed by my supervisor, 
Dr. K. Reim, who used with GST-fused full-length Complexin constructs and mouse brain 
homogenates to determine SNARE complex binding. Strong binding of Cplx1 and Cplx2 wild 
type constructs with the SNARE complex components Syntaxin-1, SNAP-25 and 
Synaptobrevin-2 was evident, while minimal binding of Cplx3-WT to the cognate SNAREs was 
still observable but hardly any binding was detectable in case of Cplx4 (Appendix 6.2.). It 
could be thus inferred that Complexins found in the brain have a higher binding affinity to the 
neuronal SNARE core components. However, alanine point mutations on the central α-helix 
of full-length Cplx1 (K69A/Y70A), Cplx2 (K69A/Y70A), Cplx3 (K79A/Y80A) and Cplx4 
(K80A/Y81A) abolished the apparent SNARE complex binding of the respective constructs. 
Point mutation of the CAAX motif on Cplx3 (C155S) did not alter its binding to the SNARE 
complex. Hence, the mutants and the respective wild type constructs were expressed in the 
Cplx TKO neurons to obtain an insight on their functional role in transmitter release.  
 
Reintroduction of the Complexin wild type paralogs - Cplx1, Cplx2, Cplx3 and Cplx4 - in the 
Cplx TKO neurons could rescue the deficit in AP-evoked release, vesicular release probability, 
synchronicity of release and short-term plasticity (Fig.26.E. and 26.F.). It is interesting to note 
that all Cplx paralogs can significantly rescue the peak amplitudes of EPSCs in the Cplx TKO 
neurons, but Cplx1 and Cplx2 seem to have a higher efficacy in restoring the synchronicity of 
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release in the TKO neurons when compared with Cplx3 and Cplx4 (Fig.26.B.). These facts 
corroborate the different affinities of the Complexin paralogs to the SNARE complex.  
 
Similar to earlier findings, lentiviral expression of mutant Complexins devoid of a functional 
SNARE binding domain (Cplx1-K69A/Y70A, Cplx2-K69A/Y70A, Cplx3-K79A/Y80A and 
Cplx4-K80A/Y81A) in the Cplx TKO neurons could not rescue the Ca2+-evoked release, 
vesicular release probability, synchronicity of release and short-term plasticity. It is 
important to note that although endogenous Cplx3 can still bind the neuronal SNARE 
complex with lower affinity when compared with Cplx1 and Cplx2, lentiviral expression of 
wild type Cplx3 at levels far above the endogenous Cplx3 accentuates its rescue efficacy 
(Fig.29. and 34.A.). The presence of a functional farnesylation motif on the over-expressed 
wild type Cplx3 increases its local concentration once targeted to membranes (Reim et al., 
2005), and this in turn, likely promotes the binding of Cplx3 to more SNARE complexes and 
efficiently supports vesicle fusion. This claim is also justified by the finding that the SNARE 
binding domain mutant Cplx3-K79A/Y80A, albeit possessing an intact farnesylation site, is 
unable to rescue the synaptic deficits in the TKO neurons. Comparably, the lack of a 
functional farnesylation site on Cplx3 (C155S), while not affecting the SNARE binding of 
Cplx3 due to the presence of its functional central α-helical domain (Appendix 6.2), is 
expected to abolish the increased local concentration of the proteins at the membranes, and 
the resultant cytosolic Cplx3 protein is expected to act less efficiently due to its low SNARE 
complex binding affinity. These predictions are met by my observation that Cplx3 (C155S) is 
much less efficacious in rescuing the synaptic defects in Cplx TKO neurons than wild type 
Cplx3 (Fig.29.). Similarly, wild type Cplx4 does not show an apparent binding to the neuronal 
SNARE complex, but it possesses the ability to partially rescue the synaptic deficits in the 
Cplx TKO neurons unlike its SNARE binding domain mutant Cplx4-K80A/Y81A or its 
farnesylation mutant Cplx4-C157S (Fig.30.). A plausible explanation for this result is that 
Cplx4 may still bind the neuronal SNARE complex with very low affinity, undetectable by 
standard biochemical methods. Analogous to Cplx3, farnesylation of the translated Cplx4 
protein product targets it to the membranes (Reim et al., 2005), which would increase its 
local concentration and support binding to the SNARE complex in a more physiological 
environment within neurons.  
 
In summation, the biochemical and physiological data clearly define that mammalian wild 
type Complexins play a significant positive role in facilitating and synchronizing Ca2+-
triggered release. Farnesylation of Cplx3 and Cplx4 likely increases their local concentration 
at synapses and this bypasses their rather low SNARE complex binding affinity.  
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4.2.2.  Mammalian Complexins act on a fusion-competent vesicle  
pool in glutamatergic autapses. 
 
A recent ultrastructural study showed that the number of membrane tethered and membrane 
attached (docked) vesicles at the presynaptic active zone in hippocampal synapses of Cplx 
CTRL and Cplx TKO was unaltered (Imig et al., 2014). By the application of a hyperosmotic 
sucrose (500 mM) solution, the RRP of vesicles at the presynaptic terminal is completely 
depleted. The RRP is measured as the total charge of the transient synaptic current released 
during this Ca2+-independent process (Rosenmund and Stevens, 1996). The RRP size was 
unaltered irrespective of whether and which Complexins were expressed. In correlation with 
the morphological data from EM studies and the functional data, it can be inferred that 
Complexins do not play an essential role in docking or priming of vesicles at the active zone. 
Xue et al. (2007) have shown that a significant reduction in the fraction of pool released and 
response onset latency was apparent at submaximal osmotic concentrations (250 mM 
Sucrose). This finding led to the conclusion that Complexin binding to the SNARE complex is 
required for lowering the energy required for fusion and increasing the propensity of vesicles 
to fuse, i.e. that Complexins act to increase the fusogenicity of vesicles. 
 
Apart from exhibiting an increased spontaneous release rate, shRNA mediated knockdown of 
Complexins in cultured cortical neurons show an apparent reduction in RRP size, which has 
been attributed to a priming defect (Kaeser-Woo et al., 2012). One may argue that the 
increased spontaneous release or ‘an unclamping effect’ in the absence of Complexins may 
cause a consistent depletion of the RRP, although the spontaneous release rates in the 
absence of Complexins are unlikely to deplete the RRP. Further, the clamping and priming 
functions are separable in the Complexin knockdown neurons. It has been shown that 
introducing a Complexin ‘poorclamp’ mutant (K26E/L41K/E47K) in the knockdown neurons 
does in fact restore the pool size to wild type levels indicating that an RRP of vesicles can still 
be present in Complexin knockdown neurons if Complexin is otherwise functional (Yang et 
al., 2010). It is obvious that the low Ca2+-evoked release at knockdown synapses implies an 
inherent defect in the vesicle fusogenicity in the absence of Complexins. It is likely that the 
highly fusogenic or ‘superprimed’ state of vesicles (Maximov et al., 2009) is unstable due to 
the acute loss of Complexins and thus the propensity of vesicles to fuse is decreased likely, 
causing a lower fraction of vesicles to be released even if a normal RRP is present. Another 
line of argument that could raise suspicions regarding the notion of changed RRP in the 
Complexin knockdown synapses concerns the methodology of application of the 
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hyperosmotic sucrose (500 mM) solution. Hypertonic sucrose unlike the intermediate 
concentration (250 mM), when applied to neurons using our fast perfusion system 
immediately floods the synaptic terminals to release all vesicles at the Cplx TKO synapses 
(Xue et al., 2008). However, the knockdown studies have invariably used a ‘picospritzer’ for 
sucrose application, which provides a point-source-like way of application, so that the target 
neurons likely receive a gradient of sucrose concentrations. In summary, I would argue based 
on my results and the arguments outlined above that Complexins are not involved in vesicle 
priming and RRP maintenance.  
 
4.2.3. Mammalian Complexins do not ‘clamp’ vesicle fusion at glutamatergic 
synapses. 
 
In the present study, the spontaneous release in the Cplx TKO neurons, measured by blocking 
action potentials, was reduced to a small extent. It is interesting to note that the frequency of 
spontaneous release (mEPSC) events is not significantly altered in Cplx TKO neurons 
expressing the Complexin SNARE binding domain mutants and farnesylation mutants when 
compared with neurons expressing the respective wild type Complexins, indicating that 
spontaneous vesicle fusion can occur independently of Complexin binding to the SNARE 
complex. This leads to the conclusion that a functional or functionally redundant Complexin 
does not necessarily have an effect on the spontaneous release in the neurons. In my study, I 
have shown that the preassembled SNARE complex in the presence of other SNARE co-factors 
but without Complexins does possess an intrinsic ability to catalyze fusion, albeit less 
synchronously. Thus, it is possible that the partially zippered SNARE complex, which is highly 
stable and protected at its central layers (Chen et al., 2002), is able to cause spontaneous 
fusion of vesicles in a probabilistic fashion, occurring on a prolonged time scale.  
 
It is surprising to note the stark differences between spontaneous release observed in 
Complexin knockout neurons and knockdown neurons. Both autaptic and mass cultures of 
hippocampal neurons from Cplx TKO mice showed hardly any changes in spontaneous 
release. However, shRNA mediated Complexin knockdown caused a strong increase in 
spontaneous release in cultured cortical neurons. Lentiviral expression of Complexin carrying 
a ‘4M’ (R48/R59/K69/Y70) alanine mutations, which abolishes SNARE complex binding in 
the knockdown neurons, behaved like an ‘unclamping Complexin’, exhibiting extremely high 
rates of spontaneous release, while point mutations on the Synaptobrevin-2 motif (Syb-2 3A) 
phenocopied the Complexin knockdown (Maximov et al., 2009). In this case, it was shown 
that Complexin binding to the SNARE complex is essential for its clamping function. High or 
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low extracellular Ca2+ does not cause the increase in mini-frequency seen upon Complexin 
perturbation (Yang et al., 2010), and it is unlikely that the neuron culture technique 
employed may cause such a dramatic phenotype, because mass cultured and autaptic 
hippocampal neurons of Cplx TKO mice exhibit similar phenotypes. Developmental 
compensation by the maturing synapses has been considered as a plausible cause of the lack 
of effects on spontaneous release in the constitutive Complexin knockout neurons (reviewed 
by Melia, 2007). On the other hand, it is possible that there may be off-target effects of the 
shRNA mediated knockdown in neurons, which leads to defects in the endogenous miRNA 
processing (Fineberg et al., 2009; Baek et al., 2014) and subsequent gene dysregulation. This 
might, in turn, cause an up-regulation or down-regulation of protein function and thus, 
incongruities in synaptic function.  
 
4.2.4. Mode of Complexin function – Synaptotagmin interaction in transmitter 
release 
 
My study sheds new light on the mode of action of Complexins along the molecular pathway 
governing synaptic vesicle exocytosis. All mammalian Complexins are facilitators of the 
synaptic vesicle fusion and act at a late-step of Ca2+-dependent vesicle fusion. Primed vesicles 
release synchronously in the presence of Complexins. Although previous studies have shown 
that the N-terminus of Complexins is essential for facilitating release (Xue et al., 2010), in 
order achieve synchronicity of release, the intact function of the central α-helical domain is 
essential in all Complexin paralogs. With the unique motif for post-translational 
farnesylation, the Cplx3 and Cplx4 are targeted to membranes and thus, are likely present at 
high local concentrations to bind SNARE complexes and catalyze efficient fusion.  
 
With respect to Cplx3 and Cplx4, both the farnesylation motif and the SNARE binding motif 
are indispensable for their function. The Complexins likely operate in the synaptic vesicle 
fusion pathway by initially binding to the partially assembled SNARE complex, stabilizing it to 
a metastable state wherein the vesicle is highly fusogenic or superprimed, and aiding the 
complete zippering of the SNARE complex by reducing the energy barrier of membrane 
fusion. It is easy to envision that this action, coupled with the arrival of a Ca2+ trigger and 
Synaptotagmin binding to the SNAREs, causes the apposing membranes of the vesicle and the 
presynapse to fuse, resulting in neurotransmitter release.   
 
In my study, I have attempted to contribute to the dissection of the molecular mechanisms of 
interaction of the primary Ca2+-sensor Syt-1 and Complexin in the synaptic vesicle release 
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process. Syt-1 is anchored to the vesicle membrane and most studies imply that loss of Syt-1 
almost completely eliminates synchronous vesicle fusion in neurons (Geppert et al., 1994; 
Nishiki and Augustine, 2004). In such a scenario, it is important to note that endogenous 
Complexins are unable to facilitate synchronous fusion in the absence of Syt-1. However, 
genetic deletion of Cplx1 and Cplx2 from Syt-1 KO animals reduced the mainly asynchronous 
transmitter release elicited in the Syt-1 KO neurons even further (Xue et al., 2010), showing 
that Complexins can indeed mediate some vesicle fusion independently of Syt-1. My data 
corroborate these findings in an interesting way. The total charge of EPSCs elicited in the 
absence of Complexins (Cplx TKO) is approximately 77% of the EPSC charge elicited by 
synchronous release in the presence of Complexins (Cplx CTRL) (Fig.25.A. and 25.B.).  
Correspondingly, the data I have acquired with exogenous application of EGTA-AM indicate 
that despite the presence of endogenous Syt-1 in the Cplx TKO neurons, the synchronous 




Figure 36. Complexin and molecular pathway of synaptic vesicle release. 
Munc18 binds to the closed conformation of Syntaxin-1 and the N-
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peptide of Syntaxin-1A, after which various proteins, such as SNAP-25, 
Munc13, Syntaxin-1, Munc18, assemble to form the SNARE acceptor 
complex. As the synaptic vesicle approaches the active zone, it is 
docked to the membrane by the four-helical bundle formed by the 
SNARE core components. This process is supported by priming 
proteins, such as Munc13s, and CAPSs. Thereafter, Complexin binds to 
the preassembled SNARE complex with a high affinity via its central α-
helical domain and maintains the SNARE complex in a ‘metastable 
state’ so that the vesicles are highly fusogenic (Superprimed). Upon 
arrival of a Ca2+-trigger, the vesicles fuse by the co-operative action of 
Complexin and Synaptotagmin. Complexin binding to the SNARE 
complex improves the release efficacy. (Adapted and modified from 
Jahn and Fasshauer, 2012).  
 
This observation is in nice correlation with the fact the Complexin and Syt-1 both co-
operatively function in synchronizing vesicle release at synapses. Single vesicle content 
mixing assays have shown that cooperative action of Syt-1 and Ca2+ are the main thrust for 
fusion pore expansion, while Complexin is involved in pore formation and more robustly at 
the early stages of fusion-pore expansion (Lai et al., 2013). Also, ITC and TIRF microscopy 
based studies have shown that Cplx1 and a fragment of Syt-1 containing the C2AB domains 
can simultaneously bind to membrane-anchored SNARE complexes, and that full length Cplx1 
binds more tightly to the membrane anchored SNARE complex and is not displaced by Syt-1 
(Xu et al., 2013). Therefore, it can be interpreted that in-vivo Syt-1 is likely required for 
maintaining the speed of synchronous Ca2+-dependent vesicle fusion, while Complexins are 
required to maintain the number of highly fusogenic vesicles via SNARE interaction, and thus 





















5.  Summary and Perspectives 
 
5.1.  Summary and Perspectives - SNAP-29 
 
SNAP-29 belongs to the SNAP-25 family of proteins and shares about 17% sequence identity 
with SNAP-25, the major neuronal SNARE protein. Early studies claimed that over-expression 
of SNAP-29 negatively modulates neurotransmission in SCG neurons by inhibiting SNARE 
disassembly post vesicle fusion, however, the role of endogenous SNAP-29 was neglected. In 
the present study, it is clear the conditional knockout of SNAP-29 from the forebrain 
glutamatergic neurons caused no obvious changes in synaptic parameters measured such as 
EPSC amplitudes, RRP size, vesicular release probability, and miniature release, when 
compared with wild-type littermate neurons. Similarly, constitutive knockout of SNAP-29 
also caused no significant alterations in the synaptic parameters at both glutamatergic and 
GABAergic neurons, however, the new-born mice suffered from a keratoderma phenotype 
and were susceptible to perinatal lethality. Although synaptic deficits can be excluded as a 
possible cause for lethality, loss of the ubiquitously expressed SNAP-29 may have adverse 
effects on other secretory pathways. 
 
Loss of SNAP-25 in neurons leads to dramatic deficits in synaptic parameters such evoked 
EPSC amplitudes, RRP size but the miniature spontaneous release was not severely affected. 
These results led to claims that endogenous SNAP-29 may play a role in mediating 
spontaneous fusion in the SNAP-25 null mutant neurons. However, loss of SNAP-29 does not 
cause any significant changes in spontaneous vesicle fusion, which may be compensated by 
the presence of endogenous SNAP-25. It would be interesting to test the SNAP-29 KO in the 
background of the SNAP-25 KO (SNAP-25/SNAP-29 DKO) to ascertain the effects of loss of 
both the proteins and to test the efficacy of transmitter release by individually reintroducing 













5.2.  Summary and Perspectives  - Complexins 
 
Complexins are small, highly charged proteins involved in the process of synaptic 
neurotransmitter release. Four mammalian Complexins paralogs Cplx1, Cplx2, Cplx3 and 
Cplx4 exist, of which Cplx1, Cplx2 and low levels of Cplx3 are expressed in the brain, while 
Cplx3 and Cplx4 are prominently expressed in the retina. Cplx1 and Cplx2 share 84% 
sequence identity while Cplx3 and Cplx4 share 58% sequence identity. All the paralogs have a 
conserved central α-helical domain that is essential for binding to the SNARE complex during 
the synaptic transmitter release process. Cplx3 and Cplx4 have a unique CAAX motif at their 
C-terminal end, which farnesylates the translated proteins and targets them to membranes. 
In the present study, genetic deletion of Cplx1, Cplx2 and Cplx3 (Cplx TKO) from the mouse 
brain impairs neurotransmitter release. Synaptic parameters such as evoked EPSC 
amplitudes, vesicular release probability, synchronous release and short-term plasticity are 
profoundly diminished in the Cplx TKO glutamatergic neurons. Lentiviral expression of wild 
type Cplx1, Cplx2, Cplx3 and Cplx4 in neurons can rescue the synaptic deficits and improve 
transmitter release significantly, but to variable extents. It is corroborated by their variable 
affinities to SNARE complex binding. Cplx1 and Cplx2 bind to the neuronal SNARE complex 
with high affinity, while Cplx3 binds with comparatively lower affinity and Cplx4 does not 
show any detectable binding to the neuronal SNARE complex. Point mutations on the central 
α-helical SNARE binding domain of Complexins abolished binding to the SNARE complex. 
None of the SNARE binding domain mutant Complexins could rescue the synaptic deficits in 
the Cplx TKO neurons. Point mutation on the CAAX motif of Cplx3 and Cplx4 was shown 
previously to abolish protein targeting to membranes and the farnesylation mutant Cplx3 and 
Cplx4 could also not rescue the synaptic deficits in the Cplx TKO neurons. Thus, it can be 
concluded that wild type Complexins can efficiently mediate synchronous neurotransmission 
in neurons. Intact functional central α-helix on Complexins is essential for binding to the 
SNARE complex. The farnesylation of Cplx3 and Cplx4 increases their local concentration at 
membranes and circumvents their low SNARE binding affinity, which facilitates transmitter 
release.  
 
Complexins are essential for fast Ca2+-triggered synchronous release in neurons, and their 
absence leads to a two-fold reduction in the apparent Ca2+ sensitivity of release. Exogenous 
application of tens of millimolar of Ca2+ could simply bypass this phenotype (Reim et al., 
2001; Xue et al., 2008). However, extracellular Ca2+ in the range of tens of millimoles is not an 
optimal physiological measure to determine the efficacy and kinetics of evoked transmitter 
release, which occurs on a time scale of a few milliseconds sustained by very low 
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intraterminal Ca2+ concentrations. Experiments on uncaging-Ca2+ at the presynaptic terminals 
by UV-flash photolysis have shown that intracellular Ca2+ concentration in the range of a few 
hundred nanamolar is sufficient to trigger efficient transmitter release (Burgalossi et al., 
2012). Therefore, it would be ideal to perform photolysis of caged-Ca2+ by UV-flash on Cplx-
control and Cplx-TKO neurons to determine the exact amounts of Ca2+ diffusing into the 
terminal causing simultaneous release. Assessment of the kinetics of release will give a clear 
picture about the fusogenicity of primed vesicles at the synapse in the presence and absence 
of Complexins. This experiment will provide new insights on the molecular mechanisms 
underlying synaptic release mediated by the SNARE-complex bound Complexin in response 

































6.  Appendix 
 
6.1.  Genetic deletion of SNAP-29 in mice 
 
Exon 2 (E2) of the SNAP-29 gene was flanked by two LoxP sites on a target vector. Cre-
mediated recombination to delete E2 was driven by crossing the floxed-mice with mice 
expressing cre-recombinase under the Nex promoter (Nex-cre mice, Goebbels et al., 2006), 
resulting in a conditional knockout of SNAP-29, or with mice expressing cre-recombinase 
under the adenovirus EIIa promoter, resulting in a constitutive knockout of SNAP-29 (as 
shown below). 
 
Targeted SNAP-29 allele: 
 
 
                 
 
















                  (Data from Dr. Kerstin Reim) 
 
Mouse brain homogenates from Cplx1 WT and Cplx1 KO animals were used for co-
sedimentation assays to determine the binding affinities of various Complexins to the SNARE 
complex. Full-length constructs for Cplx1, Cplx2, Cplx3 and Cplx4 were used as wild type, 
carrying double point mutations on the lysine (K) and tyrosine (Y) residues in the respective 
SNARE binding domains. Point mutation of the Cysteine residue on the farnesylation domains 
(CAAX motif) of Cplx3 and Cplx4 was also used in the study. In the Cplx1 WT sample, SNARE 
binding of Cplx1-WT, Cplx2-WT and Cplx3-WT (at higher exposure times) is detectable. In the 
Cplx1 KO sample, binding of Cplx1-WT and Cplx2-WT to the cognate SNAREs is detectable at 
lower exposures, whereas binding of Cplx3-WT and Cplx3-C155S mutant (with an intact 
SNARE binding domain) is detectable at higher exposures. SNARE binding of Cplx4-WT is 
undetectable irrespective of the exposure times. Mutation of the SNARE binding domain on 
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